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Abstract 
Malaria is a leading cause of morbidity and mortality worldwide, and results in 
approximately 600,000 deaths annually. The life cycle of the parasite is complex, and has 
several distinct stages of development. The transitions between these stages are brought 
about through tightly controlled and highly synchronized changes in gene expression. 
Plasmodium falciparum causes the most lethal form of malaria in humans. The parasite is 
particularly virulent as it is able to evade immune detection by the infected host. This 
virulence is directly related to the expression of variable antigens on the surface of infected 
red blood cells. The control of gene expression is known to be largely regulated via RNA 
Polymerase II (RNAPII) transcription initiation, but in P. falciparum the underlying 
mechanisms have not been determined. This primarily because very little is known about 
both the key protein factors and DNA elements which guide the assembly of RNAPII 
components into the transcription initiation complex. Bioinformatics studies have shown 
that there is very little amino acid sequence conservation between human and Plasmodium 
RNAPII transcription initiation components. Together with the observation that the 
Plasmodium genome has an extremely high A+T content, this suggests that Plasmodium 
may have specific mechanisms to initiate transcription, which could be targeted by novel 
anti-malarials. The general transcription factor TFIIB and the TBP-like protein (TLP) are 
key proteins involved in the recognition of the core promoter, and the initiation of RNAPII 
transcription initiation complex assembly. TFIIB stabilises DNA binding of the primary 
promoter recognition factor, TATA-box binding protein (TBP), and is involved in promoter 
recognition through interactions with specific DNA sequences up- and downstream of the 
TBP DNA binding site. TBP-like protein is a member of the TBP protein family that has 
been implicated in life cycle stage specific gene transcription initiation in various eukaryotic 
model organisms. This research study reports the first successful expression and purification 
of recombinant epitope-tagged Plasmodium falciparum TFIIB and TLP proteins. 
Preliminary assays demonstrate DNA-binding activity for the recombinant Plasmodium 
TBP-like protein, and suggest DNA-binding activity in Plasmodium TFIIB protein, which 
has not been demonstrated before in eukaryotic TFIIB. 
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 Plasmodium falciparum 
1.1.1 The impact of Plasmodium infection 
Malaria is a leading cause of morbidity and mortality across the globe (World Health 
Organisation 2014). Approximately 40% of the world population live in malaria endemic 
areas. In 2013 malaria resulted in about 200 million infections, and approximately six 
hundred thousand deaths. The vast majority of infections (~80%) occur in Africa, with ~90% 
of the deaths occurring on this continent, the majority of which are children under the age of 
five years. Malaria in humans is caused by four species of Plasmodium. These include P. 
malariae, P. vivax, P. ovale, and as the cause of cases with the highest rates of complications 
and death, Plasmodium falciparum.  
1.1.2 Life cycle of Plasmodium falciparum  
Plasmodium falciparum is an alveolate protist, of the group apicomplexa. Apicomplexans 
consist of single-celled eukaryotic organisms, many of which are parasitic to both 
invertebrates and vertebrates, leading to a host of diseases. As a group, the apicomplexans 
typically have multi-stage lifecycles, and with variable morphologies as they inhabit their 
multiple species-specific hosts (Neva & Brown 1994).  
Plasmodium falciparum infects the female Anopheles gambiae mosquito and the human 
host. In taking up a blood meal from an infected human host, the mosquito takes up male 
and female gametocytes. Within the mosquito midgut, the male-derived micro- and female 
gametocyte-derived macrogametes of the parasite fuse to form a zygote (entering into the 
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sporogenic cycle), which proceeds to form the ookinete. The ookinete passes through the gut 
wall, and encysts on the exterior wall of the gut to form the oocyst. The oocyst eventually 
ruptures, and releases sporozoites into the mosquito body cavity. The sporozoites then travel 
to the mosquito salivary glands.  
The sporozoites are released into bloodstream of the human host when the mosquito next 
feeds (the exo-erythrocytic cycle). The sporozoites then rapidly invade the hepatocytes of 
the liver. For P. falciparum, in the next 6-9 days the sporozoites develop into trophozoites, 
and then undergo multiple rounds of nuclear division forming a schizont, a single cell 
containing multiple nuclei without cell segmentation. After several rounds of nuclear 
division, the cell segments to form thousands of merozoites. Note that in P. vivax, the 
sporozoites may instead differentiate into hypnozoites, which may lie dormant in the liver, 
and are the cause of recurrent bouts of malaria (Karunaweera et al. 1992). Several tens of 
thousands of merozoites may be released from a bursting hepatocyte, and then individually 
invade red blood cells (erythrocytes; RBCs) entering the erythrocytic cycle (Cowman & 
Crabb 2006). Symptoms typically appear 7 – 14 days post sporozoite inoculation. In order 
to infect the erythrocytes, P. falciparum parasites recognise and bind to the erythrocyte 
surface receptors, for example, the sialoglycoproteins, glycophorins A and B. The parasites 
bind to glycophorin surface receptors with glycophorin-binding proteins (GBPs) via tandem 
binding repeats present on the GBP surface (Perkins 1984; Cowman & Crabb 2006). Having 
bound to the RBC, the parasite invades the target cell and resides within the parasitophorous 
vacuole.  
Chapter 1 Introduction 
3 
Figure 1: Overview of the erythrocytic-stage life cycle of Plasmodium falciparum 
A. Life cycle of P. falciparum. Main stages of development are indicated.
B. Stages of the erythrocytic cycle of P. falciparum. Approximate time post-inoculation for the stages
of development are indicated.
Illustrations are referenced from microscopy images of infected erythrocytes (White 2008; Alano
2007). 




In the erythrocytes, the merozoites differentiate into the (immature) trophozoites. This is 
often called the ‘ring’ stage due to the morphology seen on a blood smear (Neva & Brown 
1994). This is a highly metabolic stage, where the trophozoite enlarges for the next 12 hours, 
ingesting the erythrocyte cytoplasm and proteolysing the host haemoglobin (Francis et al. 
1997). The mature trophozoites then differentiate further into a schizont. The schizonts 
produce a large number of merozoites (32 nuclei per schizont). The released merozoites then 
invade additional erythrocytes (Neva & Brown 1994).  
Note that during the early erythrocytic stage (approximately 6 hours post-erythrocyte 
infection) some merozoites may differentiate into male and female gametocytes. These 
gametocytes reside within the erythrocytes until taken up again by the mosquito vector, and 
so complete the life cycle (Alano 2007). The mechanisms behind the commitment to sexual 
reproduction are unknown (Winzeler 2009).  
The erythrocytic stage of the Plasmodium falciparum occurs over approximately 48 hours, 
from invasion to the bursting of the infected erythrocyte. The development into the ring stage 
occurs approximately 6 hours post-erythrocyte infection, the trophozoites mature at 
approximately 24 hours, the schizont forms at approximately 40 hours (Neva & Brown 
1994).  
1.1.3 Pathology of Plasmodium falciparum 
The symptoms of malaria caused by P. falciparum differ from malaria caused by other 
Plasmodium species. As with all malaria infections, classic symptoms include paroxysm, a 
cyclical onset of sudden coldness followed by fever and sweating (Greenberg & Lobel 
1990). Typically, paroxysms occur synchronously with the merozoite release in the 
intraerythrocytic stages. In P. vivax/ovale infections, this occurs every two days, and every 
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three days for P. malariae. P. falciparum infection may not have the classic paroxysms, and 
instead exhibit a continuous fever (Neva & Brown 1994).  
In the determination of the severity of falciparum malarial infection, a primary determinant 
is the expression of proteins which are exported to the surface of infected erythrocytes, 
(Miller et al. 2013). The proteins expressed include the knob-associated histidine rich protein 
(KAHRP) and  P. falciparum erythrocyte membrane protein 2 and 3 (PfEMP2, PfEMP3), 
which form a layer directly beneath the cell membrane, inducing a protruding ‘knob’ in the 
area by interacting with the host cellular structures and proteins (Lanzer et al. 1993). KAHRP 
proteins act as a platform for the presentation of the P. falciparum erythrocyte membrane 
protein 1 (PfEMP1). This presentation of knobs and associated structures are a primary 
determinant of cytoadherence and severe malaria (Lanzer et al. 1993). The knobs cause 
infected red blood cells (iRBCs) to cytoadhere both to one another as well as other cells. 
Cytoadherence of iRBCs to non-infected RBCs as well as endothelial and other intravascular 
cells of the body prevents the clearance of the iRBCs by the spleen, and facilitates the 
positioning of infected cells to regions of optimum parasite growth (Buffet et al. 2010). 
These infected cells become sequestered in the micro-vascular structures of organs such as 
the heart, lungs and brain, and placenta, separate from peripheral blood circulation (Khoury 
et al. 2014). The consequence of this accumulation and sequestration of cells in organs is the 
onset of severe disease state of the human host, such as cerebral malaria, the outcome of 
which may be fatal comas and seizures (Buffet et al. 2010).  
PfEMP1 is encoded by the highly variable (var) genes. P. falciparum possess approximately 
60 var genes, although only one is expressed at any one time (Guizetti & Scherf 2013). P. 
falciparum infections are detected by the host immune system when the parasites are in free 
peripheral circulation, and through the detection of iRBCs by the antigenic PfEMP1 variants. 
The mechanism of switching the var genes allow the parasite to evade immune attack by the 




host, preventing long-term immunity and so persist as a chronic infection (Bachmann et al. 
2012). 
The control of gene expression is not only required for the parasite to alter the erythrocyte 
displayed antigens rapidly, rather the complex life cycle of P. falciparum as a whole requires 
strictly controlled and co-ordinated changes in gene expression. Clearly, understanding of 
the molecular mechanisms underlying the control of gene expression will be a prerequisite 
to fully understand Plasmodium biology and the molecular basis of Plasmodium 
pathogenesis. 
1.1.4 The Plasmodium genome 
The genome of P. falciparum was published in 2002 (Gardner et al. 2002). This has allowed 
remarkable insight into the parasite, and it is hoped that insights from this resource will drive 
the knowledge of this parasite forward, not only in facilitating investigations into potential 
treatments and vaccines, but also into understanding the physiology and pathology of the 
organism. The P. falciparum genome contains up to 27 million bases, is separated into 14 
chromosomes and expresses approximately 5500 genes (Florens et al. 2002).  
An interesting feature of the P. falciparum genome is its adenine and thymine nucleotide (A 
+ T) richness,  with A + T contributing to an average of 80 -90% of the genome (Gardner et 
al. 2002). Other Plasmodium species do not have this degree of A+T richness, it being the 
highest A+T content of any genome sequenced. Several theories have been posited to explain 
the A+T content, including that the high levels of A+T richness may allow for rapid 
evolution and recombination, and so allow for increased immune system evasion. Due to the 
A+T richness it was found that protein sequences have diverged so extremely that they 
complicate the association of protein identity to hypothetical proteins. Of the ~5300 proteins 
predicted to be encoded by the genome, 60% do not have sufficient similarity to proteins in 




other organisms to imply function/identity. This is likely due to the A+T-richness of the 
genome, and consequentially, the suite of codons available for use.  
Proteins in the P. falciparum genome are heavily populated with low complexity regions 
(Zilversmit, Volkman, DePristo, et al. 2010). It has been found that the P. falciparum 
proteome is richer in low complexity regions (LCRs) than other organisms studied, with at 
least one LCR present in 87% of genes. Other organisms average between 65-70% of genes 
having LCRs. These LCRs also fall into different classes, which may have effects on their 
function and rate of evolution. There are multiple theories about the function of LCRs. LCRs 
may be an adaptive mechanism to adjust translation rates (Frugier et al. 2010), may be a 
method of regulating messenger ribonucleic acid (mRNA) stability, may be involved in 
generating antigenic diversity through recombination, or may simply be the result of 
increased recombination rates due to the A+T rich genome, discussed by Zilversmit et al. 
(2010). 
1.1.5 Gene expression in Plasmodium falciparum 
There is evidence to support regulation of gene expression at various levels (reviewed in, 
Horrocks et al. 2009) including gene activation, post-transcriptional regulation, as well as 
epigenetic regulation.  
Evidence for gene expression regulation arising from control of gene transcription has been 
shown in whole-genome/proteome studies (Florens et al. 2002; Bozdech, Llinás, et al. 2003). 
These studies making use of both microarray and proteomic data, and support a model of 
expression of genes in a life cycle stage-dependent manner, in which transcription of genes 
is tuned temporally for the physiological processes that are likely to occur at that stage of 
development. There is some evidence that this ‘just in time model’ needs revision (Horrocks 
et al. 2009). For example, it has been found that changes in the environment, such as the 




stresses endured by temperature changes or glucose starvation, result in global expression 
changes.  This suggests that the parasite is not locked into a specific pattern of gene 
expression (Horrocks et al. 2009). Further studies have also shown a lag between changes in 
mRNA transcript and protein levels, as well as a life cycle stage-specific rate of controlled 
mRNA decay, with increasing mRNA stability across the 48 hour erythrocytic cycle (Shock 
et al. 2007). Similarly, it has been found that the parasite also produces different sets of 
ribosomal RNAs (rRNAs) depending on life cycle stage, which is likely to be an additional 
level of translational control (Gardner et al. 2002). Altogether there is evidence now that 
there is a deeper level of transcriptional control than the ‘just in time’ model would suggest, 
and will remain the focus of future research. 
The presence of LCRs maybe an additional mechanism used by the organism to regulate 
translation rate (Frugier et al. 2010). Other organisms may adjust translation rates by altering 
the codons in a gene to make use of more or less abundant transfer RNAs (tRNAs), and so 
either speed up or slow translation, but P. falciparum only has one copy of each tRNA-
coding gene, suggesting equal numbers of the tRNAs, and so the loss of this method of 
translational regulation. Instead, by over-utilising a set of tRNAs in an LCR, the translational 
rate of the region is likely to reduce, and so allow more time for folding of complex 
secondary structures, such as the alignment of β-strands to form β-sheets (Frugier et al. 
2010). 
There has been a focus on regulation of transcription through epigenetics, due to the 
identification of multiple chromatin remodelling proteins (Coulson et al. 2004). Chromatin 
structure affects gene expression through either allowing the activation of genes through 
increasing the accessibility to them, or silencing gene expression through silencing of the 
region. A partial explanation for the stage-specific gene expression seen previously (Florens 
et al. 2002), is that genes of a shared process may be closely located on the chromosomes, 




and so share activation by chromatin remodelling. Multiple studies investigating histone 
modifications have been performed, reviewed in (Hoeijmakers et al. 2012; Guizetti & Scherf 
2013; Cui & Miao 2010).  
Control of gene expression in P. falciparum at the transcriptional level is supported by the 
presence of features common to other eukaryotes, as found in early studies (Lanzer et al. 
1992a; Lanzer et al. 1992b; Horrocks et al. 1998; Lanzer et al. 1993). Similar to model 
eukaryotes, transcription is regulated through a bipartite promoter system, consisting of (i) 
a core promoter region at which RNA polymerase II (RNAPII) forms the pre-initiation 
complex (PIC) with the general transcription factors (GTFs) and drives transcription from 
the transcription start site (TSS). Additional regulatory regions control the activity of the 
core promoter region, including (ii) cis-acting regulatory elements, to which additional 
specific transcription factors (TFs) may bind. Analogous to other model organisms, the 
binding of these cis-acting regulatory elements by positive or negative regulators may either 
support or inhibit the formation of the PIC, and so are correlated with the activity of the 
promoter and the accumulation of mRNA (Horrocks et al. 2009). Transcription of P. 
falciparum genes typically results in monocistronic transcripts which contain intronic and 
exonic regions, conserved splicing sites (and machinery) as well as 5’ and 3’ untranslated 
regions (UTRs), which are themselves modified by capping and polyadenylation, 
respectively (Horrocks et al. 2009).  
The formation of the PIC as the key step in transcriptional gene control made it a target for 
finding the Plasmodium protein orthologues involved. The key components of the PIC 
machinery were identified by hidden Markov model profile searching in the P. falciparum 
genome (Bischoff & Vaquero 2010). This search uncovered orthologues of RNAPII and 
most, but not all, GTFs. These include the TATA binding protein (TBP) and some of the 
other components of the transcription factor IID (TFIID) system, the TBP-associated factors 




(TAFs). So far, only TAFs 1, 2, and 7 could be identified in P. falciparum. By contrast 
metazoans possess at least 13 TAFs. The search also uncovered orthologues for the 
transcription factors (TFII-) A, B, E, F, and H, and the TBP homologue TBP-like protein 
(Bischoff & Vaquero 2010). Interestingly, the TAFs that have not been found (excepting 
TAF5) all have histone-fold domains. Similarly, the histone H1, which also contains this 
motif, is absent in P. falciparum. Identification of other transcription-associated proteins 
resulted in only approximately 1.3% of the proteins uncovered, about one third of the number 
found in other free-living eukaryotes (Coulson et al. 2004). This has led to the suggestion 
that control of gene expression may arise predominantly from post-transcriptional and 
epigenetic regulatory mechanisms.  
The A+T richness of the Plasmodium genome may be partly responsible for the paucity of 
transcription factors found by bioinformatics approaches, due to low sequence homology of 
Plasmodium genes to other protists. Of the proteins which have been putatively identified as 
being involved in transcriptional regulation, very few have been fully characterised, either 
in vitro or in vivo. The Plasmodium Apicomplexan AP2 (ApiAP2) factors are a group of 
transcription factors common to the apicomplexan group, which have been studied in vitro 
through EMSA and protein-binding microarray assays. Five of the ApiAP2 factors have also 
been characterised in vivo. These include factors involved in the function of sporozoites 
(Yuda et al. 2010), the expression of invasion related genes, var gene silencing, and two 
factors important for gametocytogenesis (De Silva et al. 2008; Painter et al. 2011; Sinha et 
al. 2014). Two other transcription factors have been partly characterised, the PfMyb1 protein 
which binds to several promoters and controls the expression of the associated genes (Gissot 
et al. 2005), and the PREB protein, which has been shown to bind and activate gene 
expression at the Pf1-cys-prx cis-element (Komaki-Yasuda et al. 2013).  




Locating cis-acting recognition elements, as well as the sequences for the core promoter has 
been particularly challenging, in part due to the A+T content of the genome (~90% 
intergenic), but also due to technical challenges in the mapping of TSSs (Wakaguri et al. 
2009; Horrocks et al. 2009; Brick et al. 2008).  Several studies have attempted to identify 
these regions through bioinformatics (Young et al. 2008; Jurgelenaite et al. 2009; Brick et 
al. 2008), however, the sequences obtained sometimes conflict, and without biochemical 
investigation cannot be confirmed.  
Although several of the general transcription factors and RNAPII have been identified in 
silico, there is still very little information available regarding the function of this crucial 
transcription apparatus. Without this information the understanding of transcriptional 
regulation in Plasmodium, as well as understanding of the characteristics of the unique 
genome cannot be uncovered.  
1.1.6 The RNA polymerase II pre-initiation complex 
The following description of the formation of the PIC and the components thereof are 
thoroughly reviewed in Thomas & Chiang, (2006). The formation of the PIC occurs at the 
core promoter region surrounding the TSS (designated as +1 on the sense strand) Figure 2B. 
These core promoter elements have been identified in other eukaryotes, such as humans and 
yeast (Decker & Hinton 2013). They include the TATA box, a conserved region of sequence 
TATAWAAR (in metazoans), which is occasionally present in the core promoter, 25-30 
nucleotides upstream of the TSS, and to which TBP binds. In metazoans and yeast, the PIC 
is nucleated by the binding of TBP, as part of the TFIID complex, to the core promoter 
region. The binding of the TFIID protein-complex is an induced fit mechanism, where the 
binding of DNA by TBP and insertion of the conserved phenylalanine residues leads to 
bending of the DNA, causing torsional stress on the DNA as well as a conformational shift 
in the TFIID complex itself (Cianfrocco & Nogales 2013). The PIC then forms in a step-




wise fashion. The binding of TFIIA stabilises TBP-DNA binding, and competes with 
proteins which inhibit TBP DNA-binding and/or function (Kokubo et al. 1998; Grünberg & 
Hahn 2013). TFIIB binds next, and enhances TBP binding to the TATA box (Zhao & Herr 
2002; Imbalzano et al. 1994). TFIIB then assists in the recruitment of TFIIF and RNAPII 
(Chen & Hampsey 2004; Kostrewa et al. 2009; Bushnell et al. 2004; Tubon et al. 2004), and 
Figure 2: Simplified model of the core promoter and RNA polymerase II pre-initiation complex 
(PIC) assembly. 
A. The PIC is initiated by (i) the binding of TBP as part of the TFIID complex (not shown) to the 
TATA-box (pink region) which causes a bend in the DNA. (ii) TFIIA and TFIIB bind to TBP and 
stabilise the association to DNA, and to recruit (iii) RNAPII and the rest of the GTFs. The DNA 
around the transcription start site is melted and transcription is initiated. 
B.  A simplified illustration of gene regulatory regions present in eukaryotes. The core promoter 
contains the transcription start site (TSS) and core promoter elements, such as the TATA box 
(recognised by TBP) and B-recognition elements up- (u) and downstream (d) of TATA, recognised 
by TFIIB. PIC assembly at the core promoter is regulated by proximal and distal (enhancer) promoter 
regions that contain binding sites for sequence-specific DNA-binding transcription activator or 
repressor proteins. 




finally TFIIE and TFIIH. The binding of additional GTFs causes the DNA to melt, promoter 
opening, and transcription to occur (Figure 2A). The TATA box is not ubiquitous in the core 
promoter, and other core promoter elements may be present, both in tandem with TATA, or 
without (Thomas & Chiang 2006). The combination of core promoter elements differ 
between genes, and none have been found to be indispensable, although some combinations 
do occur more frequently than others.  
The core promoter may contain an initiator (Inr) sequence, which surrounds the TSS, and is 
bound by TAFs 1/2, a downstream promoter element (DPE) 28-34 nucleotides downstream 
of the TSS (in Drosophila) bound by TAFs 6/9 (Thomas & Chiang 2006). There may also 
be a motif ten element (MTE, at +18 to +29) which functions in tandem with the Inr region, 
and may substitute for a missing TATA box and/or DPE (in conjunction with the Inr region). 
The downstream core element (DCE) is present (as three sub-elements at +6 to +11, +16 to 
+21, and +30 to +34) but mutually exclusive with the DPE (located at +23 to +34) interact 
with TAFs 1 and 6 respectively (Thomas & Chiang 2006). TFIIB stabilises the TBP-DNA 
interaction through the recognition of elements in the core promoter, the B-recognition 
elements up and downstream of the TATA box (BREu and BREd, -38 to -32 and -23 to -17 
respectively, in yeast) (Lagrange et al. 1998; Deng & Roberts 2005). The presence or 
absence of these BREs also selects for the mutually exclusive recruitment of either TFIIA or 
NC2 (respectively) (Deng et al. 2009).  
1.1.1 The general transcription factors 
TFIID 
TFIID is a multi-protein complex, composed of TBP and the TAFs. TBP is the predominant 
DNA-binding component of TFIID and recognises the TATA-box (in core promoters with 




this element) while the TAFs recognise other core promoter elements, (Thomas & Chiang 
2006; Juven-Gershon et al. 2008).  
TBP (and its homologues/orthologues) consist of a very highly-conserved carboxyl- (C-) 
terminal domain, with a large and variable amino- (N-) terminal domain, to which no 
structure has been prescribed (Akhtar & Veenstra 2011). The C-terminal domain, or core 
domain, is responsible for DNA binding. The core is saddle-shaped, with a concave and 
positively charged surface which makes contact with the DNA, while the convex surface 
makes contact with other proteins/factors (Figure 3). The functional role of the variable N-
terminal is not well characterised. Early in vitro studies suggested that the domain is required 
for TATA-dependent transcription, (Lescure et al. 1994), although others have shown no 
loss of cell-growth or transcription in mice with homozygous deletions of the N-terminus 
(Schmidt et al. 2003). In mice, the loss of the N-terminus has only been shown to lead to 
rejection of implanted embryos in females, while males were seemingly unaffected (Hobbs 
Figure 3: Tertiary structure of human TATA-box binding protein (core region). 
Concave region formed by β-sheets (orange) which interact with DNA. Phenylalanine residues 
highlighted in red. Convex region formed by α-helices in purple. Structure model shown was 
prepared using PyMol based on the PDB entry 1CDW (Nikolov et al. 1996). 
 




et al. 2002). The expansion of the glutamine repeats in the region leads to spino-cerebellar 
ataxia in humans (van Roon-Mom et al. 2005), although the mechanism is not understood.  
P. falciparum TBP (PfTBP) was cloned before the bioinformatics identification of the 
general transcription factors (McAndrew et al. 1993), but has only been partially 
characterised thus far in a single study (Ruvalcaba-Salazar et al. 2005). In this study, the 
core region of PfTBP was recombinantly expressed and N-terminally tagged with 
glutathione-S-transferase (GST). The DNA-binding sites of the protein was examined by 
electrophoretic mobility shift assay (EMSA) and DNase I foot printing assay to the kahrp 
and gbp-130 genes.  This study was successful in mapping the PfTBP binding to TATA-like 
sequences upstream of the TSS, at -81 and -186 nucleotides upstream from the TSS of the 
kharp and gbp-130 genes respectively. This conservation of the TATA-locality of TBP 
binding is remarkable, given the A+T rich genome, and the prevalence of cryptic TATA-
like elements. Interestingly, Brick et al. (2008) suggest the presence of physiochemical 
signals in the region of the TSS, identified computationally, may be used to identify the core-
promoter elements. 
TBP-related factors. 
Although TBP is the most studied of the proteins in the family, there exist several TBP-
related factors (TRFs), reviewed extensively by Akhtar & Veenstra (2011).  
The discovery of TRFs at different times and in different organisms, with different numbers 
of TRFs, and combined with difficulty in establishing homology of these TRFs, has led a 
fair amount of confusion in the naming of the TRFs. The first TRF was discovered in 
Drosophila, and was named TRF1. This TRF1 is not found in vertebrates. Metazoans may 
have another TRF, in Drosophila named TRF2, as it is in humans, but may alternately be 
named the TBP-related protein (TRP) or TBP-like factor (TLF) or the TBP-like protein 




(TLP) or TBP-like protein 1 (TBPL1). TLP is the name of the orthologue that will be referred 
to in this thesis. Another TRF is present in vertebrates, named alternately TBP2 or TRF3, or 
TBPL2 (Zhang et al. 2001).  
The functional roles of the TRFs are less well characterised than TBP. It has been suggested 
that the role of the TRFs is to provide an additional method of gene transcriptional regulation. 
In this model TBP-like protein of TFIID is switched for TBP and allows expression from 
tissue specific promoters (Hochheimer & Tjian 2003).  
TBP2 is the most similar of the TRFs, with ~90% similarity between the human paralogs 
over the core domain. TBP2 is known to be able to associate to the TATA box, and may 
replace TBP at certain genes (Bartfai et al. 2004; Jallow et al. 2004). For example, TBP2 of 
Xenopus laevis has been shown to be expressed predominantly in the oocytes, as an 
alternative to TBP (Akhtar & Veenstra 2009). TBP2 in mice gametogenesis appears to 
complement TBP, seemingly activating alternative genes to TBP (Gazdag et al. 2007). TRF1 
from Drosophila appears to function predominantly with RNA polymerase III transcription 
(Akhtar & Veenstra 2011). 
TLP is a more distant paralogue to TBP and TBP2 (Akhtar & Veenstra 2011), with lower 
genetic similarity than the relationship between TBP2 and TBP (over the core domain). It 
has not been demonstrated to have affinity for the TATA box (Moore et al. 1999), however 
TLP does appear to be able to bind both TFIIA and TFIIB, as well as the TFIIA-like factor 
(ALF). TLP has been shown to act as both a transcriptional inhibitor as well as an activator, 
(Moore et al. 1999). Interestingly, in a study of the TATA-less promoter of deoxynucleotidyl 
transferase, an insertion of a TATA-element removed the ability of TLP to activate 
transcription, (T. Ohbayashi et al. 2003). A dependence on TLP by some embryogenesis 
genes, complementary to TBP, has been seen in TLP knockouts of X. laevis, (Veenstra et al. 




2000). Similar results have been seen for embryogenesis in C. elegans, (Dantonel et al. 
2000). Knockdown studies in mice have shown that TLP does not appear to have a role in 
embryogenesis, but is important for spermatogenesis (Martianov et al. 2001). In these 
knockout mice, females had no phenotype and were fertile, while males were unable to 
complete sperm production, due to inhibition of the elongation of the spermatids.  
In the identification of GTFs in P. falciparum, a candidate gene named TFIID-like was 
found, (Bischoff & Vaquero 2010) (accession number PF3D7_1428800.2 on PlasmoDB, 
www.plasmodb.org). In Plasmodium there appears to be only a single TBP-like protein 
(hereafter referred to as Plasmodium falciparum TLP or PfTLP). This protein has not been 
characterised thus far, but may hold an intriguing avenue of exploration for the 
characterisation of transcription initiation. Notably, and similarly to other TLPs described 
thus far, proteomic and transcriptomic data suggests upregulation of the PfTLP gene/protein 
during the sexual development stages, such as gametocytogenesis (Aurrecoechea et al. 
2009). This is in contrast to PfTBP expression which appears to be either downregulated or 
expressed at lower levels than PfTLP during these stages. Should PfTLP be involved in the 
transcription of specific genes, this may provide interesting and possibly useful insights into 
transcription initiation, and potentially future drug targets. 
TFIIB 
TFIIB is has been implicated in many aspects of transcription, both in the initiation as well 
as in the elongation of the RNA strand (Kostrewa et al. 2009). As TBP induces a dramatic 
bend in the DNA, TFIIB binds to TBP and strengthens the association of the complex to 
DNA through its interactions with the BREu and BREd regions up- and downstream of the 
TATA box. TFIIB also recruits RNAPII, and assists in the identification of the transcription 
start site (Imbalzano et al. 1994; Zhao & Herr 2002; Nikolov et al. 1995; Lagrange et al. 
1998; Chen & Hahn 2004; Chen & Hahn 2003; Kostrewa et al. 2009).  




Structurally, TFIIB is composed of an N-terminal region which binds and directs RNAPII 
to the TSS (Figure 4; Tubon et al. 2004; Kostrewa et al. 2009). The region in the N-terminus, 
which binds to RNAPII has been termed the B-ribbon, and consists of a zinc-finger domain 
which is conserved in eukaryotic and archaeal bacterial TFIIB proteins (Qureshi & Jackson 
1998; Gietl et al. 2014). Adjacent to the B-ribbon is the B-reader which contains a helix-
loop structure, thought to assist in the localisation of RNAPII to the TSS, through the 
identification of Inr sequence motifs.  
The N-terminal region also regulates transcription through a highly conserved region 
consisting of multiple charged residues, called the charged cluster domain. TFIIB may exist 
in either a closed state, where intramolecular interactions between the N and C terminals 
appear to prevent transcription initiation (but not the formation of the PIC), or the open state 
where initiation is possible (Elsby & Roberts 2004; Glossop et al. 2004; Zhang et al. 2000).  
The C-terminal or core domain of the TFIIB molecule is composed of two cyclin-like 
repeats, made up of 5 α-helices, and connected by a linker region which contains an 
 
Figure 4: Tertiary structure of TFIIB. 
The structure of the N-terminus of ScTFIIB (left, (Kostrewa et al. 2009)) is composed of a zinc-finger 
domain, a B-ribbon made up of anti-parallel β-sheets (orange), the B-reader composed of an α-helix 
(purple) and a loop region, and the B-linker composed of a β-strand and α-helix. The C-terminal cyclin-
like repeats of human TFIIB (right, (Nikolov et al. 1995)) are each composed of four amphipathic α-
helices surrounding a core α-helix, separated by a linker region.  
Structure models shown were prepared using PyMol based on PDB entries 3K1F.M (Kostreva et al. 
2009) and 1VOL (Nicolov et al. 1995). 
 




additional α-helix (Figure 4). This linker region has been shown to form a cleft, into which 
TBP binds to TFIIB, while the α-helix region interacts with and stimulates the activity of 
RNAPII (Xin Liu, David A. Bushnell, Dong Wang, Guillermo Calero 2010; Tsai & Sigler 
2000; Nikolov et al. 1995).  
TFIIB is theorised to be involved in the transition between initiation and elongation of 
transcription (Kostrewa et al. 2009). TFIIB assists TBP in the melting of the DNA, opening 
a bubble in the DNA and exposing this DNA to RNAPII. Whilst bound to RNAPII after the 
formation of the DNA bubble, the B-linker is then located in a position to stabilise the 
transcription bubble, while the B-reader is able to locate the Inr, and localise RNAPII to the 
TSS. The RNA-strand grows as a DNA-RNA hybrid, and after growth beyond seven 
nucleotides, TFIIB is released and the elongation complex is formed (promoter escape).  
The identification of GTFs in P. falciparum led to identification of  a TFIIB orthologue 
(Bischoff & Vaquero 2010). Given the importance of TFIIB in the formation of the PIC, 
through interactions with various GTFs and RNAPII, the characterisation of the molecule is 
predicted to be fundamentally important for the characterisation of transcriptional initiation 
in the parasite. 
 The aims of this study 
Currently, a major focus of the work in the research group is to identify the DNA sequences 
which direct the formation of the pre-initiation complex, and so direct transcription in 
Plasmodium falciparum. Studies which have utilised bioinformatics approaches to identify 
TSSs to map and predict promoter regions and regulatory sequences have yielded largely 
inconclusive results due to the A+T-richness of the P. falciparum genome.  
In the formation of the PIC, the P. falciparum GTFs must localise to the gene promoter 
regions. It may, therefore, be assumed that by characterising the binding specificity of GTFs 




specifically that of PfTBP/PfTLP in conjunction with PfTFIIB and PfTFIIA, will provide an 
important starting point to identifying P. falciparum promoter regions, and subsequently the 
mechanisms behind P. falciparum transcriptional regulation. 
Currently, the expression and characterisation of PfTBP and PfTFIIA are being investigated 
by another student in the research group (Robert Milton). TFIIB is known to be important 
for promoter recognition, discussed above, through the identification of the BREs. The 
possibility that PfTFIIB performs a similar role in P. falciparum promoters must be 
investigated. Additionally, the potential of PfTLP to regulate gene expression as an 
alternative to PfTBP at certain genes, and hence, recognise alternative promoter sequences 
to PfTBP is a possibility that must be explored. Canonically, TBP is known to bind to the 
TATA-box with high affinity. It is the focus of this research group to answer the question of 
how the P. falciparum TBP orthologue is able to recognise a TATA-box, in a veritable sea 
of A+T. 
The specific aims of this research project were to investigate whether epitope-tagged 
PfTFIIB and PfTLP can be expressed in a soluble form in E. coli BL21-CodonPlus RIL cells 
and, if so, optimise expression conditions for maximal yield. Establish the affinity-
purification of PfTFIIB and PfTLP. Finally to establish an investigation into the potential 
DNA-binding properties of PfTFIIB and PfTLP.  
The aims of this research project form part of current research activities in the lab, that aim 
to make use of recombinant P. falciparum GTFs to determine the sites of PIC assembly, both 
in previously characterised putative P. falciparum promoters, and through a systematic 
evolution of ligands by exponential enrichment (SELEX) strategy (Ogawa & Biggin 2012).  





Materials and Methods 
 Bioinformatics analysis of protein structure and function  
2.1.1 Multiple sequence alignments 
Gene sequences used for multiple sequence alignments: 
The TBP/TRF and TFIIB protein sequences used in the multiple sequence alignments are 
listed in Table 6 in the Appendix 5.1, and were retrieved from the National Centre for 
Biotechnology Information (NCBI) online database (www.ncbi.nlm.nih.gov/). Plasmodium 
protein sequences were retrieved from the PlasmoDB database (Aurrecoechea et al. 2009) 
with the exception of P. reichenowi, retrieved from NCBI. 
Multiple sequence alignments (MSA) were performed using Clustal Omega, hosted on the 
Analysis Tool Web Services from the EMBL-EBI (Larkin et al. 2007; McWilliam et al. 
2013; Sievers et al. 2011), on the default settings. As well as the Constraint-based Multiple 
Protein Alignment Tool (COBALT, www.ncbi.nlm.nih.gov/blast; Papadopoulos & Agarwala 
2007), on the default settings. 
Phylogenetic analysis of proteins performed in MEGA6 program (Tamura et al. 2013), using 
the Minimum Evolution method on the default settings: Interior-branch test (bootstrap) with 
500 iterations; Substitution model: Poisson model; Uniform rate among sites. Tree Inference 
Options: Close-Neighbour-interchange; initial tree by Neighbour-joining.  
2.1.2 Domain identification in protein sequences 
BLASTp as well as Domain Enhanced Lookup Time Accelerated (DELTA)-BLASTp 
(Altschul et al. 1997; States & Gish 1994) were performed on the full-length PfTLP and 
PfTFIIB translated protein sequences (Appendix 5.1) with the default parameters. Conserved 




domain information was determined from the results of the Conserved Domain Database 
search (Marchler-Bauer et al. 2009; Marchler-Bauer & Bryant 2004; Marchler-Bauer et al. 
2011).  
2.1.3 Secondary and tertiary structural prediction of proteins 
Phyre (version 2.0; Phyre2) was used to predict the secondary and tertiary structures in the 
PfTLP and PfTFIIB,  using the Intensive modelling mode (Kelley & Sternberg 2009).  
Visualisation of tertiary protein structures 
Visualisation and analysis of protein structures were performed in PyMol v1.6.00 
(Schrödinger, LLC 2010) and Chimera v1.8.1 (Pettersen et al. 2004) programs. Solved 
protein structures used for comparison purposes include: HsTFIIB C-terminus: PDB entry 
1VOL (Nikolov et al. 1995); ScTFIIB N-terminus: PDB entry 3K1F.M, (Kostrewa et al. 
2009); HsTBP core: PDB entry 1CDW (Nikolov et al. 1996). 
 Vectors and primers used for gene cloning and sequencing 
2.2.1 Vectors used for gene cloning 
The plasmid vectors for the cloning and expression of the Plasmodium proteins PfTLP and 
PfTFIIB were derived from the commercially available pET11d vectors (Novagen). The 
pET11d expression vectors contain the β-lactamase gene which confers ampicillin 
resistance. The vectors used in this study are summarised in Table 9 in the Appendix 5.4, 
as are the vector diagrams. The NdeI and BamHI restriction enzyme sites of the multiple 
cloning sites in the vectors were used for cloning in this study. The pET11d-6His-HsTBP 
vector was obtained from Dr T. Oelgeschläger, and this served as the vector frame for the 
cloning of pET11d-6His-PfTLP. The pET11d-GST-6His vector was constructed by 
Chenjerai Muchapirei, and served for the cloning of PfTLPco.  




2.2.2 Primers used for gene cloning and sequencing 
The primers used for cloning and sequencing of the PfTLP open reading frame (ORF) are 
listed in Table 1. Primers for cloning were designed in order to overlap the N-terminus and 
C-terminus of the target gene. Restriction enzyme (endonuclease) sites were incorporated in 
the primers for insertion of the PCR product into digested vector frame. Primers for cloning 
were designed by hand in SerialCloner (Version 2.6.1, SerialBasics), melting temperatures 
and self-complementarity of the primers was checked using OligoCalc 
(www.basic.northwestern.edu/biotools/oligocalc.html). 
Table 1: List of primers for cloning and sequencing 
Endonuclease restriction sites are shown underlined, start codons are bold, and the stop 
codons are in italics.  










3 PfTLP-IntFWD GTCCCCGTCACTTTAAGTAC 
 
N/A PfTLP 















9 T7-FWD TAATACGACTCACTATAGG 
 
N/A  











 Cloning and sequencing of Plasmodium TLP 
2.3.1 Agarose gel electrophoresis 
Electrophoresis of DNA was performed using 0.8-2% (w/v) agarose containing 0.02µg/ml 
ethidium bromide (EtBR). Gels were prepared using either 0.5×TBE (40mM Tris-Cl pH 8.3, 
45mM boric acid, 1mM Ethylenediaminetetraacetic acid [EDTA]) or 1×TAE (40mM Tris-Cl 
pH 8.3, 0.11% (v/v) glacial acetic acid, 1mM EDTA) buffer. Electrophoresis was conducted 
at 80-100volts until the DNA was sufficiently separated. DNA bands were visualised by 
employing a long wavelength (365 nm) UV trans-illuminator. 
2.3.2 Polymerase chain reactions (PCRs) 
PCR reactions (Sambrook et al. 1989) were performed using KAPA Taq PCR Kits making 
use of Buffer A (Kapa Biosystems), following the manufacturer’s instructions, in 50µl 
reaction volumes. dNTPs for the reactions were supplied by Thermo Scientific. 
Amplification of the PfTLP and PfTLPco genes, with their respective primers, made use of 
the same reaction cycling conditions (Table 9). The PCR reaction profile was adjusted to 
include a long and lower elongation temperature due to the A+T richness of the gene 
sequences (Su et al. 1996). 
PCR amplification of the open reading frame for Plasmodium TLP was performed using 2µl 
of each of the cDNA libraries MRA-296 and 297 (MR4, ATCC® Manassas Virginia; 
contributed by D. Chakrabarti). 




A synthesised PfTLP gene, optimised for expression in E. coli was ordered from GenScript, 
(www.genscript.com/) termed ‘PfTLP codon optimised’ or PfTLPco gene, and was supplied 
in a pUC57 vector as a lyophilised powder. The vector was reconstituted in reverse osmosis 
purified water (RoH2O; Milli-Q purified, Millipore) to a final concentration of 200ng/µl. 
5.5fmol of the vector was used per PCR reaction.  
All PCR products were analysed by agarose gel electrophoresis, and then purified using 
either the MinElute™ Reaction Cleanup Kit (Qiagen) or QIAquick PCR Purification Kit 
(Qiagen), following the manufacturer’s instructions. Purified DNA concentrations were 
determined with a NanoDrop 2000 spectrophotometer (‘Nanodrop’, Thermo Scientific). 
2.3.3 Restriction enzyme digestion and ligation of PCR amplified inserts 
The original PfTLP ORF purified PCR product was simultaneously digested with NdeI and 
BglII restriction enzymes in 2×tango buffer (Thermo Scientific) to cleave the N and C-
termini respectively, leaving ‘sticky’ ends compatible with the expression vector. The 
digested PCR product was then gel isolated after agarose gel electrophoresis, and purified 
with the QIAEX II Gel Extraction Kit (Qiagen) following the manufacturer’s protocol, and 
the concentration determined by Nanodrop and confirmed by agarose gel electrophoresis 
with a calibrated molecular weight marker. 
Table 2: PCR cycling conditions for PfTLP gene 
amplification 
Duration Temperature (°C) Number of Cycles 
      
10 min 95 1 
      
30 sec 90 25 
30 sec 58 
90 sec 60 
      
10 min 60 1 
10 min 72 1 
 




The PfTLPco purified PCR product was digested with NdeI restriction enzyme in NdeI buffer 
(New England Biolabs) and purified with the MinElute Reaction Cleanup Kit (Qiagen). The 
purified DNA was then digested with BamHI restriction enzyme in BamHI buffer (Thermo 
Scientific), and purified with the MinElute Reaction Cleanup Kit. All procedures following 
the manufacturer’s instructions. The concentration of the purified insert DNA was 
determined by Nanodrop and confirmed by agarose gel electrophoresis with a calibrated 
molecular weight marker. 
2.3.4 Preparation of pET11d-vectors for cloning 
Plasmid isolation 
In order to generate sufficient vector frame for the cloning of the PfTLP and PfTLPco genes, 
either One Shot® Stbl3™ or TOP10 Chemically Competent E. coli cells (Stbl3, TOP10, 
Invitrogen) were transformed with the appropriate vector (pET11d-6His-HsTBP or pET11d-
GST-6His), according to the manufacturer’s instructions. Transformants were spread-plated 
on lysogenic agar plates (LA; 1% w/v tryptone powder, 0.5% w/v yeast extract, 0.5% w/v 
NaCl, 1.5% w/v agar, pH adjusted to 7.5) containing 100µg/ml ampicillin, and grown 
overnight (8-12 hours) at 37°C. The transformed cells were then used to inoculate 10ml 
lysogenic broth (LB; 1% w/v tryptone powder, 0.5% w/v yeast extract, 0.5% w/v NaCl, pH 
adjusted to 7.5) cultures containing 100µg/ml ampicillin, and grown overnight at 37°C with 
shaking. Plasmid DNA was isolated from the cultures making use of the GeneJET Plasmid 
Miniprep Kit (Thermo Scientific), following the manufacturer’s instructions. The 
concentration of purified plasmid DNA (pDNA) was determined by Nanodrop, and 
confirmed by linearizing the DNA by restriction enzyme digestion, and agarose gel 
electrophoresis with a calibrated molecular weight marker.  
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Vector restriction enzyme digestion 
Purified plasmid DNA was double digested with BamHI and NdeI in 2×Tango buffer 
(Thermo Scientific) and analysed by agarose gel electrophoresis. The cleaved vector frame 
was dephosphorylated with FastAP Thermosensitive Alkaline Phosphatase (FastAP, Thermo 
Scientific) and the sample heat inactivated at 75°C for 10 minutes. The cleaved vector frame 
was then isolated after agarose gel electrophoresis, and purified with the QIAEX II Gel 
Extraction Kit. The concentration of purified plasmid vector frame was determined by 
Nanodrop, and confirmed by agarose gel electrophoresis with a calibrated molecular weight 
marker. All procedures were performed following the manufacturer’s instructions.  
2.3.5 Isolation of PfTLP expressing pET11d-vectors 
Ligation, plasmid isolation identification of succefuly cloned vectors 
Digested insert and vector frame were ligated by incubation with T4 DNA Ligase (Thermo 
Scientific), insert:vector ratios of 1:1 and 3:1 respectively, in 20µl volumes. The ligation 
mixes were incubated for 2 hours at room temperature. Of the ligation mixes, 1/10 volume 
of each ligation mix was then transformed into 25µl-100µl of either Stbl3 or TOP10 
Chemically Competent E. coli cells, following the manufacturer’s instructions. The 
transformed cells were then spread-plated on ampicillin containing lysogenic agar (LA) 
plates, and incubated overnight at 37°C.   
Colonies successfully transformed with insert-containing vectors were identified by colony 
PCR. In this assay, a colony is lightly touched with a sterile pipette tip. The tip is dipped into 
2µl of RoH2O, and heated to 90°C for 5 minutes. This is then used in the PCR reaction 
(described above) with the appropriate forward and reverse primers, and the cycling 
conditions in Table 2. PfTLP-FWD and PfTLP-REV primers were used to identify 
transformants containing pET11d-6His-PfTLP and pET-11d-GST-6His-PfTLP vector, and 
PfTLPco-FWD and PfTLPco-REV primers for transformants containing the pET-11d-GST-




6His-PfTLPco vector (Table 1). 1/5 volume of the PCR reactions were analysed by agarose 
gel electrophoresis, and vector DNA isolated from positively identified colonies, as 
described above. The sequences of the vectors were then confirmed by DNA sequence 
analysis (Stellenbosch Central Analytical Facility, Stellenbosch, South Africa) on an 
ABI3730xl DNA analyser (Applied Biosystems, Foster City, USA). The pET11d-6His-
PfTLP and pET11d-GST-6His-PfTLP vectors were sequenced with the primers 3, 4, 9, and 
10; pET11d-GST-6His-PfTLPco vector was sequenced with the primers 7, 8, 10 and 11 
(Table 1) to ensure full sequence coverage. Sequence data was analysed using Chromas 
software (Version 2.01, Technelysium Pty Ltd, Queensland, Australia), and SerialCloner.  
2.3.6 Transformation of protein expression vectors into protein expressing 
cells 
Note that the cloning of the pET11d-GST-6His-PfTLPco was initially unsuccessful, and a 
vector was isolated with an additional two codons in between the 6His-tag and PfTLPco 
ORF. This vector, termed pET11d-GST-6His-PfTLPco(aa), was used in expression trials 
until the correct pET11d-GST-6His-PfTLPco vector could be cloned. 
The pET11d-6His-PfTLP, pET11d-6His-PfTFIIB (cloned in the lab, and provided by Dr 
Thomas Oelgeschläger), pET11d-GST-6His-PfTLP, pET11d-GST-6His-PfTLPco and 
pET11d-GST-6His-PfTLPco(aa) vectors were transformed into BL21-CodonPlus® (DE3)-
RIL competent cells (Agilent Technologies, Stratagene 2005) for expression, following the 
manufacturer’s instructions. Transformants were spread plated onto either LA plates or 
Super Optimal Broth with Catabolite Repression (SOC; 2% w/v tryptone powder, 0.5% w/v 
yeast extract, 10mM NaCl, 2.5mM KCl, 10mM MgCl2, 20mM glucose, 1.5% w/v agar) 
plates, containing 50µg/ml chloramphenicol and 100µg/ml ampicillin, and incubated 
overnight at 37°C. 




 Expression of recombinant Plasmodium proteins in E. coli 
Note that in all of the following experiments, the LB media used contained both ampicillin 
and chloramphenicol antibiotics at 100µg/ml and 50µg/ml.  
Starter culture procedure 
Either 10 or 20ml of LB, with or without 1% (w/v) glucose, was inoculated from either a 
single colony from a freshly transformed plate, or from a scraping of the top of a frozen 
glycerol culture (maintained at -80°C). The inoculated culture was incubated with shaking 
at 37°C overnight (typically for 16 hours). The overnight culture was pelleted by 
centrifugation for 5 minutes at 2822 relative centrifugal force (RCF) in a Beckman Ultra 
Centrifuge for 10 minutes at 4°C. The cell pellet was resuspended in 10ml of fresh LB in 
order to remove secreted β-lactamases in the cell culture, and used to inoculate 200ml of LB. 
If the expression culture was 100ml of LB, 5ml of starter culture was used (1/20 vol.). The 
optical density of the cell culture was measured at wavelength of 600nm (OD600nm) making 
use of a light spectrophotometer.  
2.4.1 Expression of recombinant PfTFIIB protein in E. coli BL21-
CodonPlus® (DE3)-RIL cells 
Original expression of PfTFIIB protein protocol  
Two 200ml flasks of cell culture containing E. coli BL21-CodonPlus® (DE3)-RIL cells 
transformed with pET11d-6His-PfTFIIB were incubated at 37°C, and OD600nm of the cell 
cultures recorded. Protein expression of one culture was induced with 1mM Isopropyl β-D-
1-thiogalactopyranoside (IPTG) at cell densities which ranged from 0.4 - 0.8 OD600nm units. 
The culture densities of both the induced and non-induced were monitored, and 
approximately 2-2.5 hours post-induction the cell cultures were pelleted through 
centrifugation at 3468 RCF for 10 minutes. The cell pellets were frozen and stored at  
-20°C.  




Expression of recombinant PfTFIIB through auto-induction  
Overnight cell cultures of E. coli BL21-CodonPlus® (DE3)-RIL cells transformed with 
pET11d-6His-PfTFIIB were grown in LB containing 1% glucose, and pelleted by 
centrifugation as above. Pelleted overnight cultures were resuspended in fresh media and 
used to inoculate two 200ml flasks of LB (containing 1% glucose). The flasks were 
incubated at 37°C for several hours, and the densities of the cell cultures monitored. The cell 
cultures were pelleted through centrifugation at 3468 RCF for 10 minutes. The cell pellets 
were frozen and stored at -20°C. 
2.4.1 Expression of recombinant PfTLP protein in E. coli BL21-
CodonPlus® (DE3)-RIL cells 
Expression of recombinant PfTLP protein 
E. coli BL21-CodonPlus® (DE3)-RIL competent cells transformed with pET11d-6His-
PfTLP, pET11d-GST-6His-PfTLP or pET11d-GST-6His-PfTLPco/(aa) were used to 
inoculate 10-20ml cultures and incubated overnight (8-10 hours) at 37°C. Overnight cultures 
were used to inoculate expression cultures as described above. The expression culture was 
incubated at 37°C and the OD600nm of the culture monitored. Protein expression was induced 
with 0.1-1mM IPTG, final concentration. Cultures may or may not have been cold-shocked 
to 20-25°C in an ice-bath (indicated in the Results section), and the temperature monitored 
with a sterile thermometer. Cultures were then incubated for up to 20 hours between 20-
25°C (as indicated). The OD600nm of the cultures were recorded, and then pelleted through 
centrifugation at 3468 RCF for 10 minutes. The cell pellets were frozen and stored at -20°C. 
2.4.2 Preparation of E. coli glycerol stocks 
Bacterial glycerol stocks were prepared by taking 0.75ml of mid-exponential phase  
(~0.4-0.6 OD600nm) bacterial culture, and adding 0.25ml sterile 60% ice-cold glycerol in a 




1.5ml microcentrifuge tube. The cell solution was vortexed to ensure even dispersal, and 
then snap-frozen in liquid nitrogen and stored at -80°C. 
2.4.3 Determination of recombinant protein expression by pilot-scale 
affinity purification 
Isolation of the total soluble E. coli cellular protein fraction  
Frozen cell pellets were resuspended in sonication buffer, at 5ml/g of cell pellet. Sonication 
buffer is composed of 50mM Tris-base (pH 7.2 at 21°C), 300mM KCl, 20mM imidazole, 
0.01% Triton™ X-100 (Sigma-Aldrich®), and 10mM β-mercaptoethanol. 
50µl of Protease Inhibitor Cocktail for use in purification of Histidine-tagged proteins 
(protease inhibitor; Sigma-Aldrich®) and either 0.5 or 1 mg/ml of Lysozyme from chicken 
egg white (lysozyme; Sigma-Aldrich®) was added to the resuspended cell solution. The 
resuspended cell solution was then incubated on ice for an hour, and then the cells were 
sheared through physical disruption by sonication. Sonication was performed with an 
Ultrasonics Inc. Cell Disruptor Model W-225R for 6 rounds of 10 seconds, with 20 second 
refractory period, on ice at power level four. The cell lysate was then centrifuged at 15000 
RCF for 30 minutes at 4°C. The cleared cell lysate was then siphoned from the cell debris 
pellet, and kept on ice until purification, or a stored at -20°C. 
Isolation of insoluble E. coli cellular protein fraction 
After the soluble protein was removed from the lysed cell pellet, the resultant pellet would 
be resuspended in sonication buffer containing 8M urea, through sonication. The insoluble 
protein would then be then centrifuged at 15000 RCF for 30 minutes at room temperature, 
and the supernatant collected and kept on ice until purification, or a stored at -20°C. 




Pilot-scale glutathione affinity purification 
Pilot-scale purification of GST-tagged proteins was performed making use of glutathione-
affinity purification from the cleared cell lysate using glutathione-agarose (Sigma-
Aldrich®). In brief, 50μl of 40% (v/v) glutathione-agarose resin slurry in 2M NaCl and 1mM 
sodium azide, was equilibrated in 1ml of sonication buffer containing 0.1% Nonidet™ P 40 
Substitute (NP 40; Sigma-Aldrich®). The resin was settled by brief centrifugation at 350 
RCF for 1 minute, and the sonication buffer siphoned from the settled resin. 1ml of cleared 
cell lysate with 0.1% NP 40 was added to the resin and then mixed for 1 hour at 4°C. The 
glutathione-agarose was then recovered by brief centrifugation, and the unbound protein 
fraction siphoned off and stored on ice. The resin was washed once in 1ml of sonication 
buffer, and moved to a sterile microcentrifuge tube. The resin would then be suspended in 
2×SDS loading dye (typically 45µl in volume) and the proteins heat denatured at 95°C for 5 
minutes. The resultant denatured protein would then be moved to a fresh tube for SDS-PAGE 
analysis, or a stored at -20°C. 
1) Pilot-scale nickel affinity purification 
Pilot-scale purification of the hexa-histidine (6His)-tagged proteins was performed making 
use of nickel-affinity purification from the cleared cell lysate using PureProteome™ Nickel 
Magnetic Beads (Merck Millipore; Ni-beads). In brief, 5 or 10µl of suspended beads would 
be pipetted into a sterile microcentrifuge tube. The beads were separated from the storage 
buffer using a magnetic separator stand. The beads were equilibrated in 1ml of sonication 
buffer (with or without 0.1% NP 40), and recovered using the magnetic separator. 1ml of 
cleared cell lysate was added to the beads, and mixed for 1 hour at 4°C. The nickel magnetic 
beads were recovered with the magnetic separator, and the unbound protein fraction removed 
and stored on ice. The beads were washed either 3 times in 50µl of sonication buffer, or once 
in 1ml of sonication buffer. The resuspended beads were moved to a sterile microcentrifuge 




tube. The beads were suspended in 2×SDS loading dye (typically 30µl in volume) and heated 
at 95°C for 5 minutes to denature the proteins. The resultant denatured protein would then 
be moved to a fresh tube for SDS-PAGE analysis, or a stored at -20°C. 
SDS-PAGE analysis 
SDS-PAGE gels were either poured in custom SDS-PAGE casting plates, and 
electrophoresis performed with custom gel apparatus, or the Bio-Rad mini-gel system was 
used. The volumes of stacking and running gel were adjusted accordingly. Typically the 
custom gels required 5ml of the 5% stacking gel and 10ml of the 12 resolving gel. The Bio-
Rad mini-gels required approximately 1.25ml 5% stacking gel and 4.5ml 12% resolving gel. 
Combs of 1mm width were used for all the gels.  
Table 3: SDS-Page solutions 
12% Resolving gel: Reagent Volume 
Water 4.2ml 
40% 37.5:1 bis-acrylamide/acrylamide mix (Sigma-Aldrich®) 3ml 
1.5 M Tris-HCl pH 8.8  2.5ml 
10% SDS solution  0.1 ml 
Ammonium persulphate (100mg/ml) 0.2ml 
Tetramethylethylenediamine (TEMED) 10µl 
Total 10ml 
 
5% Stacking gel: Reagent Volume 
Water 3 ml 
40% 37.5:1 bis-acrylamide/acrylamide mix (Sigma-Aldrich®) 0.625 ml 
1.0 M Tris-HCl pH 6.8  1.25 ml 
10% SDS solution  50µl 




Ammonium persulphate (10% w/v in H2O) 0.1 ml 
Tetramethylethylenediamine (TEMED) 5µl 
Total 5ml 
 
Samples were mixed to be in either 1 or 2×SDS loading dye (100 mM Tris-Cl (pH 6.8), 4% 
(w/v) SDS, 0.2% (w/v) bromophenol blue, 20% (v/v) glycerol, 200mM dithiothreitol [DTT]) 
and heated to 90°C for 2 minutes. Samples were then briefly centrifuged to allow the 
condensate to mix into the sample. The samples were then loaded into the SDS-PAGE and 
electrophoresis begun, with the ampere kept constant at typically 35-45mA until completion. 
The gels were removed from the glass plates, and washed in deionised water 3 times for 10 
minutes, and then stained with Bio-Safe™ G-250 Coomassie premixed stain (Bio-Rad) for 
30 minutes to an hour. The gels were de-stained by washing repeatedly with water. Gels 
were visually inspected to determine the presence of protein, and photographed. 
2.4.4 Identification of 6His-PfTLP and 6His-PfTFIIB proteins by mass 
spectrometry based analysis 
SDS-PAGE gels loaded with the 2×SDS loading dye denatured proteins (6His-PfTLP and 
6His-PfTFIIB loaded onto separate gels) was performed. The proteins on the SDS-PAGE 
were visualised with Coomassie staining, described above, and the protein bands to be 
investigated excised. An additional control band of visually blank gel was also excised. The 
gel slices were sent for peptide mass fingerprinting (PMF) analysis to the Centre for 
Proteomic and Genomic Research (Faculty of Health Science, University of Cape Town, 
South Africa). MALDI/MS analysis was performed using a 4800 MALDI ToF/ToF system 
(AB SCIEX) with instrument control through Series Explorer. A summary of the identified 
proteins, and PMF spectra was returned.  




 Accumulation and purification of recombinant Plasmodium TFIIB protein  
2.5.1 Accumulation of recombinant 6His-PfTFIIB expressed protein E. coli 
cell mass 
Overnight cultures of 5×10ml, inoculated from a glycerol stock of E. coli BL21-CodonPlus® 
(DE3)-RIL cells transformed with pET11d-6His-PfTFIIB (0.6 OD600nm at the point of 
making the glycerol stock), were allowed to grow for approximately 12 hours at 37°C. The 
overnight cultures were pelleted at 2000 RCF for 10 minutes at room temperature, and the 
supernatant removed. The cells were resuspended in media (containing 1% glucose) and 
used to inoculate 400ml cultures. The OD600nm was measured to be 0.03-0.05 OD600nm at this 
time. The cell culture was then grown to OD600nm of approximately 1.6 - 1.8, approximately 
7 hours. The cell culture would then be pelleted by centrifugation at 2000 RCF and the cell 
pellet weighed and small scraping of cell pellet taken for protein expression analysis, as 
described above, prior to freezing the pellet in liquid nitrogen and storage at 
-80°C. This was repeated until sufficient cell mass was generated.  
2.5.2 Bulk purification of 6His-PfTFIIB protein by Nickel-affinity 
purification 
Production of soluble protein in cleared cell lysate 
The accumulated cell pellets were resuspended in 3-5ml of sonication buffer containing 5µM 
ZnCl2, per gram of cell pellet, up to 20ml per cell pellet. The resuspended cell pellets were 
incubated with 1mg/ml final concentration of lysozyme for 30 minutes on ice. The cell 
solutions were sonicated until the cell pellets were suspended, 9 rounds of 10 second bursts 
with 20 second refractory periods. The cell lysate was centrifuged at 15300 relative 
centrifugal force for 40 minutes. The cleared cell lysate was then decanted into chilled and 
sterile plastic tubes and the remaining cell debris/insoluble cell fraction was frozen and 
stored at -80°C. 




Purification of 6His-PfTFIIB with Ni-NTA affinity purification resin 
2.1ml packed resin volume of Sigma HIS-Select® HF-Nickel Affinity Gel agarose resin was 
equilibrated in 20× resin volume sonication buffer. The buffer was removed, and the resin 
incubated with half of the cleared cell lysate in sterile plastic 50ml tubes for 1 hour with slow 
mixing at 4°C. The tubes were centrifuged in a clinical centrifuge at approximately 300RCF, 
and the protein fraction not bound to the resin was removed. The resin was then incubated 
with the remainder of the cleared cell lysate as before. Finally, the samples were centrifuged, 
and the unbound sample removed. The resin was washed twice in 20×packed resin volume 
of wash buffer (20mM Tris-Cl pH 7.2, 0.2mM EDTA, 100mM KCl, 0.1% NP 40, 20mM 
imidazole, 5µM ZnCl2) by mixing the resin in the buffer, slowly centrifuging the slurry, and 
removing the wash buffer. The resin was resuspended in 10×packed resin volume of wash 
buffer, and the resin loaded equally onto two Poly-Prep® Chromatography columns 
(BioRad). The wash buffer was allowed to flow through the columns by gravity-flow, and 
collected. Each column was then loaded with 5×packed resin volume of elution buffer 
(20mM Tris-Cl pH 7.2, 0.2mM EDTA, 100mM KCl, 0.1% NP 40, 250mM imidazole, 5µM 
ZnCl2). Fractions of the elution of approximately 200µl were collected into sterile micro-
centrifuge tubes.  
Determination of protein containing elution fractions: 
10µl of the BioRad Protein assay solution was incubated with 1µl of each fraction, to test 
for protein content. The highest protein containing fractions (PCF) were then pooled; as well 
as the first 4 fractions and first 5 fractions of columns 1 and 2 respectively. Fractions 9-11 
of both columns were pooled together. Aliquots of the PCF were then made, and the crude 
protein preparation flash-frozen in liquid nitrogen and stored at -80°C. Finally, titrations of 
bovine serum albumin (BSA) protein (Roche), and the PCF were loaded onto an SDS-PAGE 
gel to estimate recombinant PfTFIIB protein quantity and purity. 




2.5.3 Further purification of 6His-PfTFIIB by Sepharose® resins 
6His-PfTFIIB was further purified making use of the Sepharose® Fast-Flow resins Q, 
DEAE, CM, or SP as indicated. In each case 20µl of settled Sepharose® resin volume was 
equilibrated in BC-100 buffer (20 mM Tris, pH 7.2 at RT, 100mM KCl, 0.02mM EDTA, 
10mM β-mercaptoethanol, 0.1% NP 40). Approximately 200ng of recombinant PfTFIIB 
protein preparation was incubated with the resin on ice for up to an hour. The resin was 
centrifuged at 380RCF for 2 minutes, and the unbound fraction removed. The resin was 
washed in 100µl of BC-100 buffer, centrifuged again and the wash fraction removed. 30µl 
of BC-× buffer was added, where ‘×’ is the concentration of KCl in the buffer required to 
give the desired final KCl concentration (taking void-volume of the resin into account) The 
resin was incubated for 2-5 minutes on ice, and the eluted protein removed by centrifugation 
and aspiration. The next buffer of increased KCl concentration was added. This was repeated 
in step-wise fashion. Finally, after aspiration of the final buffer, the resin was suspended in 
2×SDS-loading buffer. The elution buffer from each step-elution was mixed with 2×SDS-
loading buffer, and then the maximum amount of sample capable of being loaded was loaded 
(10µl of the buffer eluted, effectively 1/3rd of the eluted protein). 
The experimentation was analysed by SDS-PAGE analysis. 
 
Nuclease treatment of protein prior to use 
From initial experiments, it was determined that nucleic acids may be contaminating the 
PfTFIIB preparation. In order to investigate the effect of DNA on the binding of PfTFIIB, 
Benzonase® endonuclease (nuclease; Sigma-Aldrich®) was used to treat the protein 
preparation. Approximately ~0.2µl of nuclease (~50 units of enzyme) and incubated at 37ºC 
for 15 minutes. The purification on SP-Sepharose® resins continued as above.  




 Accumulation and purification of recombinant Plasmodium TLP  
2.6.1 Accumulation of recombinant GST-6His-PfTLP expressed protein E. 
coli cell mass 
Overnight cultures of 150ml LB containing 1% glucose were inoculated from a glycerol 
stock of E. coli BL21-CodonPlus® (DE3)-RIL cells transformed with pET11d-GST-6His-
PfTLPco (0.6 OD600nm at the point of making the glycerol stock), and allowed to grow for 
12 hours. The overnight cultures were pelleted at 2000 RCF for 10 minutes at 4°C, and the 
supernatant removed. The cells were resuspended in LB and used to inoculate 500ml 
cultures. The OD600nm was measured to be typically 0.03-0.05 OD600nm at this time. The cell 
culture was then grown at 37°C to OD600nm of approximately 1.5 - 1.6, approximately 5 
hours, and then cold-shocked to 21°C and maintained at 21°C with shaking for half an hour 
prior to induction with 0.5mM IPTG. The cells were incubated for approximately 23-25 
hours at 21°C. The cell cultures were pelleted by centrifugation at 2000 RCF and the cell 
pellets weighed. A small scraping of cell pellet was taken for protein expression analysis by 
pilot-scale affinity purification, prior to freezing the pellet in liquid nitrogen and storage at 
-80°C. This was repeated until sufficient cell mass was generated. 
2.6.2 Preparation of soluble protein  
The accumulated cell pellets were resuspended in sonication buffer (50mM Tris-HCl pH7.2, 
300mM KCl, 20mM imidazole, 0.01% triton-x100, 10mM β-mercaptoethanol) 3ml of 
sonication buffer per gram of cell pellet. The resuspended cell pellet solution contained 
0.5mg/ml of lysozyme enzyme, 40μl/g cell pellet of protein protease inhibitor, and 1250 
units of Bensonaze®. The resuspended cell solution was incubated on ice for one hour. The 
resuspended cell pellets were sonicated until the cell pellets were suspended, 5 bursts of 10 
seconds each on power level 5 with 20 second refractory period. The resuspended cell pellets 
were then incubated on ice for 2 hours. The sample were then sonicated at power level 4 for 




6 bursts of 10 seconds, with 20 seconds of refractory period after each burst. This occurred 
while chilled on ice. Additional sonication buffer was then added to the tubes for 
centrifugation purposes. The cell lysate was then centrifuged at 10,000 RCF for 40 minutes, 
and the cleared cell lysate then decanted into a sterile plastic tube. This cell lysate was then 
centrifuged once more for 20 minutes at 10,000 RCF, and the supernatant decanted into a 
sterile plastic tube. 
2.6.3 Binding to Glutathione-Agarose (Sigma-Aldrich®): 
500µl of packed resin volume glutathione-agarose was loaded onto a Poly-Prep® 
Chromatography columns. The resin was equilibrated with 20×resin volume of sonication 
buffer. The cleared cell lysate was loaded onto the column. The unbound flow-through was 
collected. The column was washed with 20×resin of wash buffer (20mM Tris-Cl pH 7.2, 
0.2mM EDTA, 100mM KCl, 0.1% NP 40). The protein was eluted from the column with 
4ml glutathione-elution buffer (20mM Tris-Cl pH 7.2, 0.2mM EDTA, 100mM KCl, 10mM 
β-mercaptoethanol, 0.1% NP 40, 20mM glutathione, solution adjusted to pH 8 with 5N 
NaOH), collecting fractions of approximately 250µl. 5µl of fractions 1, 3, 5, 7, 9, and 11 
were analysed for protein content by SDS-PAGE analysis. Protein containing fractions were 
pooled, and titrated with BSA on an SDS-PAGE gel to estimate the quantity of protein 
obtained. 
2.6.4 Thrombin cleavage of GST-6His-PfTLP 
2000 units of thrombin enzyme (Thrombin Factor IIa, Sigma-Aldrich®) were incubated with 
the pooled protein preparation, and incubated at 4°C for several hours. Thrombin cleavage 
of the GST-6His-PfTLP protein preparation analysed making use of 200µl of the protein 
preparation and pilot-scale nickel affinity batch purification and SDS-PAGE analysis, as 
above.  




2.6.5 Nickel affinity purification of cleaved 6His-PfTLP protein 
A settled resin volume of 0.5ml of HIS-Select® Nickel Affinity Gel was loaded onto a Poly-
Prep® Chromatography Column and equilibrated with the glutathione-elution buffer used 
previously. The remaining protein preparation was loaded to the column (~3.7ml), and the 
unbound flow-through stored on ice. The column was washed with 20×resin volume wash 
buffer (20mM Tris-Cl pH 7.2, 0.2mM EDTA, 100mM KCl, 0.1% NP 40, 20mM imidazole). 
The protein was to be mixed with glycerol for freeze protection (40% glycerol solution) after 
elution. The elution buffer was, therefore, twice as concentrated (40mM Tris-Cl pH 7.2, 
0.4mM EDTA, 200mM KCl, 20mM β-mercaptoethanol, 0.1% NP 40), so that it may be 
diluted down to 'BC-100' with 40% glycerol. The imidazole concentration was kept at 
250mM for the elution.  The protein was eluted in 250µl fractions, and the fractions analysed 
by SDS-PAGE for protein content. The protein containing fractions were then pooled and 
the 6His-PfTLP protein quantified by SDS-PAGE with a BSA titration.  
It was found that the ‘unbound’ flow-through still contained 6His-PfTLP. This was most 
likely due to the presence of competing 6His-peptides cleaved from the G6Hp. The unbound 
fraction was then passed through a Ni-column a second time, and the protein eluted as above. 
2.6.6 Investigation of SP-Sepharose® purification of 6His-PfTLP 
Made use of SP-Sepharose® Fast Flow resin (Sigma-Aldrich®).  The protocol used was 
similar to that described in 2.5.3, albeit without making use of the nuclease enzymes in these 
assays. 
2.6.7 Depletion of GST from PfTLP protein preparation 
Glutathione-agarose (0.5ml settled resin volume) was equilibrated in 20×resin volume of 
BC-100 buffer (20 mM Tris, pH 7.2 at RT, 100mM KCl, 0.02mM EDTA, 10mM β-
mercaptoethanol, 0.1% NP 40). The eluted fractions from the nickel-affinity purification 




were loaded onto the column. The protein was incubated on the column for 30 minutes at 
4°C. The protein was then allowed to flow through and collected. A small amount of resin 
(~10µl) was taken for analysis. Analysis of the experiment was performed by SDS-PAGE.  
 Protocol for immunoblot analysis 
Immunoblots were performed making use of the Mini Trans-Blot® Electrophoretic Transfer 
Cell (Bio-Rad), following the manufacturers suggestions. An overview of the methodology 
is used is below:  
Transfer of protein to PVDF membrane 
Millipore Immobilon-P transfer membrane (PVDF) was activated in 100% methanol for 15 
seconds, then Membrane and filter pads were equilibrated in ice-cold transfer buffer. The 
gel for transfer was first washed briefly in deionized water then in ice-cold transfer buffer 
(25mM Tris, 192mM glycine). The ‘sandwich’ was then assembled. The gel was transferred 
at between 70-100volts for at least 1 hour (dependent on voltage achieved by power supply 
used). After transfer, the membrane was washed in 1×TBST buffer (137mM NaCl, 2.7mM 
KCl, 19mM Tris, 1% Tween-20 [Sigma-Aldrich®]) 3 times for 5 minutes. The excess TBST 
buffer was drained. The membrane was then blocked with blocking buffer (5%fat-free milk 
powder made up in 1×TBST buffer) either over night or for at least 1 hour at 4ºC with 
shaking. Excess blocking buffer was washed off with three washes in TBST.  
Visualisation of immunoblots 
The membrane was then incubated with the appropriate primary antibody for 1 hour at room 
temperature. The primary antibody was removed and the membrane washed 3× for at least 
10 minutes with TBST. The secondary antibody was diluted to either 1:5000 or 1:3000 (10ml 
total) in 1×TBST buffer, and incubated with the membrane for 30 minutes to 1 hour at room 
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temperature. The secondary antibody was poured off and the membrane washed 3 x 10 min 
with TBST. 
Chemiluminescent detection was performed with the ThermoScientific Pierce ECL Western 
Blotting Substrate kit, following the manufacturer’s instructions, enough substrate was used 
to cover the membrane. Excess substrate was removed from the membrane, and the 
membrane wrapped in plastic film. X-ray films were then exposed to the membrane, treated 
with developer and fixer.   
Characterisation of PfTLP antibody 
The production of polyclonal antibodies was performed by BioGenes (BioGenes, Berlin, 
Germany). Peptide-antibodies were raised in rabbits against the peptide sequence: 
294-307: C-NDENKSNDNKEQND
Cleared cell lysate from cells in which expression of G6H-PfTLP was induced was mixed 
with 30ng of purified 6His-PfTLP: 
Name Enriched MW Purified Enriched 














BC-100 4 7 4 
Total (µl) 10 4 10 10 
The samples were mixed with equal volume 2×SDS-loading buffer, separated on a 5/12% 
SDS-PAGE gel, and transferred to a PVDF membrane and visualised as described above. 
The strips were probed with decreasing concentrations of anti-serum, shown is 1/1000 and 




1/3000 dilutions of the anti-serum in TBST buffer. The secondary antibody used was 
horseradish peroxidase-conjugated anti-rabbit IgG; produced in goat (Sigma-Aldrich®). 
 DNA binding assays. 
2.9.1 Preparation of DNA probes 
Promoter sequence overview 
The vectors containing the Plasmodium probes were produced by Tomas Hessler 
(unpublished results, 2014). In brief, the region from -179 to +57 of the gbp-130 transcription 
start site were amplified (region includes positions 654647 – 654882 on chromosome 10; 
TSS at 654703), from a gDNA library of Plasmodium 3D7, and cloned into a pGEM-72f 
(Promega) derived vector. Similarly, the region from -171 to +65 of the kahrp TSS were 
also cloned (106605 to 106840 on chromosome 2; TSS at 106669). See amplified probe 
below.  
EMSAs 
The EMSA probes were produced by PCR reactions making use of both 5’ and 3’ 
biotinylated primers. These probes were amplified, gel extracted and purified prior to use.   
Grey regions are primer amplification sites, the underlined and bold nucleotide indicate the 
TSS. Note that the probes have been constructed with the upstream region of the TSS on the 
3’ end, and the downstream region on the 5’ end.  




















The Ad2ML EMSA probe was amplified from the pTOG5TdT(-41TATAto+33) vector, 
provided by Dr T. Oelgeschläger. The ‘TATAWAAR’ consensus sequence of the canonical 
TATA-box is underlined in bold. The probe was produced by PCR reactions making use of 
both 5’ and 3’ biotinylated primers. 





Immobilised template assays 
The immobilised template assay probes were longer than the EMSA probes, as they were 
generated by a different primer set. Additionally, to ensure that the probes bound only on 
one end to the streptavidin beads, only one end (5’) was biotinylated. Additionally, the 
immobilised template assay probes contained 5 GAL4 sites, although these were not 
expected to effect the binding of transcription factors to the probes.  The additional length 
of the probes was used to ensure that the TSS of the probes was of sufficient distance away 
from the beads, and would allow the proteins to bind unhindered. Lower case regions 
indicate the sequence of the gene of interest. Note that the probes have been constructed with 
the upstream region of the TSS on the 3’ end, and the downstream region on the 5’ end. 
 
 




The template DNA for PCRs were the Plasmodium promoter containing vectors and the 
pTOG5TdT(-51TATAto+62) vector for Ad2ML.   
 
The forward primer was biotinylated, resulting in 5’-end biotin labelled probes. 
 
Biotin-pTOPCRUS-Fwd 5’- AAT TGG GCC CGA CGT CGC A -3’   
pTO(G5)TdTPCR-Rev 5’- AAC GCG TTG GGA GCT CTC C -3’ 
 

































Generating immobilised template assay probes by PCR 
Immobilised template assay probes were generated by PCR (as above) with the following 
cycling conditions:  
Duration Temperature (°C) Number of Cycles 
      
5 min 95 1 
      
30 sec 95 30 
30 sec 56 
90 sec 72 
      
10 min 60 1 
10 min 72 1 
 
 
The probes were analysed on 0.5×TBE/1.5% agarose/EtBr gel. After checking the correct 
sizes, the remainder of the probes were separated on an agarose gel, the bands excised, and 
purified using the Thermo Scientific GeneJET Gel Extraction Kit to purify the DNA from 
the gel, following the manufacturer’s instructions. The purified probe concentrations were 
then determined by Nanodrop and confirmed by an agarose/EtBr gel.  
Binding of probes to Streptavidin magnetic beads 
Dynabeads® M-280 Streptavidin (Invitrogen™) were used. Biotinylated probes were bound 
to the beads following the manufacturer’s instructions, albeit making use of twice the 
quantity of beads recommended. Probe-bound beads were resuspended in the 1×wash buffer 
(10mM Tris-Cl pH 7.5 at RT; 0.5mM EDTA; 1M NaCl) containing 100ng/µl BSA protein 
(in BC-100 buffer). BSA was included to pre-block the beads with protein prior to 
immobilised template assays, to reduce non-specific protein-bead associations.  
The binding efficiency of the beads was tested by washing an aliquot of the beads in 1×wash 
buffer without NaCl (10mM Tris-Cl pH 7.5 at RT; 0.5mM EDTA) or BSA. The beads were 
then boiled in this buffer with 0.2% SDS for 10 minutes at 100°C, to disrupt the biotin-




streptavidin binding. The beads were then separated from the supernatant in a magnetic 
separator, and loaded on a 1% agarose gel, and quantitated from a molecular weight marker 
with known DNA concentrations.  
2.9.2 Polyacrylamide gel electrophoresis mobility shift assay 
Native polyacrylamide gels were poured (8cm, made use of the Bio-Rad 4-gel Mini-
PROTEAN Tetra cell system, with 10-well 1mm casting combs) of either 5 or 3.5% 49:1 
bis-acrylamide/acrylamide solutions (Sigma-Aldrich®), containing 0.5×TBE, 0.5mM 
dithiothreitol (DTT), 2mM MgCl2. Gels were then allowed to set overnight, before pre-
running for one hour at 4°C with 0.5×TBE containing 2mM MgCl2.  
For each reaction mix, two solutions, a DNA containing buffer (8µl; 33mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid pH 8.4 [HEPES], 8.3mM MgCl2, 167ng/µl 
BSA, 0.17% NP 40) and the tested protein(s) in BC-100 buffer (12µl); 20mM Tris-Cl pH 
7.2, 0.2mM EDTA, 100mM KCl, 10mM β-mercaptoethanol, 0.1% NP 40) were combined 
to form a DNA-protein reaction mix buffer.  The reaction mix was then incubated at 30°C 
for 45 minutes. For loading purposes, 15% Ficoll® PM 400 (Sigma-Aldrich®, made up in 
1M Tris-Cl pH 7.2) was then added to the reaction mixes and mixed.  
The reaction mixes were then loaded onto the gel, along with a lane containing only free-
probe and dye (0.2% Bromophenol blue dye. 0.2%, Xylene cyanol dye, 0.2% Orange G) and 
run at 400volts for 5 minutes, and then 100 volts until the dye had migrated sufficiently.  
The gel was then removed from the glass plates, and transferred to a (pre-equilibrated) 
positively charged Immobilon-Ny+ nylon membrane (nylon membrane; Merck Millipore), 
making use of the Bio-Rad Mini Trans-Blot® Electrophoretic Transfer Cell and ice-cold 
0.5×TBE (no MgCl2). Transfer was conducted at 100volts for 2 hours at 4°C. After transfer, 
the DNA was crosslinked to the membrane at 120mJ/cm2 using a commercial UV-light cross 




linker. The DNA probe was visualised on X-ray film using the Chemiluminescent Nucleic 
Acid Detection Module (Thermo Scientific).   
Human transcription factors EMSAs 
The EMSA with human transcription factors made use of 6His-HsTBP, 6His-HsTFIIB in 
BC-100 and recombinant human TFIIA (p55/p12), obtained from Dr T. Oelgeschläger.  
Probe concentrations 
It was found that as little as 2fmol of double-biotin tagged probe was able to be visualised 
in this method, 5fmol was more commonly used.  
2.9.3 Agarose gel electrophoresis mobility shift assay 
For the agarose EMSAs, a 1.4% agarose/0.5×TBE gel was used, containing 5mM 5mM 
MgCl2. The gel was pre-run for 1.5 hours at 100volts, in 0.5×TBE (5mM MgCl2) at 4°C.  
Protein-DNA reactions were performed as above, making use of half the total volume (10µl). 
For these assays, 10fmols of the probes were used. The gels were loaded as above, and 
electrophoresis occurred for approximately 2 hours at 100 volts at 4°C, 0.5×TBE used as 
running buffer. 
Probe transfer 
A 240mbar diaphragm pump (Charles Austen DA7C) was utilised in conjunction with 
Southern blotting apparatus (ATTO, USA) to construct horizontal vacuum-assisted transfer 
apparatus for agarose gels. The wells of the gel were filled with molten but cooled agarose, 
and the gel placed on top of the nylon membrane. A vacuum-proof mask covering the gel 
and nylon membrane sandwich, and subjected to vacuum. Vacuum was adjusted manually 
through the usage of a screw-valve. The vacuum was set at a negative pressure from which 
from visual observation <50% of the gel was contracted. Transfer was allowed to occur for 
two hours room temperature, using ice-cold 0.5×TBE. After transfer, the DNA was 




crosslinked to the membrane at 120mJ/cm2 using a commercial UV-light cross linker. The 
DNA probe was visualised on X-ray film using the Chemiluminescent Nucleic Acid 
Detection Module (Thermo Scientific).   
2.9.1 Immobilised template assay 
Reaction conditions 
The reaction conditions for the immobilised template assays were performed in 40µl reaction 
volumes. The reaction mix was the same as that described for the EMSA assay above, with 
the exception that magnetic beads bound to probe were used in place of the free-probe. In 
these assays, the equivalent of 1000fmol of DNA-probe were used in the assays. For the 
negative, ‘No DNA’ control, the equivalent amount of streptavidin magnetic beads were 
used. These beads were treated and prepared in the same manner as the DNA-bound beads, 
albeit without DNA probe bound.   
In this assay, the same reaction was repeated with beads bound to probe, and beads without 
probe. The beads were equilibrated in the DNA-protein reaction mix without protein prior 
to use. After removal of this equilibration buffer, the protein-reaction mix with the 
appropriate protein was added. The reactions were then incubated at 30°C for 45 minutes. 
Afterwards, the beads were separated from the reaction mix (containing the unbound protein 
fraction), making use of a magnetic stand. The beads were then very briefly washed in 100µl 
of the equilibration buffer, and this wash buffer removed making use of the magnetic stand. 
The beads were then resuspended in 20µl of 2×SDS-loading buffer. Of the unbound fraction, 
10µl was taken and 10µl of 2×SDS-loading buffer added (this results in all of the unbound 
fractions visualised on the immunoblot as being ¼ of the input protein). The samples were 
then heated at 95°C for 5 minutes.  




An SDS-PAGE gel was then performed. A titration curve of the input protein was included, 
of quantity equal to the input protein, half the input, a quarter of the input and an eighth of 
the input. The unbound fraction (1/4 of total) was loaded, was the supernatant of the SDS-
denatured beads. Molecular weight markers were included (4µl of Precision Plus 
Kaleidoscope, Bio-Rad).  
The SDS-PAGE was then transferred to a PVDF membrane and visualised as described 
above.  
Proteins used for the immobilised template assays 
For each reaction, 1000fmol of each protein was used. In the results Chapter I report on 
immobilised template assays performed with 6His-PfTLP; 6His-HsTBP and recombinant 
6His-HsTFIIB (both provided by Dr T. Oelgeschläger).  
Antibodies used for immunoblot visualisation of the immobilised template assays 
A commercially available antibody was used for the detection of 6His-HsTFIIB (1/2000 
dilution of anti- HsTFIIB rabbit antibody (SC-225; Santa Cruz biotechnology). The  
anti-HsTBP and anti-HsTFIIA antibodies were provided by Dr T. Oelgeschläger, and are 
not commercially available, they were used at dilutions of 1/2000 and 1/3000 respectively.  
The secondary antibody used was the Anti-Rabbit IgG peroxidase; produced in goat (Sigma-
Aldrich®) at 1/3000 dilution.  
 
  





Results and Discussion 
 Bioinformatics analysis of putative PfTFIIB – structure and function 
3.1.1 Amino acid sequence alignment analysis 
In order to assess the evolutionary conservation of PfTFIIB with well-studied TFIIB 
proteins, amino acid sequence analysis was performed. Sequence alignments provide 
information about the evolutionary relationship between proteins, and this information may 
be useful to infer structural and functional information.  
Pairwise alignments with human (HsTFIIB) and S. cerevisiae TFIIB (ScTFIIB; SAU7) was 
performed with BLASTp on the default settings. 
The amino acid sequence of PfTFIIB shares 28% sequence identity and 45% similar residues 
(amino acid substitutions where the amino acids share similar physiochemical properties) 
with ScTFIIB and 24% sequence identity and 45% similarity with H. sapiens TFIIB. 
Conservation of these proteins to PfTFIIB was especially low over the second cyclin repeat, 
with the presence of several ‘gaps’ in the alignment (not shown). 
The low sequence homology of PfTFIIB to HsTFIIB and ScTFIIB prompted the use of a 
multiple sequence alignment. TFIIB molecules from evolutionarily separate eukaryotes were 
used for the alignment in order to gain insight into the sequence diversity of TFIIB, as well 
as to highlight regions of greater conservation, often an indication of residues which are 
functionally important. Shared conservation of these regions in PfTFIIB may indicate 
conserved functions of the molecule.  
The multiple sequence alignment of PfTFIIB and TFIIB molecules from eukaryotes 
including fission (Schizosaccharomyces pombe) and budding yeast (Saccharomyces 




cerevisiae), Homo sapiens, Drosophila melanogaster, the related protist Toxoplasma gondii, 
and the archaea bacterium P. furiosus is presented in Figure 5. Regions and residues which 
are known to be functionally important for HsTFIIB or ScTFIIB function are indicated (by 
colour) in the alignment (Tsai & Sigler 2000; Kostrewa et al. 2009; Lagrange et al. 1998; 
Deng & Roberts 2005).  
 
  





Figure 5: Multiple sequence alignment of TFIIB proteins.  
A Schematic of HsTFIIB, with functional regions identified in colours. Secondary structures are indicated 
by purple and orange bars (α-helices and β-sheets respectively).  
B Multiple sequence alignment performed with Clustal Omega of diversely related eukaryote TFIIB 
sequences. Structural regions are indicated by colour bars above sequences: B-ribbon, B-reader and B-
linker  regions are shown in shades of green. Cyclin repeats are shown in blue. Residues with known 
functional interactions are highlighted with coloured bars according to colour code in A. Interaction 
partners are referred to. Extreme amino acid substitutions in PfTFIIB as compared to HsTFIIB/ScTFIIB 
indicated with red exclamation marks. 
Abbreviations used: BH: β-helices; TSS: Transcription start site; BREu/d:up-/downstream B-recognition 
element .   





Figure 5 continued – Comparison of the C-terminus of eukaryotic TFIIB proteins. 




PfTFIIB shares conservation of many functionally important residues 
Eukaryotic TFIIB (including PfTFIIB) molecules do not share a great deal of conservation 
across the N-terminal region. This is especially true for the N-most terminal region (blocked 
in grey, up to residue 49 in PfTFIIB) which is variable in both length and composition. This 
region is also the least conserved between putative Plasmodium species TFIIB proteins with 
less than 50% similarity between P. falciparum and other Plasmodium TFIIB proteins. 
Beyond the 49th amino acid residue (relative to P. falciparum) there is close to 90% 
sequence identity across P. vivax, P. cynomolgi, P. knowlesi, P. chabaudi (chabaudi), P. 
berghei, and P. yoelli (yoelli), as compared to P. falciparum (data not shown).  
Beyond the 49th residue (relative to PfTFIIB) there is increased conservation of residues with 
known function, both in position as well as the identity of the residues. These residues are 
highlighted in colours associated to their function in Figure 5.  
The N-terminus of PfTFIIB maintains conserved functionally important residues 
The function of the N-terminus in eukaryotic TFIIB includes the formation of the zinc-finger 
containing B-ribbon domain which interacts with the “dock” domain of RNAPII in the 
formation of the PIC (ScTFIIB - residues C45, C48, L50, L52 and E62 (Kostrewa et al. 
2009)). Adjacent to the zinc-ribbon motif is the B-reader region. The B-reader region (when 
associated to RNAPII) follows the RNA exit channel from which synthesised RNA extends. 
The B-reader contains helix and loop structures which are thought to locate RNAPII to the 
+1 position (TSS) of the template strand. The mutation of these residues leads to an alteration 
of the TSS (Deng & Roberts 2007). TFIIB localises RNAPII to the TSS through recognition 
of Inr sequence motifs (Fairley et al. 2002; Butler & Kadonaga 2002) (YYANWYY in 
mammals, TCAKTY in Drosophila and TYAYWWW in the apicomplexan Babesia bovis, 
(Yamagishi et al. 2014) with specific residues (in yeast; ScTFIIB – E62, W63, R64, F66, 
R78, V79) (Kostrewa et al. 2009). Interestingly these residues are conserved in PfTFIIB, 




although so far an Inr motif has not been identified or confirmed in P. falciparum gene core 
promoters.  
Between the B-reader region and the first cyclin lies the B-linker region. This region is 
required to bind to the clamp coiled-coil of RNAPII and the residues contained are required 
for promoter opening (ScTFIIB – L71, S72, T73, I75; Grünberg et al. 2012). Although the 
linker region is shorter in PfTFIIB as compared to the human and yeast homologues (by 10 
residues), these residues are largely conserved in PfTFIIB. 
Additionally, a highly conserved region, called the charged cluster domain (CCD; indicated 
by a red bar), is important in regulating the overall TFIIB conformation. TFIIB may be in 
either a closed state, where intramolecular interactions between the N and C terminals appear 
to prevent transcription initiation (but not the formation of the PIC), or the open state where 
initiation is possible (Glossop et al. 2004). The residues implicated in this are highlighted in 
Figure 5B, (HsTFIIB - R53 and R66) and are conserved in PfTFIIB.  
The C-terminal cyclin domains of PfTFIIB differ in conservation to other eukaryotic TFIIBs 
In HsTFIIB, The C-terminal domain (B-core or TFIIBC) is composed of two imperfect direct 
repeats, each consisting of 5 α-helices, termed BH1-5 in the first repeat (amino acids 124-
200), and BH1’-BH5’ in the second repeat (218-294) Figure 5A. HsTFIIBc interacts with 
TBP in the cleft formed by residues linking the two cyclin-like domains. The amino acid 
sequences over the linker region between the cyclin-like repeats differ considerably between 
species, both in length and composition (Figure 5). This region has been shown to form 
another α-helix (BH0), absent in Figure 5, which makes contact with RNAPII (Liu et al. 
2010). The variable length of this region has been suggested partly explain the inability for 
human TFIIB to substitute for yeast TFIIB in  yeast cells (Shaw et al. 1997; Shaw et al. 1996; 
Liu et al. 2010). 




In the stabilisation of TBP-DNA binding, HsTFIIBc interacts with DNA and makes 
sequence-specific contact with DNA elements located directly upstream and downstream of 
the TATA box. This interaction brings additional stability to the TFIIB-TBP-DNA ternary 
structure by increasing the total number of DNA residues contacted in the ternary 
TBP/TFIIB/TATA complex (Tsai & Sigler 2000). These sites are termed the B-recognition 
elements, upstream BRE (BREu) and downstream BRE (BREd) respectively, with the 
consensus sequences of  SSRCGCC and RTDKKKK (Lagrange et al. 1998; Deng & Roberts 
2005). The amino acid sequence over the first cyclin-like repeat domain shows conservation 
of residues thought to interact with the TBP molecules, as well as moderate conservation at 
residues thought to interact with BREd (Figure 5). 
The sequence over the region of the second cyclin-like domain in HsTFIIB shows less 
conservation of PfTFIIB to other eukaryotic TFIIB proteins. It is thought that the BREu is 
contacted by the helix-turn-helix motif composed of evolutionarily conserved residues 
exposed on the recognition loops between the BH4’-BH5’ helices of HsTFIIBc (Lagrange et 
al. 1998). This interaction is thought to be TBP-independent, and to help direct the direction 
of the forming PIC. As in yeast, there is very low conservation of the residues at this site in 
PfTFIIB (Tsai & Sigler 2000). However, there is conservation of positively charged R/K 
residues in the region of the HTH motif which does suggest some conservation of function.  
In addition, there is low conservation of the residues which in the human system interact 
with TBP (and TLP) (Tsai & Sigler 2000). The interaction between PfTBP and PfTFIIBc 
was modelled computationally in 2005 by Buendía-Orozco and co-workers (Buendía-
Orozco et al. 2005), who note that certain residues in the supposed interaction surfaces are 
conserved, such as the highly conserved residues which form the salt-bridge between HsTBP 
and HsTFIIB, but that PfTFIIB also contains several unique amino acid substitutions which 




do not support interactions between the molecules. These predictions need to be tested 
directly in protein-protein interaction and mutation analysis studies  
3.1.2 Prediction of PfTFIIB secondary and tertiary structures 
The low-conservation of the overall sequence of PfTFIIB to the well-described HsTFIIB and 
ScTFIIB prompted the determination of a predicted secondary and tertiary structure for the 
molecule. The program Phyre was used for this analysis.  
Phyre makes use of the PsiPred, SSPro and JNet programs in order to generate secondary 
structure predictions (Kelley & Sternberg 2009), based on the comparison of the input 
sequence to homologous sequences with solved tertiary structures.   
Phyre provides a confidence score from 0-9 on the prediction of secondary structures or 
disordered regions. The scores which are assigned to the secondary structures are illustrated 
in Figure 6.  
PfTFIIB has similar secondary structure arrangement to solved eukaryotic TFIIB molecules 
The secondary structures of HsTFIIB, along with the structural interaction sites/residues 
important for TFIIB function described in the literature, are displayed in Figure 6A. The 
secondary structure arrangement predicted for PfTFIIB, along with the functionally 
important residues homologous to HsTFIIB, are in Figure 6B. Table 7 in the Appendix 5.3 
lists the positions of predicted secondary structures. 
Overall it appears as though the secondary structures of PfTFIIB are highly conserved with 
those present within the known structures of HsTFIIB and ScTFIIB. The predicted structure 
of putative PfTFIIB is predicted to have the secondary structure arrangement necessary to 
form the zinc-finger, supported by the presence of conserved cysteine residues (in red), and 
most probably the rest of the secondary structures of the canonical N-terminus. Although 
Phyre only predicts these structures with low confidence, this is most probably due to the 




lack of structures of the N-terminus present in the protein databases (Kostrewa et al. 2009). 
The length of the region, and the conservation of key interaction residues would suggest the 
formation of the same secondary structure arrangement. The Phyre analysis also predicts the 
presence of conserved cyclin repeats, with a similar number of B-helices in each repeat and 
at locations comparable to the HsTFIIB core domain. There does appear to be a longer C-
terminal region beyond this core domain in PfTFIIB, conserved in Plasmodium spp. which 
may be a feature of Plasmodium TFIIB proteins.  
Overall, Phyre predicts that PfTFIIB has a similar structure to other studied TFIIB proteins. 
Along with general conservation of functionally described residues, this suggests similar 
functionality of PfTFIIB to known eukaryotic TFIIB proteins. Additionally, given the high 
degree of sequence homology, these functions are conserved in other Plasmodium 
orthologous, Figure 6C.  
 
  


































































































































































































































































































































































PfTFIIB protein tertiary structure is similar to eukaryotic TFIIB proteins 
Phyre generates a predicted tertiary structure derived from solved structures previously 
deposited in molecular databanks. The predicted secondary structures of the putative 
PfTFIIB were compared to solved TFIIB structures, shown in Figure 7A and B. The N-
terminal domain description is derived from a solved crystal structure of ScTFIIB, PDB entry 
3K1F.M, solved by Kostrewa et al. (2009). The C-terminal or TFIIB-core domains structural 
information are inferred from the solved structure PDB entry 1VOL (Nikolov et al. 1995).  
Phyre predicts that PfTFIIB contains a C-terminus with two cyclin-like direct repeats 
composed of 5 alpha-helices each, and separated by a linker region (Nikolov et al. 1995), as 
described in other eukaryotes.   
A comparison of the residues present in the cyclin domains was performed as a simple, non-
quantitative test of the integrity of the predicted tertiary structure of PfTFIIBC. Cyclin 
domains are characterised by the presence of 5 alpha-helices, 4 of which surround a central 
alpha-helix. In order to achieve this structure, the central helix (H3/H3’) is composed of 
predominantly hydrophobic residues, while the 4 external helices (H1, H2, H4, H5/H1’, H2’, 
H4’, H5’) are amphipathic, with hydrophobic residues facing inwards towards the central 
helix. The second cyclin shows the lowest sequence homology of PfTFIIB to other 
eukaryotic TFIIBs, as is shown here. The residues in the second cyclins of HsTFIIB and 
PfTFIIB were coloured according to their broad physiochemical properties at pH 7 (Monera 
et al. 1995) (Figure 8). From a comparison of the two structures, it is revealed that the 
predicted cyclin regions of PfTFIIB contain amino acid residues that would contribute 




towards the folding of the cyclin domains. This supports the Phyre prediction that the 
PfTFIIB C-terminal region folds into the canonical cyclin domains.  
Figure 7: Comparison of TFIIB solved crystal structure with predicted PfTFIIB tertiary 
structure. 
Solved and predicted structures of known TFIIB (Sc and HsTFIIB) and Phyre predicted PfTFIIB 
are shown in box insets, with a schematic of the broad secondary structure arrangements shown 
above. α-helices are coloured in purple, β-sheets are coloured orange. Disordered regions are 
coloured in yellow. The (cys/his) residues responsible for the formation of the zinc-finger are 
coloured red. The α -helices of the TFIIBc are labelled as B-helices or BH 1-5 and 1’-5’, 
respectively. HsTFIIB C-terminus: PDB entry 1VOL (Nikolov et al. 1995); ScTFIIB N-terminus: 
PDB entry 3K1F.M, (Kostrewa et al. 2009). 




3.1.3 Summary of in silico analysis of PfTFIIB 
The amino acid sequence alignments and the in silico analysis of the putative PfTFIIB 
structure suggest an overall conservation of the main structural and functional features of 
classical TFIIB. Although there is a low-sequence homology at the amino acid level of the 
protein, there is strong support to the classification of the protein as a TFIIB molecule, albeit 
with some notable Plasmodium-specific features.  
  
Figure 8: Comparison of the second cyclin domain of HsTFIIB and PfTFIIB. 
Physiochemical properties of the residues of HsTFIIB (A) and predicted PfTFIIB (B) proteins are 
shaded according to the residue physiochemical properties at pH 7: 
Yellow - hydrophobic residues of H3' core 
Green - hydrophobic residues interacting with H3' core 
Pale blue - hydrophobic residues that do appear to interact with H3' core 
Red – Charged (acidic and basic) residues (K,R,D,E) 
Orange - non-charged residues 




Although the majority of the molecule is very highly conserved between Plasmodium spp., 
the N-most terminal region is longer in P. falciparum (49 residues) and is extremely basic. 
This region has an average calculated isoelectric point of 12.53, higher than that calculated 
in human TFIIB, Table 4. Similarly, the C-most terminal region is longer than other 
eukaryotic TFIIB molecules, and is more positively charged at pI 10.19 as compared to 
HsTFIIB with a pI of 4.45. Phyre predicts the possibility of helices in both of these regions. 
This may suggest the presence of additional DNA-binding motifs in PfTFIIB not seen in 
other eukaryotic organisms. Future work into visualising this region may be important to the 
understanding of this putative TFIIB orthologue.  
There is conservation of canonical N-terminal structures and residues important for TFIIB 
inter- and intramolecular interactions in PfTFIIB. These interactions, such as those involved 
in RNAPII interactions, are supported by the deep conservation of these TFIIB and TFB 
molecules in the eukaryote and archaebacterial orthologues studied (Kostrewa et al. 2009; 
Liu et al. 2010). It seems likely, therefore, that PfTFIIB maintains its role in the formation 
of the PIC. Interestingly, considering the A+T richness of the P. falciparum genome, there 
is also conservation of the residues involved in both the localisation of RNAPII to TSS, as 
well as the residues used to identify the Inr motif in other eukaryotes, although the Inr motif 
has not been identified in P. falciparum.  
Table 4: Comparison of calculated charge of human and putative Plasmodium TFIIB 
proteins, separated by region 
Region PfTFIIB  HsTFIIB 
 Residues pI  Residues pI 
N-terminus 1 - 48 12,53  1 - 13 10,4 
B-ribbon 49 - 81 4,26  14 - 45 4,04 
B-reader 82 - 108 4,38  46 - 71 4,59 
B-linker (sheet) 109 - 121 3.55  72 - 85 3.49 
B-linker (helix) 127 - 140 11.28  86 - 113 10.24 
Core (BH1-BH5') 141 - 338 9,69  114 - 293 9,88 
C-terminus 339 - 367 10,19  294 - 316 4,45 
      
Average  9.73   8.48 
 




There appears to be greater conservation of the first cyclin domain than that of the second 
cyclin domain. There is greater conservation of classical TBP-interaction sites in the first 
repeat than in the linker region and second cyclin. The reciprocal residues in TBP, and 
potential interactions between the molecules, should be investigated.  
The increased conservation of the first cyclin compared to the second is also true for the 
residues implicated in locating the BREd sequence motif, as compared to the less conserved 
BH3’-BH4’. It is possible that P. falciparum promoters contain a BREd element similar to 
the classical BREd motifs described. The BREu recognition HTH motif in PfTFIIB is far 
less conserved, with the exception of the basic residues in the HTH and supporting H3’ helix. 
This is similar to plants and yeast, where the HTH motif appears to be largely missing (Tsai 
& Sigler 2000). This suggests either a divergence of the BREu motif in Plasmodium 
promoters, or perhaps significant alteration to the consensus sequence. 
 
  
   




 Bioinformatics analysis of putative PfTLP – structure and function 
3.2.1 Amino acid sequence alignment analysis 
In order to assess the evolutionary conservation of PfTLP as a member of the TBP-family, 
amino acid sequence analysis was performed.  
Pairwise alignments of PfTLP with HsTBP (the core region, amino acids 163-339) or HsTLP 
were attempted. However, it was not possible to generate a meaningful result from these 
alignments. The low sequence homology of PfTLP to HsTBP or HsTLP resulted in large 
gaps and low-confidence alignments (data not shown). 
PfTLP is 368 residues in length, HsTLP is 186 residues in length, and the full-length HsTBP 
molecule is 339 amino acids in length, with a core region of about 180 residues. Whereas 
HsTBP and many of its homologues, have a long and variable glutamine-rich N-terminus 
which extends the length of the protein, PfTLP instead has lengthy low-complexity regions 
(LCRs) in the sequence. The presence of LCR regions combined with the sequence 
divergence of Plasmodium protein, prevents pairwise alignments with the protein 
orthologues in other eukaryotes. 
In view of the inability to perform direct one-on-one alignments of PfTLP with other TBPs, 
several (simultaneous) approaches were made to define the regions which contain TBP-like 
functional regions of PfTLP.  
Firstly, a multiple-sequence alignment was performed  with TBP and TRF molecules from 
various organisms making use of the constraint-based alignment tool (COBALT) for 
multiple protein sequences (Papadopoulos & Agarwala 2007), a summary of which is 
displayed in Figure 9. PfTLP has not been described at all in the literature, and the 
relationship it holds with other TBP or TBP-related factors is unknown. Plasmodium is an 
apicomplexan protist, and is evolutionarily distant from organisms which have well-




characterised TBP/TRF molecules. For this reason, a selection of TBP/TRFs were chosen 
for the alignment, and included animal (Homo sapiens, the insect Drosophila melanogaster, 
Danio rerio, Xenopus laevis), plant (Arabidopsis thaliana), yeast (Saccharomyces 
cerevisiae), archaebacterial (Pyrococcus furiosus, Methanococcus maripaludis), as well as 
other putative apicomplexan (Plasmodium falciparum, Theileria annulata, Toxoplasma 
gondii) TBP and TRFs. For ease of interpretation only a selection of the proteins from the 
alignment are shown in Figure 9.  
Appended to Figure 9 are residues which have been identified in HsTBP to have functional 
roles, such as interactions with TFIIB, TFIIA, and DNA, as entered in the NCBI entry for 
HsTBP (Nikolov et al. 1995; Kim & Burley 1994; Geiger et al. 1996). Additionally, for the 
ease of interpretation, the LCR regions of PfTLP and the variable N-terminal regions of the 
TBP molecules are not fully displayed. 
PfTLP shares conservation of functionally important residues 
Eukaryotic (and prokaryotic) TBP and TRFs differ substantially in the N-terminal region. 
The core region shows a great deal of conservation across the proteins, especially at the 
functionally important residues (residues which interact with TFIIB, TFIIA and DNA). 
PfTLP does not appear to have many of the residues conserved for the association to TFIIA 
(green in Figure 9). There are extreme amino acid substitutions at these residues. 
Additionally, the presence of the large LCR adjacent to the canonical TFIIA binding site 
does suggest that PfTFIIA may not bind to the Plasmodium orthologue of TFIIA. This stands 
in contrast to the conservation of many homologous residues required for the binding of 
TFIIB. 




Finally, when TBP binds to the TATA box a conserved set of phenylalanine residues are 
projected into the minor groove of the DNA, and cause the DNA to bend. These 
phenylalanine resides are highly conserved in TBP molecules, but in TLP molecules one or 
more of these resides are frequently missing. HsTLP contains only a single conserved 
Figure 9: Multiple sequence alignment of TBP-family proteins. 
COBALT alignment of selected sequences from a multiple sequence alignment of TBP and TBP-
related factors from a range of eukaryotic and prokaryotic organisms. Inset in the box are the full 
names of the species displayed.  
Secondary structures of HsTBP are shown below the sequences. H and S refer to α-helices (purple) 
and β-sheets (orange) respectively. Low complexity regions in PfTLP are indicated in pale yellow. 
HsTBP sites which interact with HsTFIIA, HsTFIIB and DNA are coloured in green, blue and grey 
respectively. The conserved DNA-interacting phenylalanine residues are indicated in red. Invariant 
residues are indicated by an asterisk. Homologous residues are indicated by a colon, and in cases 
where the majority of the residues are conserved between species, a period is used.  
 




phenylalanine residue, and the DNA binding of this molecule is not sequence specific for 
TATA box (Thomas & Chiang 2006). This is not the case for PfTLP, where all four 
phenylalanine residues are conserved. This is interesting given the A+T rich content of the 
P. falciparum genome. Also intriguingly, PfTBP is missing the first phenylalanine residue.  
PfTLP may be a distinct member of the TBP-related factors 
Apicomplexan TLPs have not been described in the literature. In order to gain an 
understanding of their relatedness to other TRF proteins, the multiple-sequence alignment 
generated for Figure 9 was used to generate a minimal-evolution phylogenetic tree (Figure 
10). The phylogenetic analysis places the apicomplexan TBPs and TLPs into separate clades. 
PfTBP is placed in a large clade which encompasses both eukaryotic and archaebacterial 
TBP proteins. PfTLP and the other putative apicomplexan TLPs are placed distinctly 
separately from the rest of the TLP molecules. Note that Toxoplasma gondii TLP and TBP 
molecules are placed in alternate clades. The sequence alignment data combined with the 
phylogenetic information suggest that the proteins have been incorrectly annotated; TgTBP 
is most likely a TLP and vice versa. 
The separation of the putative apicomplexan TLPs suggest that they may have arisen from 
an alternative gene expansion event from those which gave rise to the other eukaryotic TLPs. 
However, several caveats to this analysis must be mentioned. Firstly, it was not possible to 
take into account the very varied rates of evolution between such diverse organisms. In the 
formation of the dataset, gaps and missing data were removed from the aligned sequences, 
(157 positions were used in the final dataset) this would have removed the LCR regions as 
well as affected any other variable regions between the molecules. The effect of these 
variable length regions have not been characterised, and the impact they have on the rate of 
evolution is unknown. This result, therefore, is determined from the minimal evolution that 
would be required to generate the core-regions of the TBP and TBP-like proteins compared. 





3.2.2 Prediction of PfTLP secondary and tertiary structures 
The high degree of conservation of PfTLP to other TBP/TLP molecules suggested in Figure 
9 suggests that PfTLP has many features that are common to TBP/TLPs. However, the 
presence of the low-complexity regions does call into question if the molecule can form the 
appropriate secondary structures ascribed to TBP molecules, and if so, whether this structure 
is able to fold into an appropriate tertiary structure.  
Figure 10: Phylogenetic analysis of TBP-family proteins. 
Minimum-Evolution (CNI algorithm) tree of a sequence alignment of members of the TBP-family of 
proteins aligned in COBALT (Figure 9). Branch length is proportional to evolutionary distances 
computed by Poisson correction. Bootstrap test (500 replicates) was performed. 
Colours are used to make the clades distinct. Red/pink indicate TBP/TBP2; orange indicates TLP 
(TRF2/TLF); yellow indicates TRF1 (Drosophila specific).  
 
 




TBP (and its homologues/orthologues) core region/ C-terminal domain is a semi-
symmetrical saddle-shaped structure, with a concave and positively charged surface which 
makes contact with the DNA, while the convex surface makes contact with other 
proteins/factors (Nikolov et al. 1995). The concave surface is made up of anti-parallel β-
sheets, S1-S5 and S1’-S5’. Two long α-helices run along and on top of this beta-barrel motif, 
with two short α-helices at either end.  
Phyre secondary structure prediction was performed with the PfTLP sequence. The result of 
this prediction is presented in Figure 11, where it is compared to the known secondary 
structure of HsTBP.  
In Figure 11, the regions boxed together are the regions with the greatest sequence 
homology. There appears to be general conservation of predicted secondary structures of 
PfTLP to HsTBP in these boxed regions. Additionally, the general arrangement of secondary 
structures in this region are similar to those in HsTBP. The large LCR region between the 
presumptive S3 and S4 beta-sheets also has several predicted structures. These structures are 
likely the result of repetitive sequences in the region, which may make partial alignments to 
regions in the scaffold sequences used to generate the secondary structure prediction. 
Interestingly, there is symmetry in the location of the LCR regions, with one LCR placed 
between the S3 and S4 sheets, while the other is placed between the S3’ and S4’. 


































































































































































































































































































































































































































Chapter 3 Results and Discussion 
73 
Plasmodium TLP multiple sequence alignment 
In order to investigate whether the predicted LCRs are likely to be correct, and not a feature 
of TLPs in Plasmodium TLP proteins, a multiple sequence alignment of putative, 
computationally identified, Plasmodium TLPs were compared. This alignment is presented 
in Figure 12, and the core region of HsTBP has been appended to the graphical alignment to 
give positioning to the described TBP structural arrangement. From this figure it becomes 
clear that the conservation between the Plasmodia TLPs is greatest in the regions which are 
most conserved with other organisms, and least in the first LCR. The ~70-200 amino acid 
residue regions of PfTLP show very little homology to regions in the other Plasmodium spp. 
barring that P. reichenowi, a very close relative. Increased susceptibility to mutations 
through less stringent evolutionary pressure on the residues to remain the same may account 
for both the variability in amino acids as and the variation in length of this region in the 
Plasmodium TLPs. There is moderate homology in the second LCR, between S3’ and S4’, 
but not the degree that is present in the presumed functional regions.  
Interestingly, in PfTLP the first LCR (from residue ~74 to residue ~222, or nucleotides ~222-
666) has a guanine + cytosine (G, C) content of 18.3% (a Heterogeneous LCR) while the
second LCR (from residues ~293-326, or nucleotides ~879-978) has a G+C content of 33.3% 
and appears to be a HighGC class LCR (Zilversmit, Volkman, Depristo, et al. 2010). Note 
that it is difficult without confirmed structural and functional data to assign rigid boundaries 
to the LCR positions in the PfTLP sequence. These locations have been chosen with 
consideration given to their alignments against other TBP/TLP molecules, as well as the 
predicted secondary structure locations. They are open to further definition. 
Although both LCRs are present within symmetrically 



















































































































































































































positioned loops, at the S3-S4 loop and S3’-S4’ loop. It is known that LCRs typically form 
at turns, and are positioned as a loop out of the main globular structure. Supporting this is 
that 72% of the residues in the large LCR are polar and the LCR should be water soluble. It 
should also be noted that the presence of these large low complexity regions may have an 
effect on the correct folding and expression of the proteins in heterologous systems, such as 
the prokaryotic E. coli (Mehlin et al. 2006).  
Tertiary Structure Prediction of PfTLP 
The Phyre prediction also generates a tertiary structure from databases of solved protein 
structures. The predicted structure of PfTLP is shown in Figure 13, along with the known 
structure of HsTFIIB. Appended to this figure is a 2-dimensional schematic of the proteins, 
for easy comparison.   
The predicted structure of Plasmodium falciparum TLP appears to be semi-symmetrical and 
similar to the canonical TBP structure, albeit with sets of only four β-sheet motifs, as 
compared to the five in HsTBP. Interestingly, the conserved phenylalanine residues, which 
prise into the DNA helix are conserved and placed at similar locations. The predicted LCR 
regions are placed in the turns between the S3-S4 and S3’-S4’ sheets. Interestingly, these 
LCRs are adjacent to where in humans, HsTBP is known to form complexes with TFIIB and 
TFIIA. The residues responsible for TFIIA interactions have been noted to be less conserved 
than those seen in TFIIB. This raises interest in the ability for PfTLP to bind to the 
homologues of these factors identified in Plasmodium.  
  







Figure 13: The predicted PfTLP structure is analogous to HsTBP. 
 Schematics shown to the right of 3D structures show the semi-symmetrical nature of the molecules 
and indicate the placement and direction of alternating β-sheets (orange) which form the β-barrel. α-
helices are coloured purple. 




3.2.3 Summary of in silico analysis of PfTLP 
The amino acid sequence alignments and the in silico analysis of the putative PfTLP 
structure suggest an overall conservation of the main structural and functional features of 
canonical TBP/TLP molecules, albeit with some notable Plasmodium-specific features. The 
most obvious of these is the presence of the LCRs in the molecule. Interestingly, while 
PfTLP displays these LCR structures, putative PfTBP does not. Additionally, PfTBP has the 
classical long N-terminal region, which is not true for PfTLP, nor other TRF2 molecules 
(Thomas & Chiang 2006). This suggests that putative PfTLP has correctly been annotated 
as a TBP-related factor, but as evidenced from a phylogenetic analysis, as well as the 
presence of the four phenylalanine residues, not necessarily a TRF2 orthologue. The ability 
for PfTLP to bind DNA seems likely. The protein has an overall basic charge, a pI of 9.71, 
and appears to have the ability to fold a β-barrel similar to canonical TBP proteins. It should 
be noted that the first long complexity region has a basic pI of 9.39 (residues 71-202), and 
may possibly have secondary structures form in this region. This may suggest additional 
DNA-interaction motifs. Should PfTLP be shown to have clear DNA-binding activity, this 
region should be investigated for a potential role in DNA-binding.  
Interestingly, in silico prediction of the general transcription factors, has predicted a single 
large subunit, and two small subunits (γ-subunit) of putative PfTFIIA (PlasmoDB accession 
codes Pf3d7_1250700 and PF3D7_0933700). It is known that in frog oocytes, the TLP 
orthologue interacts predominantly with an analogue to TFIIA, the TFIIA-like factor (ALF), 
which has not yet been identified in P. falciparum. Similarly, the transcriptome profile of 
PfTLP and the small TFIIA γ-subunit PF3D7_0933700, are both shown to be predominantly 
expressed in the gametocytes of the parasite (www.PlasmoDB.org). The potential for 
interactions of PfTLP/PfTBP with alternate TFIIA-gamma subunits should be investigated, 
and may shed light on the roles of these two proteins.  




 Expression and Purification of Plasmodium TFIIB  
An expression vector for PfTFIIB was cloned previously in the lab and provided by Dr 
Thomas Oelgeschläger. This vector expresses PfTFIIB with an N-terminal hexahistidine tag, 
and is driven by a T7 promoter (Figure 45). T7 polymerase is expressed BL21-codonPlus® 
(DE3)-RIL cells through induction of the lacUV5 promoter with IPTG.  
3.3.1 IPTG-induced overexpression of recombinant Plasmodium TFIIB 
leads to a reduction in cell growth in E. coli. 
IPTG-induced overexpression of 6His-PfTFIIB was performed in order to assess the effects 
of heterologous gene expression on the E. coli host cell, and to set a basis for future 
expression trials. To this end, two sets of E. coli BL21-codonPlus® (DE3)-RIL cell cultures, 
transformed with the pET11d-6His-PfTFIIB vector, were grown in liquid media at 37°C. 
The density of the cell cultures were monitored by light spectrophotometry (wavelength of 
600nm). At an OD600nm of approximately 0.5, one of the cultures was induced with 1mM 
IPTG. The cell growth was monitored, and the cell cultures harvested two hours post-
induction (Figure 14). 
Induction of protein expression by IPTG resulted in a reduction in growth of the induced cell 
culture, as compared to the non-induced control. This indicates that the IPTG-induced 
overexpression of 6His-PfTFIIB is detrimental to the host cell-growth. The reduction of cell-
growth was reasoned to be due to the metabolic stress arising from the strongly induced 
overexpression of both T7 polymerase, as well as recombinant 6His-PfTFIIB. The 
expression of 6His-PfTFIIB protein by the cells was, therefore, investigated.  
 





3.3.2 Expression of recombinant Plasmodium TFIIB can be achieved from 
non-induced cell cultures. 
In order to determine the expression of recombinant Plasmodium TFIIB protein from the 
harvested cell pellets from the IPTG-induced protein expression experiment, the cells were 
lysed and the soluble protein fraction (cleared cell lysate) recovered. Note that the cell mass 
recovered from the IPTG-induced cell culture was less than that of the non-induced cell 
culture. The cell mass to volume ratio of these cleared cell lysates were prepared identically 
(5ml of sonication buffer per gram of cell mass). A pilot-scale affinity purification with 
PureProteome™ Nickel Magnetic Beads (Merck Millipore; abbreviation: Ni-beads) was 
conducted (Figure 15). It was found that there was enrichment of a protein at the expected 
size for 6His-PfTFIIB protein in both the non-induced (A) and IPTG-induced (B) cultures. 
 
Figure 14: IPTG-induced 6His-PfTFIIB overexpression in E. coli BL21-CodonPlus-RIL cells 
leads to growth inhibition. 
 Cell densities of cultures, measured at wavelength 600nm, were plotted against the number of 
hours post-inoculation of expression culture from overnight cultures. Growth of the induced culture 
(black) is compared to a non-induced culture (grey). The time of induction with 1mM IPTG is 
indicated by a black arrow. 




The enriched protein in the non-induced sample was similar in molecular mass (kDa) and 
quantity (relative to the input lanes) to the IPTG-induced sample, which suggests that the 
enriched protein in both samples was either a contaminant, or 6His-PfTFIIB protein. 
Additional attempts to express PfTFIIB protein consistently led to similar results as in Figure 
15; IPTG-induction of 6His-PfTFIIB protein expression results in both reduced cell growth 
and cell mass recovered. Additionally, the expression of 6His-PfTFIIB may be achieved 
from the non-induced cell cultures. Considering that more cell mass can be harvested from 
the non-induced cell cultures than from induced cell cultures, and that the quantity of 6His-
PfTFIIB per gram of cell mass is similar, it was reasoned that expression of 6His-PfTFIIB 
from non-induced cell cultures would be a more efficient and cost-effective method of 
recombinant protein production.   
The media used for the experiment described in Figures 14 and 15 was prepared from 
tryptone powder. Tryptone powder is prepared from the enzymatic digestion of casein, 
Figure 15: PfTFIIB protein is expressed in both induced and non-induced E. coli cells. 
E. coli BL21-CodonPlus-RIL cells carrying the expression vector pET11d-6His-PfTFIIB were 
grown and either induced with 1mM IPTG (Panel B) or not (Panel A). Protein was purified by 
nickel-affinity purification from cleared cell lysates and analysed by SDS-PAGE. Equivalent 
amounts of cleared lysate input (In; 15/1000 vol.) and the protein fraction not bound to the Ni-
beads (unbound, Ub), and the protein fraction eluted from the Ni-beads with 2×SDS-loading buffer 
(E, ½ vol.) were loaded. A black arrow indicates the expected size of 6His-PfTFIIB protein at 
44kDa. Molecular weight marker (Mw) – 5µl of Precision Plus Protein All Blue standard 
(Bio-Rad). 
 




derived from bovine milk and it is known that tryptone powder may be contaminated with 
traces of lactose. Lactose has been extensively studied in the activation of transcription from 
the Lac operon (Perlman et al. 1969) as part of the innate metabolism regulation pathways 
in E. coli. The Lac operon has been incorporated into the E. coli BL21 strains in order to 
regulate the expression of T7 polymerase which in turn drives protein expression from 
plasmids containing a T7 promoter, in this case pET11d plasmids. The presence of lactose 
in the media may thus account for the presence of protein expressed in the non-induced 
sample.  
The Lac operon is repressed through the action of the catabolite activator protein (CAP) 
naturally expressed in E. coli in the presence of glucose (Perlman et al. 1969). It was 
reasoned that the addition of glucose to the growth media would repress the leaky expression 
of T7 polymerase, and therefore inhibit 6His-PfTFIIB expression. Should the expression of 
T7 and/or 6His-PfTFIIB negatively affect the growth of the cells, it is likely that the 
transformation of cells on plates without glucose may select against cells which express high 
levels of the proteins. For this reason, E. coli BL21-CodonPlus-RIL cells were transformed and 
plated onto media that contained 1% (w/v) glucose.  
3.3.3 Expression of recombinant Plasmodium TFIIB can be achieved from 
the release of catabolite repression in non-induced cell cultures. 
Having identified potential recombinant protein expression from non-induced cell cultures, 
it was investigated whether protein expression through an ‘auto-induction’ method could be 
increased.  
Diauxic growth of E.coli cells grown in glucose-supplemented media 
E. coli cells grown in media supplemented with glucose exhibit a diauxic growth curve as 
the bacteria alter their metabolism based on the availability of nutrients (Wong et al. 1997). 




Diauxic growth is characterised by the presence of two exponential and stationary growth 
phases. An initial exponential growth phase occurs as the cells grow on the easily 
metabolised glucose. As the glucose is depleted the cells enter a short stationary phase as 
they adjust their metabolic machinery for the utilisation of a secondary nutrient source. A 
second exponential phase begins as they start to metabolise the alternative energy source.  
This experiment sought to investigate whether the lacUV promoter driven T7 polymerase 
expression could be repressed by the supplementation of the growth media with glucose. 
Additionally, as the cell culture is depleted of glucose, whether the lifting of catabolite-
repression would result in the expression of T7 polymerase, and thus recombinant PfTFIIB.  
In this experiment, both the overnight cultures used to inoculate the expression cultures, as 
well as the expression cultures were supplemented with 1% glucose to repress leaky 
expression from the lacUV operon. Two cell cultures were grown, and the growth of the 
cells measured by spectrophotometry. One culture was harvested late into the first 
 
Figure 16: Diauxic growth of transformed E. coli cells in growth media supplemented with 
1%glucose.  
E. coli BL21-codonPlus® (DE3)-RIL cells carrying the expression vector pET11d-6His-PfTFIIB 
were grown and harvested at the late initial exponential phase or early in the second exponential 
phase. Optical densities of the cultures are plotted against time.  




exponential growth phase, when catabolite repression should be in place. A second culture 
was allowed to grow past the first stationary phase, at which point the glucose-derived 
catabolite repression would be lifted. As expected, the cell culture allowed to continue to 
grow past an initial exponential phase displayed a diauxic growth curve (Figure 16). 
PfTFIIB protein is expressed through the release of catabolite repression 
Expressed 6His-PfTFIIB protein was purified from cleared cell lysates and analysed by 
SDS-PAGE as described above. It is clear in the comparison of the protein purified from the 
culture harvested late in the first exponential phase, and that which was grown to the 
beginning of the second exponential phase (Figure 17), that protein is expressed through 
‘auto-induction’, due to the release of catabolite-repression. Additionally, due to the 
presence of glucose in the media, the rate of cell-growth was increased, and resulted in higher 
 
Figure 17: Increased expression of recombinant PfTFIIB protein in E. coli BL21-codonPlus® 
(DE3)-RIL cells through the release of catabolite repression.  
E. coli cells carrying the expression vector pET11d-6His-PfTFIIB were grown and harvested either at 
the late initial exponential phase (Panel A), or early second exponential phase (Panel B). Protein was 
purified by nickel-affinity purification from cleared cell lysates and analysed by SDS-PAGE. Equivalent 
amounts of cleared lysate input (In, 1/100 vol.), and the protein fraction not bound to the Ni-beads 
(unbound, Ub), and the protein fraction eluted from the Ni-beads with 2×SDS-loading buffer (E, ½ vol.) 
were loaded. A black arrow indicates the expected size of 6His-PfTFIIB protein at 44kDa. Molecular 









cell-density and increased harvested cell mass. These results clearly show that PfTFIIB may 
be efficiently expressed through auto-induction. The identity of 6His-PfTFIIB was 
confirmed by mass spectrometry. 
Having successfully determined the conditions necessary for 6His-PfTFIIB expression, 
accumulation of cell mass of cells which had expressed the protein was performed.  
Discussion of expression of 6His-PfTFIIB  
There is clear growth reduction upon induction with 1mM IPTG in the 6His-PfTFIIB 
expressing cells as compared to the non-induced cell culture, (Figure 14). This suggests that 
the induction of the cell cultures with IPTG led directly to either a reduction in cell growth 
and/or cell death. Upon induction with IPTG the cells are required to utilise many cell-
resources in order to synthesise both the T7 polymerase, as well as 6His-PfTFIIB proteins. 
The metabolic burden of heterologous gene expression and protein synthesis may deter cell 
growth or prove to be toxic, and this is a known issue with heterologous gene expression the 
BL21(DE3) E. coli cells (Rosano & Ceccarelli 2014; Bentley et al. 1990; Dumon-Seignovert 
et al. 2004). This protein over-production may result in cell death. It is also known that 
individual cells may vary widely both in their sensitivity to an inducing agent, as well as in 
their protein expression. It is suggested that since the protein expression per gram of cell 
mass in both cultures was the same, the cells which survived induction by IPTG ultimately 
expressed similar average quantities of protein per cell, however, due to the decrease of 
harvestable cell mass from these induced cell cultures, it was decided to instead make use of 
the auto-induction method of protein expression. 
3.3.4  Bulk purification of recombinant 6His-PfTFIIB protein 
Purification of a bulk preparation of recombinant 6His-PfTFIIB protein was performed as 
described in Chapter 2.5.2. The fractions containing the greatest amount of protein were 




pooled, and titrated against a standard curve of BSA protein ( 
Figure 18 and Figure 49 in the Appendix). The total pooled protein fraction was 1.4ml, at a 
concentration of 50ng/µl per band of the doublet, or 100ng/µl in total.  
Analysis of purified 6His-PfTFIIB 
From Figure 18 (full gel is presented in the Appendix 5.6 as Figure 49), it appears as though 
two bands are present in the region of 44kDa. The two bands are approximately 2-3kDa 
different in size, with the top band determined by a standard curve against the molecular 
weight marker being approximately 44kDa, and the lower band approximately 42kDa.  
This is consistent with the results seen throughout the optimisation of protein expression, 
during the accumulation of protein expressed cell mass, and in the purification of the sample. 
It is unclear if one of the bands of the doublet is the result of a contaminant in the protein 
preparation. Table 5 contains an abbreviated list of common proteins which may 
contaminant protein preparations purified through immobilised metal affinity 
chromatography, as was used here. Several species of proteins may have contaminated the 
preparation at the molecular weight expected for 6His-PfTFIIB, such as ArgE and ODO2, 
which are known to frequently contaminate Ni-NTA affinity preparations from E. coli 





CAT  AAA57080  25.5 5.9 
ArgE  P23908 42.3 5.5 
ODO2  P07016 44.0 5.5 
YfbG  P77398 74.2 6.3 
 
Table 5: Abbreviated table of metal-affinity purification commonly contaminating proteins; 
derived from Bolanos-Garcia & Davies (2006) 




(Bolanos-Garcia & Davies 2006). However, throughout the protein expression trials the 
protein bands of the doublet at 44kDa consistently remained at approximately the same 
quantity, and were enriched well beyond that of other contaminant proteins. Additionally, 
BL21-codonPlus® (DE3)-RIL E. coli cells not carrying an expression plasmid were grown 
under similar conditions, and the soluble protein analysed through Ni-NTA affinity 
purification (Figure 48, the Appendix 5.5). There is little indication of enrichment of proteins 
at the 44kDa molecular weight in these non-transformed bacteria, suggesting that the two 
bands of the doublet are indeed PfTFIIB.  
This suggests a number of possibilities; the protein is expressed as two isoforms of differing 
lengths perhaps due to a C-terminal degradation or the premature termination of translation.  
The doublet may also have arisen due to incomplete denaturation of the protein prior to 
 
Figure 18: Determination of concentration and purity of 6His-PfTFIIB. 
BSA standards were loaded in lanes 1-4, 5µg, 2µg, 1µg and 0.5µg respectively. Lanes 5-8, 10µl, 
5µl, 2µl, and 1µl of pooled protein fractions respectively (1.4ml total). Expected size for 6His-
PfTFIIB is 44kDa, indicated with a black arrow. Molecular weight marker (Mw) – 5µl of Precision 
Plus Protein All Blue standard (Bio-Rad). 




loading on the SDS-PAGE, perhaps due to highly stable bonds, or that a post-translational 
modification event has occurred on the protein.  
An immunoblot was performed, making use of anti-sera from rabbits immunised against a 
peptide, located on the C-most terminal end of the predicted PfTFIIB sequence, (residues 
353-367) characterised by Gertrud Talvik, an MSc student in the lab. Should the protein 
have terminated prematurely, or undergone C-terminal degradation, this region should be 
missing in the lower band of the doublet, and only the upper band of the doublet should be 
present. However, as seen in Figure 19 there is reactivity against both bands in the 44kDa 
region. It is noted that a large quantity of protein was loaded onto this SDS-PAGE, and so 
the detection of a doublet may simply be due to low-specificity of the anti-body. However, 
additional work in the laboratory has demonstrated that the anti-body is indeed specific to 
the heterologous PfTFIIB in much reduced concentrations. Additionally, recent work in the 
laboratory to express a 6His-PfTFIIB-GST protein has shown similar results, with the 
consistent expression of a doublet at the expected size (Gertrud Talvik, unpublished 
observations). This suggests that the doublet is the result of structures resistant to 
denaturation, or due to post-translational modifications. It may also be suggested that the 
doublet of protein represent a mixed TFIIB population of closed and open form, as has 
 
Figure 19: Immunoblot showing the reactivity of 6His-
PfTFIIB to peptide-raised antibody.  
150ng/µl of 6His-PfTFIIB protein preparation (per band of 
the doublet) was separated on a 5/12% SDS-PAGE and 
transferred to a PVDF membrane. The membrane was 
probed with a 1/1000 dilution of anti-PfTFIIB sera, 
followed by a 1/3000 anti-rabbit goat IgG-coupled 
peroxidase. Immunoreactivity detected with ECL 
substrate, and exposure to X-ray film. 
Black arrow indicates the doublet at the expected size of 
6His-PfTFIIB protein. Molecular weight marker - 4µl of 
Protein Plus Unstained marker (Bio-Rad). 




been described for HsTFIIB (Glossop et al. 2004). This requires additional investigation, 
and was not pursued further in this project.  
3.3.5 Further purification of 6His-PfTFIIB 
Attempts were made to remove the contaminants present within the 6His-PfTFIIB protein 
preparation through the use of ion-exchange resins. The predicted pI of 6His-PfTFIIB is 9.81 
and the BC-100 buffer the protein eluted in contains a KCl concentration of 100mM, and a 
pH of 7.8 at 4°C. The majority of the common Ni-NTA affinity preparation contaminating 
proteins have pIs below 7 (Bolanos-Garcia & Davies 2006). Therefore, the initial 
purification attempt of the 6His-PfTFIIB protein preparation was performed through batch-
purification with the strong cation exchange resin, sulphopropyl- Sepharose® Fast Flow 
(SP-Sepharose®; Sigma-Aldrich®). Proteins were bound at 100mM KCl and eluted with 
increasing KCl concentrations (Figure 20A). However, the majority of the recombinant 
PfTFIIB protein as well as the contaminants were not bound to SP-Sepharose® resin. Further 
attempts to purify 6His-PfTFIIB were conducted with different cation and anion exchange 
resins. The resins used were: quaternary ammonium-Sepharose® (Q) Fast Flow, a strong 
anion exchange resin; diethylaminoethanol-Sepharose® (DEAE) Fast Flow, a weak anion 
exchange; and carboxymethyl-Sepharose® (CM) Fast Flow, a weak cation exchange resin. 




A proportion of the 6His-PfTFIIB protein was bound to DEAE- Sepharose® resin and was 
only partially eluted with high salt concentrations from the resin (see lanes 5 and 6 of Figure 
20B). The majority of the protein, however, was still uncaptured by the resin. Only limited 
binding of contaminant proteins to Q-Sepharose® was seen (not shown). No binding of 
Figure 20: 6His-PfTFIIB binds partially to weak anion-exchange resin. 
A. PfTFIIB and the majority of the contaminants do not bind to SP Sepharose® resin. 100ng of 
6His-PfTFIIB was loaded into the input lane (In), and an equivalent amount of the protein not 
bound (unbound, Ub). 1.5× of the input is loaded in each of the KCl elution lanes 3-5.  
B. Partial binding of 6His-PfTFIIB to DEAE resin and partial elution at 400mM KCl.  100ng of 
6His-PfTFIIB was loaded into the input lane (In), and 1.5× of the equivalent amount of the protein 
not bound (unbound, Ub). 1.5× of the input is loaded in each of the KCl elution lanes 3-5. Lane 6 
contains 1/6th of the resin (R), eluted in 2×SDS loading buffer.  
Molecular weight marker (Mw) - 2µl of Precision Plus Protein All Blue standard (Bio-Rad).  
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PfTFIIB or contaminant proteins to CM-Sepharose® was seen (not shown). The partial 
binding of PfTFIIB to DEAE resin suggests heterogeneity in the protein preparation. It is 
possible that some proportion of the protein may have aggregated. The protein contains 
regions which are predicted to be negatively charged predicted with pIs of less than 4.5 (B-
linker and reader), as well as regions predicted to be positively charged, with predicted pIs 
of over 10. These may interact preferentially with one another over the binding of DNA. 
It is known that DNA is strongly bound by the weak anion exchange resin, DEAE- 
Sepharose®. It was suggested that PfTFIIB may bind weakly to DNA, as it is known to 
associate in other TFIIB homologues, albeit in the presence of TBP. Additionally, the 
calculated pI of PfTFIIB (9.73), with several regions of pI above 10 (Table 4), suggests the 
protein may be highly positively charged, and therefore may bind DNA. 
Aliquots of the 6His-PfTFIIB preparation were treated with a nuclease enzyme (Benzonase, 
Sigma-Aldrich®). The nuclease enzyme digests nucleic acids contaminating the protein 
preparation. Should 6His-PfTFIIB bind to DNA, which in turn is bound to the DEAE resin, 
then PfTFIIB in the treated protein preparation should no longer bind to the DEAE resin.  
In Figure 21B and C, the results of attempting to bind nuclease treated protein preparations 
to the various Sepharose® resins is shown. It was found that the protein was consistently 
recovered in the unbound protein fraction of each experiment. Proteins were eluted with 
500mM final KCl, similarly to previously described experiments. Notably, this is true also 
for the experiment with DEAE resin. Note that panel A in the figure is a positive control. 
The recombinant HsTFIIB protein is known to bind to strong cation exchangers, such as SP-
Sepharose®, and was used to confirm that the resin was functional.  This strongly suggests 
that recombinant PfTFIIB was able to interact indirectly to DEAE-Sepharose® due to the 
presence of DNA. 




Due to time constraints, further attempts for the purification of 6His-PfTFIIB were not 
undertaken.  
 
Figure 21: Nuclease treated 6His-PfTFIIB does not bind to ion-exchange resins. 
A. Positive control of 200ng of recombinant 6His-HsTFIIB, previously purified using Mono S 
Sepharose®. Eluted in 500mM KCl.  
B. Nuclease treated PfTFIIB protein does not bind to the SP resin.  
C. Nuclease treated PfTFIIB protein does not bind to either Q or DEAE Sepharose® resins.  
Lane 1 is the preparation prior to nuclease treatment, and lane 2 is post-treatment, used with the 
resins.  
Unbound protein (Ub) is equivalent of 50% the input (In) protein (100ng), hence the reduction in 
signal. Elution (E) with 500mM KCl, is equivalent to 63% of the input loaded. Treated input (TIn) 
is equivalent to In. Molecular weight marker (Mw) - 2µl of Precision Plus Protein All Blue 
standard (Bio-Rad).  




3.3.1 Summary of PfTFIIB expression and purification  
A number of interesting features of PfTFIIB protein were found. Firstly, PfTFIIB may be 
efficiently expressed through a method of ‘auto-induction’, by modification of the cell 
culture growth media. This is useful not only due to the ease of expression, but also because 
this method is cost-effective as there is no need for IPTG-induction.  
The purification of PfTFIIB shows the presence of a doublet. This may be related to the open 
and closed conformations that been studied in other TFIIB orthologous, (Elsby & Roberts 
2004; Zheng et al. 2004; Glossop et al. 2004; Fairley et al. 2002)  and may be implicated in 
transcription. This is supported by the conservation of the charged cluster domain, described 
previously (Chapter 3).  
Due to the inability to purify 6His-PfTFIIB further, it was decided that the research group 
would re-clone the putative PfTFIIB protein into an expression vector containing two 
flanking tags, a 6His-tag, and a GST-tag, to allow for a more stringent purification (Gertrud 
Talvik, current investigation).  
Finally, it is intriguing that evidence from the binding of 6His-PfTFIIB to DEAE resin, and 
the subsequent abolishment of this upon treatment with nuclease, suggests that PfTFIIB may 
bind to DNA in a manner not yet described for the protein. Current work in the research 
group appears to support DNA-binding activity in recombinant PfTFIIB (Gertrud Talvik, 
unpublished observations). 




 Expression of recombinant PfTLP protein 
3.4.1 Cloning of PfTLP 
Isolation of PfTLP open reading frame from cDNA libraries 
 The open reading frame for Plasmodium TLP was PCR amplified by using 2µl of each of 
the cDNA libraries MRA-296 and 297 (described in Chapter 2.3.2), and analysed on a 0.8% 
TBE/EtBr agarose gel (Figure 22). The MRA 296-299 cDNA phage libraries are derived 
from mRNA isolated from the blood stage cultures of Plasmodium falciparum clone 3D7 
extracted from parasites 16, 26, 36 hours post-synchronisation, as well as asynchronous 
parasites, respectively (Chakrabarti et al. 1994). These correspond to parasites in late ring-
stage, late trophozoite stage, schizont stage, as well as asynchronous parasites, respectively. 
It was found from the PCR analysis that mRNA for PfTLP was most prevalent at 16 hours 
post-infection (late-ring stage), which corresponds with microarray expression data obtained 
by the DeRisi lab (Bozdech, Zhu, et al. 2003), hosted on the PlasmoDB database 
(Aurrecoechea et al. 2009).  
 
Figure 22: PCR amplification of the PfTLP open reading frame from MRA cDNA 
libraries. 
Amplification of the PfTLP gene from the indicated MRA cDNA libraries was analysed on 
a 0.8% agarose gel. Lane 1 – no cDNA control (-). Lanes 2-5: 1/10 of PCR reactions with 
MRA libraries 286-299 were loaded. Expected size is 1131bp, indicated by the black arrow. 
Molecular weight marker (Mw) - 10µl of MassRuler™ DNA Ladder Mix (Thermo 
Scientific). 




Construction of the pET11d-6His-PfTLP vector 
The PfTLP gene was then digested and ligated into the pET11d-6His vector frame, as 
described in Chapter 2.3, to make the pET11d-6His-PfTLP vector.  
3.4.2 IPTG-induced expression of recombinant Plasmodium TLP leads to a 
reduction in cell growth in E. coli. 
Similarly to the initial characterisation of recombinant PfTFIIB expression, IPTG-induced 
expression of 6His-PfTLP was performed in order to assess the effects of heterologous gene 
expression on the E. coli host cell, and to set a basis for future expression trials. 
E. coli BL21-codonPlus® (DE3)-RIL cell cultures transformed with the  
pET11d-6His-PfTLP vector, were grown in liquid media at 37°C. The density of the cell 
 
Figure 23: IPTG-induced expression of 6His-PfTLP on BL21-codonPlus® (DE3)-RIL E. coli 
leads to growth inhibition.  
Cell densities of cultures, measured at wavelength 600nm, were plotted against the number of hours 
post-inoculation of expression culture from overnight cultures. Growth of the cultures induced with 
1mM and 0.1mM IPTG (black and dark grey, respectively) is compared to a non-induced culture 
(light grey). The time of induction with IPTG is indicated by a black arrow. 
 




cultures were monitored by light spectrophotometry (wavelength of 600nm). At an OD600nm 
of approximately 1, the cultures were induced with 0.1mM, or 1mM IPTG or left growing 
without addition of IPTG. Induction of expression with IPTG was found to have a negative 
effect on cell growth (Figure 23).  
The protein expression from these experiments were analysed by Ni-NTA affinity 
chromatography of cleared cell lysates. In these experiments, no soluble 6His-PfTLP could 
be detected (not shown).  
Similarly to the expression of PfTFIIB, it was decided to include glucose in the media used 
to grow E. coli cells containing expression vectors for the Plasmodium transcription factors. 
Notably, in an initial transformation with the pET11d-6His-PfTLP vector making use of LB 
plates which lacked glucose, very few transformants were obtained (5×10-2 cfu/µg of 
pDNA). Including 1% glucose in the plates increased the transformation efficiency 
significantly (2.6×103 cfu/µg pDNA). Such a dramatic increase in transformation efficiency 
was not seen in the transformation with the recombinant PfTFIIB vector, suggesting that the 
expression of PfTLP is far more toxic to the E. coli host cells than PfTFIIB. 
Attempts to express 6His-PfTLP in a similar manner to 6His-PfTFIIB (Section 3.3.3), 
through the use of glucose supplemented media and auto-induction of expression through 
the release of catabolite repression did not yield measurable protein expression (not shown). 
It is known that often recombinant proteins may be expressed and aggregate in the form of 
inclusion bodies which are insoluble and not detectable from the soluble protein fraction of 
the cells (Mehlin et al. 2006). This was thought to be especially possible due to the presence 
of presumptive low-complexity regions in the PfTLP protein. However, making use of 
purification methods for insoluble proteins, 8M urea denaturing conditions, did not yield 
detectable protein expression (data not shown).  




Cold-shock induction of 6His-PfTLP protein expression 
Expressing proteins at low temperatures (below 30°C) in E. coli may be beneficial in 
expressing recombinant proteins (Qing et al. 2004). The rapid reduction in cell temperature 
(cold-shock), as well as continued growth at low temperatures, may lead to the increased 
expression and activity of cold-shock chaperone proteins. The expression of the recombinant 
protein is lowered at low temperatures, but this may lead to a higher ratio of soluble to 
insoluble protein, as the reduced cellular concentration of protein favours folding, and 
reduces protein aggregation (Baneyx 1999).  
In this experiment, cell cultures, supplemented with glucose, were grown to mid-log phase 
at 37°C. One of the cultures was cold-shocked to 25°C, induced with 0.5mM IPTG, and 
maintained at 25°C. The second cell culture was not cold-shocked, induced with 0.5mM 
IPTG, and maintained at 37°C (Figure 24A). After three hours the cells were harvested. The 
expression of 6His-PfTLP protein was analysed by affinity purification from the cleared cell 
lysate with Ni-beads and SDS-PAGE (Figure 24B).  
It was found that recombinant PfTLP was preferentially expressed after cold-shock 
induction, as compared to the cell culture maintained at 37°C. Additionally, although both 
cultures decreased their rate of cell growth, the cell culture maintained at 25°C has a similar 
growth reduction to the cell culture maintained at 37°C. This suggests that the colder 
conditions had a protective effect on the cells after induction. Had the cells experienced a 
similar toxic effect from PfTLP expression as the cells induced at 37°C, it would be expected 
that the reduction in cell growth of the 25°C cell culture would be far greater. No protein 
could be purified under denaturing conditions.  




Mass spectrometry analysis of the sample was performed, by extracting bands of protein 
from an SDS-PAGE gel with the same sample. Peptide analysis of a band doublet seen at 
44kDa (Figure 24B) confirmed that the top band is 6His-PfTLP. 
 
Figure 24: 6His-PfTLP protein is expressed in BL21-codonPlus® (DE3)-RIL E. coli through cold-
shock IPTG-induction.  
A. Cell densities of cultures, measured at wavelength 600nm, were plotted against the number of 
hours post-inoculation of expression culture from overnight cultures. Growth of the culture cold-
shocked and grown at 25°C (black) is compared to a culture maintained at 37°C (grey). The time of 
cold-shock and induction with IPTG is indicated by a black arrow.  
B. Protein was purified by nickel-affinity purification from cleared cell lysates and analysed by SDS-
PAGE. Lanes 1-3 cell culture cold-shocked and grown at 25°C. Lanes 4-5 cell culture maintained at 
37°C. Equivalent amounts of cleared lysate input (In; 1/100 vol.) and the protein fraction not bound 
to the Ni-beads (unbound, Ub), and the protein fraction eluted from the Ni-beads with 2×SDS-loading 
buffer (E, ½ vol.) were loaded. A black arrow indicates the expected size of 6His-PfTFIIB protein at 
44kDa. Molecular weight marker (Mw) - 5µl of Precision Plus All Blue standards (Bio-Rad). 




3.4.3 Expression of GST-6His-PfTLP 
Recombinant 6His-PfTFIIB protein was purified through metal-affinity purification via a 
single hexahistidine purification tag. As shown previously, this was insufficient to achieve 
high purity, discussed in Chapter 3.3.1. Purification of 6His-PfTLP was expected to be 
similarly challenging. In addition, the toxicity of PfTLP recombinant protein expression 
resulted in low protein expression, making it logistically difficult to grow enough cell mass 
to purify sufficient protein for future studies. It is known that the addition of a soluble, easily 
expressed protein tag to a difficult to express protein often increases the yield of the fusion-
protein (Sørensen & Mortensen 2005; Smith & Johnson 1988). To this end, a GST-tag was 
inserted into the pET11d-6His expression vector to form a pET11d-GST-6His vector (Figure 
43 and Figure 47). The putative PfTLP gene was then cloned into this vector, to form the 
pET11d-GST-6His-PfTLP vector (Figure 46).  
Cold-shock induced expression of GST-6His PfTLP 
 BL21-CodonPlus® (DE3)-RIL E. coli cells were transformed with either the pET11d-GST-
6His-PfTLP or the empty pET11d-GST-6His vector. Three cell cultures were grown, two 
expressing GST-6His-PfTLP and another expressing GST-6His. This was done to compare 
the effect of expressing GST-6His to GST-6His-PfTLP protein, and so determine if the 
addition of the GST-tag would lower the toxicity of recombinant PfTLP.  
The cell cultures were inoculated from overnight cultures, and then grown at 37°C, and the 
cell culture densities monitored spectrophotometrically. When the cell cultures had an 
approximate OD600nm of 1, all of the cell-cultures were cold-shocked to 25°C and maintained 
at this temperature for three hours before harvesting (Figure 25). The cell culture 
transformed with the pET11d-GST-6His vector was induced with 0.5mM IPTG, as was one 




of the GST-6His-PfTLP cell cultures. There was an immediate decline in growth of all of 
the cell cultures, with the most dramatic decline in growth seen in the induced GST-6His-
PfTLP culture.  
The decline in cell growth of the cultures is more clearly illustrated in Figure 26, where the 
rate of cell growth over time (
𝑑𝑂𝐷
𝑑𝑡
) is plotted against time. Prior to induction, the GST-6His-
PfTLP cell cultures were growing at 0.6-0.7 OD600nm /hour. After the cold-shock, the non-
induced PfTLP cell culture growth rate was reduced, but at a much lesser extent than the 
induced culture, which ceased growth after approximately 1.5 hours. The GST-6His 
expressing cells also showed a reduction in growth after cold-shock and induction, but not 
Figure 25: IPTG-induced expression of GST-6His and GST-6His-PfTLP in E. coli BL21-
CodonPlus-RIL cells leads to growth inhibition. 
Cell densities of cultures, measured at wavelength 600nm, were plotted against the number of hours 
post-inoculation of expression culture from overnight cultures. Growth of the induced (In, black) 
and non-induced (Ni, grey) cultures expressing GST-6His-PfTLP are compared to induced GST-
6His expressing culture (GST, light grey with squares). Time of cold-shock and induction with 
0.5mM IPTG is indicated by a black arrow. 




to the same degree as the expression-induced GST-6His-PfTLP cells. This reduction in 
growth be attributed to metabolic stress of expressing both T7 polymerase as well as the 
GST-6His peptide.  
The expression of protein was investigated through nickel-magnetic bead affinity 
purification and SDS-PAGE, as described previously (Figure 27). No expression of GST-
6His-PfTLP protein could be detected from either the induced or non-induced cell cultures. 
In contrast, the expression of GST-6His was successful. It should be noted that the use of 
the Ni-magnetic beads was not able to fully deplete the cleared cell lysate of the expressed 
GST-6His tag, determined from the presence of protein in both the input and unbound 
samples of the GST-6His peptide purification (compare lanes 4, 5 and 6 in Figure 27). This 
Figure 26: IPTG-induced expression of GST-6His-PfTLP in E. coli BL21-CodonPlus-RIL cells 
reduces growth rate. 
Change in the rate of cell growth, calculated as the change in cell density (measured at wavelength 
600nm) over time, is plotted the number of hours post-inoculation of expression culture from 
overnight cultures. The growth rate of the induced and non-induced GST-6His-PfTLP expressing 
culture (TLP In, black; and TLP Ni, dark grey, respectively) are compared to induced GST-6His 
expressing culture (GST, light grey with squares). Black and grey arrows on the right indicate the 
reduction in change of growth of the cultures of the non-induced GST-6His-PfTLP cells (A) and 
the induced cells (B) respectively. Time of cold-shock and induction with 0.5mM IPTG is indicated 
by a black arrow. 




prompted the usage of glutathione-agarose resin, to which the GST-tag has strong affinity, 
for further affinity-purification experiments.  
Extended expression of G6HPfTLP at low temperature conditions 
It was reasoned that at lower temperatures, the rate of protein production is substantially 
slowed. As GST-6His-PfTLP is considerably longer than 6His-PfTLP, additional time may 
be required for the expression of the fusion-protein. Therefore, a similar experiment was 
attempted, making use of a lower expression temperature, but with a much longer time to 
express. In this experiment, cells transformed with either pET11d-GST-6His or pET11d-
GST-6His-PfTLP vectors were grown to a low optical density, cold-shocked to 20°C, 
induced with 0.5mM IPTG, and then incubated for 14.5 hours at 20°C. It was found that the 
growth of cells expressing G6H-PfTLP was severely restricted, as compared to the cells 
 
Figure 27: Cold-shock IPTG-induction does not lead to detectable expression of GST-6His-
PfTLP in BL21-codonPlus® (DE3)-RIL E. coli cells. 
Protein was purified by nickel-affinity purification from cleared cell lysates and analysed by SDS-
PAGE. A. GST-6His-PfTLP expression induced cell culture, calculated molecular weight 70.5kda. 
B. GST-6His expression induced cell culture, calculated molecular weight 27.4kDa. Equivalent 
amounts of cleared lysate input (In, 7.5/1000 volume), and the protein fraction not bound to the Ni-
beads (unbound, Ub), and the protein fraction eluted from the Ni-beads with 2×SDS-loading buffer 
(E, 1/3 vol.) were loaded. Molecular weight marker (Mw) - 5µl of Precision Plus Protein™ 
All Blue Standard (Bio-Rad). 




expressing the GST-6His peptide, suggesting the continued toxicity of the expressed protein. 
The protein expression was then investigated using affinity purification of the cleared cell 
lysate with glutathione-agarose resin (Sigma-Aldrich®), and SDS-PAGE analysis (Figure 
28). Not induced control cultures did not express protein (data not shown). An extremely 
large quantity of the GST-6His peptide was expressed, lane 2, however, very little  
GST-6His-PfTLP was expressed, lane 5. Additionally, the presence of several contaminants 
at approximately the size of the GST-6His tag were enriched by purification of the protein 
from the GST-6His-PfTLP expressing cells.  
 
Figure 28: Cold-shock IPTG-induction leads to low expression of soluble GST-6His-PfTLP in 
BL21-codonPlus® (DE3)-RIL E. coli cells. 
Protein was purified by glutathione-affinity purification from cleared cell lysates and analysed by 
SDS-PAGE. Lanes 1-2 IPTG-induced GST-6His expression, expected molecular weight 27.4kDa.  
Lanes 3-4 IPTG-induced GST-6His-PfTLP expression, expected molecular weight 70.5kDa. 
Equivalent amounts of cleared lysate input (In; 7.5/1000 vol.) and the protein fraction eluted from 
the glutathione-agarose resin with 2×SDS-loading buffer (E, 1/3 vol.) were loaded. Molecular weight 
marker (Mw) - 5µl of Precision Plus Protein™ All Blue Standard (Bio-Rad). 
 
 




Conclusion of the expression of GST-6His-PfTLP 
It was found that the use of cold-shock induction had a positive effect on protein expression, 
as seen with 6His-PfTLP expression. However, the addition of a GST-tag did not reduce the 
toxicity of PfTLP expression to the host cell.  
As with many Plasmodium genes, PfTLP contains codons which are not commonly used for 
expression by the E. coli host (Birkholtz et al. 2008a). It is thought that the usage of these 
codons in quick succession results in metabolic strain on the host cell to generate sufficient 
tRNAs, which in turn leads to ribosomal stalling. 
In the PfTLP gene, 26 codons are reportedly rare in E. coli (Zhang et al. 1991, the Appendix 
5.7). Of these rare codons, two are the CCC codon coding for proline. The rest of the codons 
are predominantly AUA, coding for isoleucine (18/26), and the rest code for arginine and 
leucine. The recombinant PfTLP gene has been expressed in BL21-CodonPlus® (DE3)-RIL 
E. coli cells, which posses additional tRNAs gene for these rare codons (argU [AGA, AGG], 
ileY [AUA], leuW [CUA]; Stratagene 2005), which are meant to alleviate the effects of rare 
codons in heterologous gene expression. However, it has been reported that expression of 
proteins in BL21-CodonPlus® (DE3)-RIL E. coli cells, where more than 5% of the amino 
acids in the heterologous protein are supplied by the RIL strain, results in growth retardation 
of the cells, low cell yield, and insoluble protein (Rosano & Ceccarelli 2009). The rare 
codons in the PfTLP make up a little over 6.5% of the gene sequence, and thus are likely to 
be responsible for the low protein yield.  
As has been shown in Chapter 3.2, the PfTLP protein also has stretches of low amino acid 
sequence complexity. Plasmodium proteins with LCRs are reportedly difficult to express in 
E. coli, most likely due to the over-utilisation of a small subset of tRNAs (Birkholtz et al. 
2008a).  




3.4.4 Expression of codon optimised GST-6His-PfTLP 
In order to investigate whether the sequence of the gene is the predominant cause of toxicity 
in heterologous expression, the PfTLP gene codon was optimised for expression in E. coli. 
Codon optimisation of PfTLP 
The PfTLP gene was codon optimised by GenScript, according to their OptimumGene™ 
Codon Optimization Analysis (http://www.genscript.com/). Codon optimisation consisted 
of adjusting the frequency of codon usage across the gene sequence, including the 
replacement of all rare codons with those more frequently used by E. coli. Additionally, runs 
of identical codons were replaced, to prevent over-utilisation of the related tRNAs. The G+C 
content of the gene was raised from 22% to 38%, to favour expression in E. coli. 
Additionally, runs of polyT and polyA (TTTTTT and AAAAAA) were removed, as these 
may form cryptic translational termination sites. Finally, an internal BamHI site was 
removed, for ease of cloning. A comparison of the codon optimised ORF and the original 
ORF of the PfTLP the gene are shown in the Appendix 5.7.  
Construction of the pET11d-GST-6His-PfTLPco vector 
The codon optimised PfTLP gene (PfTLPco) was PCR amplified from the pUC57 vector 
supplied by GenScript, and cloned into the pET11d-GST-6His vector (Figure 46). In the first 
attempt to clone the pET11d-GST-6His-PfTLPco vector, an insertion mutation occurred, and 
two additional codons were inserted in front of the initial methionine residue (pET11d-GST-
6His-PfTLPco(aa), see Table 10 in the Appendix). Expression of this mutated gene was not 
expected to differ substantially from the expression of the non-mutated gene, and so this 
vector was used to determine expression conditions while a vector containing a non-mutated 
PfTLP insert was constructed.  




Expression of GST-6His-PfTLPco protein 
BL21-CodonPlus® (DE3)-RIL competent cells were transformed with the pET11d-GST-
6His-PfTLPco(aa) vector. The cells were grown at 37°C to a cell density of OD600nm ~1.4, 
before cold-shocking to 25°C and inducing protein expression with 0.5mM IPTG. The cell 
cultures were then incubated at 25°C for 20 hours. It should be noted that the cells grew 
much more rapidly at 37°C than cells transformed with the original pET11d-GST-6His-
PfTLP vector (compare Figure 25 and Figure 29A). Additionally, the cells induced with 
IPTG did not have a reduction in cell growth. This stands in contrast to both the non-induced 
culture, as well as to cells expressing the non-codon optimised gene, suggesting that the 
toxicity of PfTLP lies in the difficulty of translating the mRNA transcript.   
 
Figure 29: Expression of codon-optimised GST-6His-PfTLP through cold-shock induction in BL21-
CodonPlus® (DE3)-RIL E. coli cells. 
A. Cell densities of cell cultures carrying the expression vector pET11d-GST-6His-PfTLPco(aa), 
measured at wavelength 600nm, were plotted against the number of hours post-inoculation of 
expression culture from overnight cultures. Cultures were grown at 37°C and then cold shocked to 
25°C. Cells induced with 0.5mM IPTG are in black, non-induced cells in grey. Black arrow indicates 
the time of cold-shock and induction. B. Protein was purified by glutathione-affinity purification from 
cleared cell lysates and analysed by SDS-PAGE. Lanes 1-2 induced GST-6His-PfTLPco protein 
expression. Lanes 3-4 Non-induced (Ni) protein expression. Equivalent amounts of cleared lysate input 
(In; 7.5/1000 vol.) and the protein fraction not bound to the Ni-beads (unbound, Ub), and the protein 
fraction eluted from the glutathione-agarose resin with 2×SDS-loading buffer (E, 1/3 vol. loaded) were 
loaded. Molecular weight marker (Mw) - 2µl of Precision Plus Protein™ All Blue Standard (Bio-Rad). 
 
 




The expression of G6HPfTLPco protein was analysed using affinity purification of the 
cleared cell lysate by glutathione-agarose resin, and SDS-PAGE (Figure 29B). GST-6His-
PfTLP protein was successfully expressed in the induced cell culture, and not in the non-
induced cell culture. Similarly to the expression from the pET11d-GST-6His vector, there 
appears to be enrichment of protein at approximately the size of the GST-tag. It is thought 
that the protein in this region is truncated peptide, due to premature translational termination. 
Confirmation that this protein contains a 6His-tag, and so is a truncated GST-6His-PfTLP 
peptide (G6Hp), is discussed below.  
Expression of the GST-6His-PfTLP protein from the pET11d-GST-6His-PfTLPco vector 
was found to be the same as from the pET11d-GST-6His-PfTLPco(aa) vector (not shown). 
In the expression from this vector, G6Hp was also present. The size of the peptide was 
 
Figure 30: Examination of the proposed region for premature translational termination. 
Sequences A and B are the amino acid and the codon coding for the amino acid respectively. Note 
that codons are written vertically, direction indicated by the arrow. Features of the expressed gene 
are underlined and indicated. The increasing molecular weight of the protein is indicated above 
the amino acid sequence in kDa. The calculated pIs of the growing polypeptide chain, measured 
from the beginning of the GST-Tag, and from the start of the PfTLP peptide are indicated above 
the sequence. The start codon of PfTLP is indicated in red. The region thought to be implicated in 
premature termination is indicated in bold.  
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estimated by using the molecular weight marker to generate a standard curve, and then 
inferring the size of the peptide to be 29 - 32kDa. The region in which the peptide may be 
truncated is mapped onto the fusion-protein sequence in Figure 30. 
 G6Hp was determined to be greater than 28kDa, and includes both the thrombin and TEV 
sites, as well as the GST and 6His-tags.  
A large scale expression study investigating recombinant Plasmodium proteins expression 
has found that proteins with high pI (>6) are difficult to express in E. coli (Mehlin et al. 
2006). The calculated pI of PfTLP is 9.71. The addition of the GST-tag to 6His-PfTLP 
lowers this to 8.97, as the pI of the tag alone is 6.51. It is possible that as the protein translates 
the fusion-protein, the rapid increase of the local pI to approximately 10, combined with the 
utilisation codons for the same amino acids in the region, leads to premature translational 
truncation. G6Hp is smaller than GST-6His-PfTLP (~28kDa versus ~71kDa), and is likely 
to be more easily translated, hence there would be a higher rate of translation of the truncated 
peptide than the full-length fusion protein, which would result in a high ratio of G6Hp to 
GST-6His-PfTLP produced. 
Overall, the codon optimisation of the PfTLP gene for expression in E. coli was successful 
in allowing for soluble expression of the protein, with lowered toxicity to the host cell. 
Despite the presence of contaminating G6Hp, the expression of PfTLP protein from the 
codon-optimised vector was substantially greater than seen previously. Additionally, the 
presence of two epitope tags allows for much more stringent purification than a single-6His 
tagged protein (Figure 29).  
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3.4.5 Purification of PfTLP protein 
Purification from accumulated cell mass 
E. coli cells containing the expression vector pET11d-GST-6His-PfTLPco were grown,
protein induced through the cold-shock induction method, and cell mass accumulated. The 
cell mass was then used to purify GST-6His-PfTLP protein. Protein was purified from the 
cleared cell lysate through affinity purification on glutathione-agarose resin as described in 
Chapter 2.5.2.  
Figure 31: Purification of GST-6His-PfTLP by glutathione-affinity agarose. 
BSA standards were loaded in lanes 3-6, 1µg, 0.5µg, 100ng and 50ng respectively. Lanes 1-2, contain 
0.5µl and 1µl of pooled protein containing fractions (PCF, 4.2ml total) respectively.  Expected size 
for GST-6His-PfTLP is 70.5kDa, indicated with a black arrow. G6Hp is present and indicated by a 
dark grey arrow. Molecular weight marker (Mw) – 5µl of Precision Plus Protein™ All Blue Standard 
(Bio-Rad). 




The glutathione-eluted protein fractions were collected as shown in Figure 31A. The 
presence of an enriched band in the region of the expected size of GST-6His-PfTLP was 
seen. Evidence from the purification of other GST-tagged Plasmodium proteins in the lab 
have shown that some Plasmodium proteins are not eluted rapidly (in the first few fractions) 
from the GST-agarose resin by glutathione, and instead tend to elute slowly over many 
fractions. This is most likely due to non-specific interactions between GST-6His-PfTLP and 
the glutathione-agarose resin, which are not disrupted by glutathione in the elution buffer. 
In contrast, the elution of G6Hp is very rapid, with the bulk of the protein eluted in fraction 
3 (lane 3, Figure 31A. This appears to be case with GST-6His-PfTLP, and so the majority 
of the fractions were pooled, in order to increase the yield of partly purified protein. This 
had the effect of diluting the protein preparation. The pooled preparation was then titrated 
against BSA protein to estimate the quantity of protein purified (Figure 31).  
A contaminant band was present at the 44kDa marker.  It is suggested that the band present 
at the 44kDa marker is the native E. coli ODO2 protein (Table 5). It has been reported that 
ODO2 may contaminate protein preparations purified by both glutathione agarose and metal-
affinity resins (Bolanos-Garcia & Davies 2006). 
It is clear from the purification that although GST-6His-PfTLP is recovered, at about 
100ng/µl, there is also a great deal of contaminating G6Hp present, at approximately 1µg/µl, 
or 10-fold the concentration of the full-length G6HPfTLP.  
Thrombin cleavage of GST-6His-PfTLP protein  
The presence of the bulky GST-tag may interfere with PfTLP protein function. For this 
reason, the GST-tag was removed from the protein through thrombin cleavage.  
Thrombin cleavage was performed as described in Chapter 2.6.4. The protein preparation 
was incubated with thrombin enzyme at 4°C, and the cleavage monitored through analysis 




of aliquots by SDS-PAGE. The protein was incubated for ~40 hours at 4°C, due to the large 
amount of GST-6His-peptide present within the protein preparation, which competed with 
GST-6His-PfTLP protein for cleavage by the thrombin enzyme. It is clear from Figure 32 
that over time 6His-PfTLP appeared at the 44kDa region, along with cleaved GST-tag at 
~26kDa. 
The presence the cleaved G6Hp peptide presented further issues for the purification of 6His-
PfTLP protein from the protein preparation. Attempts to capture 6His-PfTLP from the 
protein preparation through Ni- NTA affinity column purification were largely unsuccessful 
(Figure 33). The protein preparation (In1, lane 1) was passed through a Ni-NTA affinity-
purification column. Protein was eluted with 250mM imidazole, and fractions collected, 
analysed by SDS-PAGE, and the protein containing fractions pooled. As can be seen in 
Figure 33, lane 2, the unbound fraction still contained a large amount of 6His-PfTLP protein. 
Figure 32: Time course of thrombin cleavage of the GST-6His-PfTLP. 
Lane 1, GST-6His-PfTLP preparation prior to thrombin cleavage (0, 1µl of 4ml total), Lane 2, 20 
hours of thrombin cleavage (2µl of 4.2ml total), Lane 3, 40 hours of thrombin cleavage (5µl of total 
4.2ml, an increased volume was loaded in order to better visualise cleavage). 
Expected size of: GST-6His-PfTLP 70.5kD; 6His-PfTLP 44.4kDa, indicated by black arrows. GST-
tag and GST-6His-peptide indicated by grey arrows. Molecular weight marker (Mw) - 2μl Precision 
Plus Protein™ All Blue Standard(Bio-Rad). 




This unbound fraction was Ni-NTA affinity-purified a second time, resulting in the second 
unbound fraction (lane 3), and the imidazole-eluted protein fractions pooled.  
It is clear that the GST-6His-peptide competed against the 6His-PfTLP protein for binding 
to the Ni-NTA resin. Additionally, the G6Hp which was successfully cleaved would have 
also generated free 6His-peptides which may also have competed for binding to the Ni-NTA 
resin. It is thought that the GST-tag and G6Hp could form dimers in solution, which explains 
the presence GST-tags cleaved by thrombin digestion present in the eluted fractions (lane 4, 
PCF). The presence of two bands at the 44kDa region are most likely 6His-PfTLP, and the 
E. coli contaminant ODO2.  
Figure 33: Ni-affinity purification of 6His-PfTLP after thrombin cleavage.  
Lane 1 contains 5µl of input (In1, total 3.7ml), an equivalent amount of the protein fraction not bound 
to the resin is in lane 2, which was passed through another round of purification  (unbound, Ub1/In2), 
the protein fraction not bound is loaded in lane 3 (Ub2). The protein eluted from each column with 
250mM imadazole, was pooled and 10µl loaded in lane 4 (pooled column fractions, PCF, total 
2.2ml). Molecular weight marker (Mw) - 2μl Precision Plus Protein™ All Blue Standard(Bio-Rad). 
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Attempts at further purification with SP-Sepharose® resin 
The constituents of the PfTLP protein have differing calculated pI values; GST-tag and the 
presumed GST-6His-peptide have predicted pIs of 6.51 and 7.4 respectively, 6His-PfTLP 
has a predicted pI of 9.63. The protein preparation was stored in a buffer with a pH of 7.9 at 
4°C, suggesting that 6His-PfTLP should be positively charged while the GST-tag and G6Hp 
negatively charged. Therefore, an attempt was made to purify 6His-PfTLP from the protein 
preparation using the cation-exchange resin SP-Sepharose® (Figure 34). For this 
experiment, the pooled column fraction eluted from the second purification by nickel-
affinity was used. Proteins were bound at 100mM KCl and eluted with increasing KCl 
concentrations. It was found that 6His-PfTLP binds partially to the SP-Sepharose® resin, 
with some proportion of the protein remaining bound under high KCl concentrations. This 
suggests that there is heterogeneity within the 6His-PfTLP protein preparation. 
Figure 34: 6His-PfTLP partially binds to SP-Sepharose strong-cation exchange resin. 
10μl of the 6His-PfTLP protein preparation was loaded into the input lane (In, total volume 
100μl), and an equivalent amount of the protein not bound (unbound, Ub). KCl elutions, 
equivalent to the input, are loaded lanes 3-5. Lane 6 contains ½ of the resin resuspended in 2×SDS 
loading buffer (R, total volume of 10μl settled resin volume). Lanes 7 and 8 contain 50 and 100ng 
of BSA protein respectively. Molecular weight marker (Mw) - 2µl of Precision Plus All blue 
Standard (Bio-Rad). 
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It is unclear whether this binding is largely non-specific, or due to interactions of basic 
regions (Table 8) in the PfTLP structure to the resin. However, it is also difficult to 
distinguish between the binding of the contaminant protein (presumably ODO2 protein) and 
6His-PfTLP, as they have similar sizes, and ODO2 has been shown to bind to Sepharose® 
resins at salt concentrations above 600mM KCl (Bolanos-Garcia & Davies 2006).  
Immunoblot detection of purified 6His-PfTLP 
In order to verify the identity of purified 6His-PfTLP, immunoblot analysis was performed 
making use of an anti-hexahistidine antibody to detect the 6His-PfTLP protein (Figure 35). 
In this experiment, an SDS-PAGE gel was run containing multiple lanes of both the PfTLP 
protein preparation as well as a positive control, 6His-HsTFIIB. 
Figure 35: Immunoblot analysis of 6His-PfTLP protein with anti-6His antibody. 
Lanes 1-3: SDS-PAGE and coomassie staining analyses of PfTLP protein preparation. Lane 1 
contains 100ng of 6His-HsTFIIB protein. Lane 2 contains 100ng of 6His-PfTLP protein. 
Molecular weight marker (Mw) is 2μl of of Precision Plus Protein™ All Blue Standard (Bio-Rad). 
Lanes 3-6: Immunoblot analysis of PfTLP protein preparation. In lanes 3 and 4, 100ng of 6His-
PfTLP protein protein preparation was loaded. Lane 6 conatins 50ng of 6His-HsTFIIB protein. 4μl 
of Mw was loaded. The SDS-PAGE gel was transferred to PVDF membrane, probed with anti-
6hHis mouse monoclonal antibody. 
Expected size of: 6His-PfTLP ~44.4kDa, recombinant 6His-HsTFIIB as ~37 kDa. Truncated GST-
6His-PfTLP at ~28kDa, GST from thrombin cleavage at 26.1 kDa.  
Chapter 3 Results and Discussion 
114 
The gel was sliced in half, and one half was transferred to PVDF membrane and probed. 
This allowed side-by-side comparisons of the proteins detected in the gel and immunoblot. 
Unfortunately, the gel did not separate the bands at the 44kDa region successfully. However, 
ODO2 does not have clusters of histidines, and is thought to be non- reactive to anti-
hexahistidine antibody. It was found that in the PfTLP preparation, two bands were immune-
reactive against the antibody, at the sizes expected for the truncated GST-6His-peptide and 
that of 6His-PfTLP. The cleaved GST-tag was present at a similar quantity to the GST-6His-
peptide, but was not immune-reactive, suggesting that the antibody was specific to the 6His-
tag.  
Depletion of GST-tag by glutathione-agarose 
The purification of the 6His-PfTLP protein preparation through Ni-NTA affinity resin 
allowed for a buffer exchange and removal of glutathione from the protein preparation. 
Therefore, an attempt to deplete the contaminating GST-tag/GST6Hp peptides from the 
Figure 36: Glutathione-affinity based depletion of GST/G6Hp from the GSH Sepharose PfTLP 
protein preparation.  
Input (In, 10µl of 2.2ml protein preparation, lane 1), the unbound flow-through (Ub, 10µl of 2.7ml), 
a sample of the resin (R, 10µl of resin, denatured with 10µl of 2×SDS loading dye, total resin volume 
of 0.5ml), and 250ng and 100ng of BSA standard were loaded. Molecular weight marker (Mw) - 2µl 
of Precision Plus Protein All Blue standard (Bio-Rad). 
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preparation was attempted by passing the preparation through a glutathione-agarose (GSH) 
resin column. This successfully depleted the majority of the contaminating GST-peptide 
species from the preparation (Figure 36). However, as may be seen from Figure 36, lane 3, 
where a small percentage of the resin was heat-denatured, a great deal of the 6His-PfTLP 
protein was found to bind irreversibly to the column, presumably through non-specific 
interactions with the resin. This severely reduced the total amount of available 6His-PfTLP 
protein purified. The concentration 6His-PfTLP in the preparation shown in Figure 36 was 
estimated to be approximately 10 ng/µl (2.6ml total) based on a colorimetric protein assay 
(Bio-Rad protein assay). The protein preparation was supplemented with 100 ng/µl BSA, 
snap-frozen in liquid N2 and stored at -80˚C. 
3.4.6 Summary of PfTLP expression and purification 
The expression of recombinant Plasmodium proteins is known to be challenging. In a large 
study of recombinant expression of 1000 genes in E. coli cells, only 337 proteins were 
successfully expressed, and the majority of these were insoluble (Birkholtz et al. 2008b). As 
with the majority of the proteins which have been attempted to be expressed in E. coli, the 
initial attempts at expressing PfTLP protein showed that over-expression was toxic to the E. 
coli host cell. In this case, the toxicity of the protein expression was alleviated when the 
protein was codon optimised for E. coli. The expression of a GST-tagged PfTLP protein 
demonstrated premature translational termination of the protein. This is likely due to 
combination of factors which include the high pI of the PfTLP protein, the A+T richness of 
the ORF coding for the protein, as well as the repetitive usage of a small subset of codons. 
In the purification of PfTLP, the protein preparation was shown to be heterogeneous, and 
would partially bind to agarose-based resins (SP-Sepharose®, glutathione-agarose®). The 
binding to these resins is most likely to be non-specific, as is shown by the elution profile of 
the protein from glutathione-agarose resin, and may be due to the presence of the disordered 




LCR regions. It has been found in other recombinantly expressed Plasmodium proteins  
which contain LCRs, that during over-expression in E. coli cells there is a propensity for the 
host-cell to sporadically substitute amino acids into the LCR, which cannot be detected by 
SDS-PAGE analysis (Mehlin et al. 2006). The presence of these amino acid substitutions 
may influence the binding of the expressed protein to resins during purification. 
Additionally, the LCRs are also known to lead to recombinant Plasmodium protein 
aggregation, which would reduce the binding of the protein to affinity resins, and be a cause 
for the heterogeneity in the protein preparation seen (Mehlin et al. 2006). Finally, 
purification of recombinant PfTLP was achieved, and is sufficiently pure to continue with 
DNA-binding assays. 
 
 Examination of the DNA-binding potential of PfTLP and PfTFIIB 
Having achieved expression and purification of PfTLP protein, it was decided to begin 
investigating the potential for DNA-binding activity in PfTLP.  
 The DNA-binding activity of TLP/TRF2/TRP molecules has not been extensively studied. 
It is known that human TLP is able to bind DNA, but lacks the specificity for the TATA-
box characteristic of TBP (Ohbayashi et al. 2003). Given the divergence of PfTLP to human 
TBP/TLPs and even the putative Plasmodium TBP, the DNA-binding activity of TLP, and 
the specificity thereof, could not be fully investigated in the scope of this research project. 
Should TLP have DNA-sequence specific binding, and whether DNA-binding may rely on 
the association of other factors, will all form part of extensive future investigations in the 
lab. Additionally, the conditions that are suitable for human transcription in vitro binding 
may not be suitable or optimal for Plasmodium transcription factor DNA-binding, given the 
potential differences between the organismal cell environments of Plasmodium and human. 
However, as the research group has produced probes for the continued investigations into 




PfTBP DNA-binding assays, it was a natural extension to begin the investigation into 
potential PfTLP DNA-binding. Given the lack of adequately purified PfTFIIB and/or 
PfTFIIA protein, the majority of the assays were to be performed with PfTLP alone.  
The focus of future work in the laboratory will be to determine sequence specificity of 
PfTBP/TLP to sequences in putative Plasmodium core promoter elements. Only a single 
study has been performed with PfTBP, finding sequence specificity to TATA-like sequences 
present upstream of the TSSs of the kahrp and gbp-130 genes (Ruvalcaba-Salazar et al. 
2005). These putative promoter regions were studied in this research project, as they 
continue to be investigated by others in the lab. These genes have been targeted due to their 
role in the pathogenicity of the parasite. Gbp-130 encodes a glycophorin binding protein, 
which binds to the erythrocyte glycophorin receptor, and is instrumental in the invasion of 
the RBC by the parasite (Perkins 1984). The knob-associated histidine rich protein (KAHRP) 
interacts with iRBC cellular structures to form a platform for the presentation of the PfEMP1 
protein (Lanzer et al. 1992a). The transcription start sites of these genes have been mapped 
(Lanzer et al. 1992b; Lanzer et al. 1992a) and so may be useful in the identification of 
PfTBP/TLP recognition sites in the core promoter.  
3.5.1 Electrophoretic mobility shift assays (EMSAs)  
Electrophoretic mobility shift assays (EMSAs, or ‘gel shift’) are a commonly used method 
of detecting protein complexes with nucleic acids (Garner & Revzin 1981; Hellman & Fried 
2007). In this assay, nucleic acid probes containing sequences of interest are incubated with 
a DNA-binding protein. The protein-DNA complexes are then separated from the unbound 
DNA by electrophoresis on a non-denaturing gel, typically polyacrylamide. DNA which is 
bound to protein has retarded mobility compared to the free probe, and so migrates more 
slowly through the gel matrix (the ‘gel shift’), which can be seen through visualising the 
probes, typically through radiographic means (Hellman & Fried 2007). However, for the 




experiments discussed below an alternative non-radioactive detection method was 
performed that makes use of biotin-labelled probes. In this protocol, the electrophoresed 
probes are transferred to positively charged nylon membrane, fixed by UV-crosslinking, and 
then visualised by chemiluminescence from streptavidin-conjugated horseradish peroxidase 
with chemiluminescent substrate, and resultant luminescence detected by X-ray film.  
The binding of PfTLP to the putative promoter regions of gbp-130 and kahrp was 
investigated. Single-biotin labelled probes were designed to cover approximately 60bp 
downstream and 170bp upstream of the reported transcription starts sites of the two genes 
and were similar to those used by Ruvalcaba-Salazar et al. (2005) in their investigation of 
PfTBP DNA binding. In total, the probes are approximately 280bp in length (Chapter 2.9.1). 
Additionally, a ~200bp probe was synthesised for the adenovirus 2 major late promoter 
(Ad2ML) promoter. The Ad2ML promoter has been widely used to investigate the formation 
of the human PIC (Thomas & Chiang 2006),  and here is used in conjunction with 
HsTBP/TFIIA to confirm the assay conditions may allow for visualisation of DNA-binding.  
Human transcription factors bind to the Ad2ML probe 
The initial DNA-binding conditions were determined for the recombinant human 
transcription factors TBP and TFIIA with the Ad2ML probes. The DNA-complexes were 
resolved on a native polyacrylamide gel, and visualised. The binding of TBP to the Ad2ML 
containing probe is significantly enhanced in the presence of TFIIA, and so this recombinant 
factor was included in the protein-DNA reaction mix.  
It was found that interactions between HsTBP and the Ad2ML probe could be resolved on a 
native polyacrylamide gel, and probe shifts identified (Figure 37A). Increasing amounts of 
protein prevented the migration of the protein into the polyacrylamide gel, as seen by the 
increased retention of probe in the well.  




Polyacrylamide gels cannot resolve PfTLP-DNA complexes 
A PfTLP concentration-dependent decrease of free probe was seen in the EMSAs with 
Ad2ML and gbp-130 probes, with a corresponding increase of protein-probe complex 
retention in the wells of the polyacrylamide gel (Figure 37B). This suggests that the PfTLP 
protein preparation is capable of binding to DNA. Several alterations to the gel  
conditions were investigated in order to allow potential PfTLP-DNA complexes to enter the 
gel matrix.  
Figure 37: PfTLP DNA-binding cannot be resolved by polyacrylamide gel electrophoresis. 
A. Human TBP/TFIIA binding to Ad2ML probe. Complexes were separated on a 3.5% 49:1 native 
polyacrylamide gel. 20µl binding reactions contained 2fmol Ad2ML probe. Binding reactions 
loaded in lanes 2-3 contain 2.5 and 5fmol/µl of HsTBP protein and 17fmol/µl HsTFIIA. The 
position of the HsTBP/TFIIA/promoter complex is indicated by a grey arrow. B. Binding of PfTLP 
protein preparation (GSH-Sepharose® purified) to adenovirus 2 major late (Ad2ML) and 
Plasmodium falciparum gbp-130 promoter probe, indicated by probe retention in the wells in a 
PfTLP concentration-dependent manner. 20 µl binding reactions contained 5fmol Ad2ML or gbp-
130 probe as indicated. Binding reactions loaded in lanes 1-3 contain 70, 35 and 17.5fmol/µl of 
6His-PfTLP respectively. 
 




These included: gels prepared with lower acrylamide percentages, altering the bis-
acrylamide/acrylamide ratios of the gels, inclusion of chaotropic or non-ionic detergents in 
the protein-DNA reaction mix, as well as variations to the electrophoresis conditions. 
Unfortunately none of these alterations were successful in permitting the entry of the protein-
DNA complex to enter the gel matrix (not shown).  
There may be multiple reasons for impaired mobility/entry into the gel matrix of the PfTLP-
DNA complex. It is has been shown in Chapter 3.2 that PfTLP contains a large LCR region 
which may result in undesirable protein-protein interactions, such as aggregation, and so 
impede movement of the complexes into the gel matrix. Additionally, should the DNA-
binding of PfTLP be non-specific to the DNA-sequence, this may result in multiple PfTLP 
proteins binding to the same probe, and so diminish the ability for the probes to enter the 
gel-matrix.  
3.5.2 Immobilised template assays 
In order to investigate whether the interaction between the PfTLP protein preparation and 
the Ad2ML/gbp-130 probes were indeed dependent on the recombinant PfTLP protein and 
not another contaminant in the protein preparation, an immobilised template assay was used.  
In the immobilised template assay, biotinylated DNA probes are bound to streptavidin-
magnetic beads. The protein and DNA are allowed to interact under similar conditions to 
those used in the EMSA assay. The unbound protein is then removed from the beads, and 
bound protein is eluted in SDS-PAGE loading buffer and analysed by immunoblotting. This 
assay serves as a direct measure of the binding of protein to the DNA-probe. At this point 
the lab had obtained polyclonal antibodies against several of the putative Plasmodium 
general transcription factors, and these needed to be characterised prior to use in the 
immobilised template assays. 




Characterisation of antibodies for Plasmodium TLP 
The production of polyclonal antibodies was performed by BioGenes (Berlin, Germany). 
Peptide-antibodies were raised in rabbits against the peptide C-NDENKSNDNKEQND, 
mapping to a small LCR in PfTLP (amino acid positions 294-307).This region was chosen 
as LCR loops should extend outside of the main globular structure, to provide an accessible 
epitope. 
As described in the Chapter 2.8, 5.4µg of total protein from soluble cell lysate from E. coli 
containing full length GST-6His-PfTLP was mixed with 30ng of purified 6His-PfTLP 
(making up 0.6% of the total protein mass). Cleared lysate containing both GST-6His-PfTLP 
and added 6His-PfTLP were loaded onto several lanes of an SDS-PAGE gel, 
electrophoresed, and transferred to a PVDF membrane. The membrane was then cut into 
strips and probed with increasing dilutions of the rabbit anti-PfTLP anti-sera (Figure 38).  
It is clear from this experiment that the polyclonal antibodies have high specificity for 
PfTLP, being able to detect in cleared lysate both added purified 6His-PfTLP as well as 
expressed GST-6His-PfTLP. The cross-reactivity with the E. coli proteins in the enriched 
sample is minimal. Note that there appears to be some cross reactivity with contaminant 
 
Figure 38: Anti-PfTLP antibody is specific to 
PfTLP. 
Cleared cell lysate containing GST-6His-PfTLP 
and 30 ng added 6His-PfTLP (En, lanes 1 and 4) 
and 30 ng purified PfTLP (lane 2) were 
electrophoresed by SDS-PAGE, and transferred 
to PVDF membrane. The membrane was probed 
with anti-PfTLP anti-sera dilutions as indicated. 
Molecular weight marker (Mw) - 4µl Precision 
Plus Protein™ Unstained Standards (BioRad). 




protein at approximately 25kDa. This would correspond to the G6Hp (see Chapter 3.4.5) 
known to be in high abundance in the enriched sample, and which may contaminate the 
purified protein preparation. Note also that a similar experiment was performed with 
equivalent amount of the pre-immune serum from the rabbits, where no PfTLP-specific 
reactivity could be detected (not shown). 
Human transcription factors bind to Ad2ML in a HsTBP dependent manner 
For the immobilised template assay, the visualisation of the experiment is performed through 
immunoblotting. In order to visualise protein-DNA interactions, far more probe and protein 
is required than in EMSAs. Immobilised template reactions were therefore set to contain 
1000fmol of DNA-probe and the protein(s) tested in 40µl total reaction volume. Immobilised 
template assays were first carried out using recombinant human GTFs with the Ad2ML 
probe (Figure 39). Human TBP is shown to bind to the probe (Figure 39A). As expected, 
human TFIIB can only bind to the probe in the presence of TBP, but not on its own (compare 
Figure C and B). Like TFIIB, TFIIA binding to the Ad2ML probe was dependent on the 
presence of TBP (data not shown).  
PfTLP binds to putative Plasmodium promoters 
As seen in Figure 39 D-F, PfTLP protein was found to bind directly to both the gbp-130 and 
kahrp putative promoters (Figure 39 D and E), but not to the Ad2ML probe (F).  
The results of the immobilised template assays suggest that purified bacterially expressed 
PfTLP indeed possesses DNA-binding activity, consistent with the results of the EMSA 
experiments (Figure 37).  This result might indicate some sequence-specificity of PfTLP. 
Further studies are needed to investigate this interesting possibility. It is unclear why binding 
to the Ad2ML probe under these conditions could not be detected. It is possible that the wash 
step in the immobilized template assay may be too stringent, causing weak protein-DNA 




associations to dissociate. In the EMSA assays the protein-DNA mixtures are loaded directly 
after being allowed to associate. The stabilising effect of the EMSA gel matrix could, 
therefore, ensure that the protein-DNA interactions are able to be detected. 
Potential interactions between PfTLP and PfTFIIB could not be investigated with this 
assay and the conditions used, due to strong non-specific binding of PfTFIIB to the 
streptavidin-magnetic beads in the absence of DNA (not shown). This problem could not 
be overcome in the course of this thesis work.  
Figure 39: DNA binding of human and Plasmodium general transcription factors in immobilised 
template assays. 
Immunoblot analysis of bound (B) and unbound (Ub) proteins. A. Binding of HsTBP to Ad2ML 
probe. B and C. Binding of HsTFIIB to the Ad2ML probe is dependent on the presence of HsTBP 
D. PfTLP does not bind to Ad2ML probe. E and F. PfTLP binding to kahrp and gbp-130 probes, 
respectively. Protein input equivalent to ½ and ¼ of protein present in binding reactions was loaded 
in lanes 1 and 2. ¼ of total unbound protein (Ub) and total of DNA-bound protein (B) were loaded 
in lanes 4 and 5.  




3.5.3 Agarose EMSAs 
Due to the difficulty in resolving the Plasmodium protein-DNA complexes in 
polyacrylamide gel electrophoresis, an alternative agarose gel system was developed. 
Magnesium-containing agarose gel electrophoresis has been used previously for DNA-
binding assays with large multi-protein complexes (Zerby & Lieberman 1997). The larger 
pore size of the agarose matrix facilitate the migration of larger complexes into the gel.   
PfTLP forms complexes with Ad2ML promoter 
In order to test the conditions for agarose EMSA, binding reactions containing recombinant 
human transcription factors HsTBP and HsTFIIA and Ad2ML probe were carried out. 
Complexes were separated in 1.4% agarose gels in a running buffer composed of 0.5x TBE 
containing 5 mM MgCl2, transferred to positively charged nylon membrane, and visualised 
by chemiluminescence as described above (see Chapter 43). As expected, HsTBP formed a 
clearly detectable complex with the Ad2ML probe in a TFIIA-dependent manner.  
Incubation of bacterially expressed purified 6His-PfTLP protein with the Ad2ML probe 
resulted in the appearance of several gel shifts. Binding reactions contained 5fmol/µl HsTBP 
and 13.3fmol/µl HsTFIIA (Figure 40, lane 3) whereas PfTLP was present at a concentration 
of approximately 70 fmol/µl (Figure 40, lanes 4). While HsTBP bound the available probe 
(10fmol) quantitatively under the reaction conditions, PfTLP at a much higher concentration 
did not. This result suggests that PfTLP associates with the Ad2ML probe with lower affinity 
than HsTBP/HsTFIIA, consistent with the results of the immobilised template assays (see 
Figure 39).  
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Interestingly, the profile of PfTLP-Ad2ML binding to the Ad2ML probe suggests at least 
three gel shifts along the length of the gel, along with a smeared region. The presence of the 
smear and multiple gel-shifts may indicate that PfTLP binds to the probe with low affinity 
at multiple locations. This would suggest that PfTLP has low or no sequence specificity for 
the DNA sequence of the Ad2ML promoter, and instead binds non-specifically.  
Figure 40:  PfTLP binding to the Ad2ML promoter in agarose EMSA. 
Two different exposures of the same experiment are shown, with a one second exposure of the lower 
part of the gel containing free probe as a separate panel underneath. 10µl binding reactions contained 
10fmol Ad2ML probe, 5fmol/µl HsTBP, 13.3fmol/µl, HsTFIIA and ~70, 23, 7fmol/µl PfTLP as 
indicated. Free probe is indicated by black arrows and protein/DNA complexes are indicated by grey 
arrows.  




PfTLP forms complexes with putative Plasmodium gene promoters 
Next, the binding of PfTLP to the putative Plasmodium promoters for the kahrp and gbp-
130 genes was investigated using agarose EMSA (Figure 41). As seen in the immobilised 
template assays Figure 39B) PfTLP binds both the gbp-130 and kahrp probes. It remains to 
be determined if the presence of multiple complexes seen in these agarose EMSAs is due to 
the presence of several PfTLP molecules bound to the same probe, or the binding of PfTLP 
molecules at different locations on the DNA probe.  
Figure 41: PfTLP forms complexes with putative Plasmodium promoter sequences. 
Two different exposures of the same experiment are shown, with a one second exposure of the lower 
part of the gel containing free probe as a separate panel underneath. 10µl binding reactions contained 
10fmol kahrp or gbp-130 probe as indicated. Kahrp probe was incubated with 140, 70, 7fmol PfTLP 
as indicated. Gbp-130 probe was incubated with 70, 23, 7fmol of PfTLP as indicated. Free probe is 
indicated by black arrows and protein/DNA complexes are indicated by grey arrows. 
 




Investigating the DNA-binding potential of PfTFIIB 
In the purification of PfTFIIB, the addition of nucleases appeared to abolish the affinity of 
PfTFIIB for DEAE-Sepharose resin, suggesting a PfTFIIB-DNA-DEAE interaction. An 
agarose EMSA was performed with partially purified PfTFIIB protein preparation and the 
Ad2ML probe (Figure 42). As shown in Figure 42, a dose-dependent decrease of free-probe 
with increasing amounts of 6His-PfTFIIB preparation was observed. Unfortunately, no 
clearly defined PfTFIIB gel-shifts could be identified.  This result further corroborates the 
notion that PfTFIIB might possess DNA-binding activity, presumably mediated by its highly 
basic N-terminus.
Figure 42: Binding of partially purified PfTFIIB protein to the Ad2ML promoter in agarose 
EMSA. 
10µl binding reactions contained 10fmol Ad2ML probe, ~23 or 70fmol/µl PfTLP, 50, 100, or 
200fmol/µl PfTFIIB as indicated.  
Free probe is indicated by black arrows and protein/DNA complexes are indicated by grey arrows. 




3.5.4 Summary of the DNA binding potential of PfTLP and PfTFIIB 
The current evidence from both immobilised template assays and EMSAs indicates that 
PfTLP is able to bind to DNA (Figures 39, 40, and 41). The specificity of this binding is not 
known, however, PfTLP appears to possess greater binding affinity for the putative 
Plasmodium promoters than the Ad2ML promoter. PfTLP appears to bind in multiple 
locations on the DNA-probes. This is supported both by the inability of the protein-DNA 
complex to migrate into the native polyacrylamide gels, as well as the appearance of multiple 
gel-shifts in agarose EMSAs. Agarose EMSA supports previous experimental evidence 
which suggests PfTFIIB has DNA-binding activity, most likely mediated by its basic N-
terminal region. The specificity of this binding requires further investigation.   
 
 






 In silico analysis of PfTFIIB and PfTLP 
Putative PfTFIIB has low amino acid sequence homology to that of other eukaryotic TFIIBs 
studied, however, secondary and tertiary predictions show that the molecule has 
conservation of the main structural and functional residues important for TFIIB function. 
These include the presence of many functionally important structures and residues of the N-
terminus, including residues responsible for intermolecular interactions with RNAPII, as 
well as intramolecular interactions. Less conserved are residues associated with DNA and/or 
TBP interactions. The canonical BREd-interaction region on the N-terminal cyclin domain 
is relatively well conserved in PfTFIIB, suggesting similar conservation of the associated 
core promoter elements in the Plasmodium core promoter, but there is very little 
conservation of the BREu-interacting region in the C-terminal cyclin domain. Similarly, 
TBP-interaction sites are more conserved on the N-terminal cyclin domain than in the C-
terminal domain. Whether the corresponding residues in PfTBP have undergone 
complementary changes to retain PfTFIIB binding requires further investigation. An 
interesting feature of the molecule is the presence of highly basic N- and C- terminal regions, 
which are not conserved between the classically studied TFIIBs. These basic regions may 
have DNA-binding potential, not seen in studied eukaryotic TFIIBs. 
Although putative PfTLP has the low amino acid sequence homology to other TBP/TLP 
molecules, it has been shown to contain the main structural regions associated with 
TBP/TLPs molecules. The structure of PfTLP contains large low complexity regions which 
are thought to extend out of the main globular structure of the molecule. Interestingly, while 




many residues implicated in DNA and TFIIB binding are conserved, there is far less 
conservation of the TFIIA interaction sites. These interaction sites lie adjacent to the long 
(~130bp) LCR, suggesting that TLP may have reduced affinity for TFIIA. This stands in 
contrast to PfTBP which has retained conservation of these TFIIA interaction sites. 
However, the identification of two distinct TFIIA γ-subunits expressed in P. falciparum 
(Robert Milton and Thomas Oelgeschläger, unpublished) may indicate that PfTBP and 
PfTLP interact with alternate forms of PfTFIIA.  
 Expression and purification of recombinant PfTFIIB 
The over-expression of recombinant 6His-PfTFIIB was found to be toxic to the E. coli host 
cells. A method of expressing the protein was developed, whereby protein was expressed 
through auto-induction by release of catabolite repression. This method allowed for a large 
quantity of PfTFIIB protein to be expressed for purification. Purification attempts were 
hampered by the apparent DNA-binding activity of the recombinant protein, where 
interactions with DNA reduced the availability of purified protein. Additionally, affinity 
purification with a 6His-tag was not effective in generating sufficiently pure PfTFIIB for 
future assays. Finally, purification of PfTFIIB shows the consistent presence of a doublet of 
protein, and while this may be indicative of the open and closed conformations studied in 
other TFIIB orthologues, the clear heterogeneity of the protein preparation was of concern.  
The inability to purify 6His-PfTFIIB sufficiently has led to current work in the lab to express 
the protein with flanking GST- and 6His-tags.  
 Expression and purification of recombinant PfTLP 
Expression of recombinant PfTLP was found to be extremely toxic to the host E. coli cells, 
leading to cessation of growth in cells induced to express the protein. By codon optimising 
the gene for expression in E. coli, and expressing the gene at low-temperatures, this toxicity 
was alleviated. The cause of the toxicity of the gene is most likely due to the over-utilisation 




of codons rare in E. coli, as well as the A+T richness of the gene. The high pI of the protein 
also led to premature translational termination of the protein, and so the accumulation of 
GST-6His peptides as a significant contaminant in the protein preparation. Expression of the 
double-tagged GST-6His-PfTLP allowed for sequential affinity-purification of the protein. 
However, heterogeneity of the protein led to a significant reduction of recovered purified 
protein, as large quantities of the protein were found to bind irreversibly to agarose-based 
resins. Finally, a preparation of sufficiently purified 6His-PfTLP protein was obtained for 
DNA-binding assays.  
 DNA-binding potential of PfTLP and PfTFIIB 
Immobilised template assays and EMSAs indicate that PfTLP is able to bind to DNA, with 
greater affinity for the putative Plasmodium promoters of the kahrp and gbp-130 genes, as 
compared to the Ad2ML probe. Evidence from polyacrylamide and agarose EMSAs suggest 
that PfTLP binds to multiple locations on the DNA-probe. This is in contrast to findings that 
PfTBP binds to distinct TATA-box like sequences in these same probes (Ruvalcaba-Salazar 
et al. 2006). Other eukaryotic TLPs characterised do not have affinity to the TATA-box 
(Akhtar & Veenstra 2011), and this may be an indication that PfTLP has sequence specificity 
alternate to that of PfTBP.   
Finally, the suggestion that PfTFIIB has binding activity is supported by agarose EMSA, 
although the underlying mechanism, the specificity of this binding, and the functional 
relevance requires further investigation.   
 Overall conclusions and future work 
This research project was undertaken to investigate the similarity and/or divergence of 
PfTFIIB and PfTLP to their well-characterised orthologous in human. To this end, in silico 
analysis of the proteins was performed and has found that the putative Plasmodium 




orthologues share many of the main structural and, potentially, functional features of the 
classically studied molecules.  
Expression of the epitope-tagged molecules was also performed, and the conditions for 
expression of soluble forms of the molecules in E.coli BL21-CodonPlus RIL cells 
established. However, future work into optimising the expression conditions of recombinant 
PfTLP is required, in order to reduce the expression of truncated species, and so increase the 
yield of purified protein.  
The methodology for the affinity purification of the molecules was investigated. It was found 
that the addition of only a single His-tag is insufficient for the purification of recombinantly 
expressed protein, due to very low expression levels and multiple contaminants present after 
metal-ion affinity purification. The addition of a second affinity-purification tag, in this case 
GST, allows for far superior purification, and is recommended in the expression of other 
recombinant putative Plasmodium GTFs.  
The initial investigation into the DNA-binding potential of PfTLP and PfTFIIB has revealed 
that both molecules appear to have affinity for DNA. The specificity of this binding, as well 
as the development of optimal binding conditions will be the focus of future work. 
Additionally, the interplay of various recombinant P. falciparum GTFs will also be 
investigated, in the modulation of both DNA-binding affinity and specificity.  
Future work in the research group will focus on determining the sites of PIC assembly, 
through the mapping of sites bound by PfTBP with PfTFIIA and/or PfTFIIB, as well as 
PfTLP PfTFIIA and/or PfTFIIB, in characterised putative Plasmodium promoters, as well 
as by a SELEX strategy. The work presented in this research project has provided a basis for 
the expression and purification of these factors, as well as provided valuable insights into 
the possible structures and functions of PfTLP and PfTFIIB. 




 Accession numbers of proteins used in bioinformatics analysis 
Table 6: Protein accession numbers used for multiple sequence alignments 
Protein Organism Accession 
Number 
  Additional Notes 
   NCBI PlasmoDB    
TFIIB Plasmodium berghei ANKA  XP_678854.1 PBANKA _020290 Hypothetical 
 Plasmodium chabaudi chabaudi  XP_740955.1 PCHAS_020130 Hypothetical 
 Plasmodium cynomolgi strain B  XP_004220534.1 PCYB_021360 Hypothetical 
 Plasmodium falciparum strain 
3D7 
XP_001351037.1  PF3D7_0110800 Hypothetical 
 Plasmodium knowlesi strain H  XP_002257702.1 PKH_020280 Hypothetical 
 Plasmodium vivax Sal-1  XP_001613527.1 PVX_081260 Hypothetical 
 Plasmodium yoelii yoelii YM ETB60715.1 PYYM_0205800 Hypothetical 
       
 Schizosaccharomyces pombe 
972h- 
NP_594229.1    
 Homo sapiens NP_001505.1    
 Drosophila melanogaster NP_001260349.1     
 Encephalitozoon cuniculi NP_585866.1  Putative 
 Saccharomyces cerevisiae S288c NP_015411.1   Sua7p 
 Arabidopsis thaliana NP_181694.1   TFIIB-1 
 Toxoplasma gondii ME49 XP_002368543.1  Putative 
 Pyrococcus furiosus DSM 3638 NP_579106.1   TFB 
     
TLP/TBP Plasmodium berghei ANKA  XP_680184.1 PBANKA_101590 Putative TLP 
 Plasmodium chabaudi chabaudi  CDU21643.1 PCHAS_101670 Putative TLP 
 Plasmodium cynomolgi strain B  XP_004224372.1 PCYB_132990 Putative TLP 





 Plasmodium knowlesi strain H  XP_002260735.1 PKH_132150 Putative TLP 
 Plasmodium vivax Sal-1  XP_001616687.1 PVX_085105 Putative TLP 
 Plasmodium yoelii yoelii 
17XNL/YM XP_726291.1 PYYM_1017400 
Putative TLP 
 Plasmodium reichenowi CDC CDO66755.1 PRCDC_1428100.1 Putative TLP 
 Toxoplasma gondii ME49 XP_002365082.1  Putative TLP* 
 Homo sapiens NP_004856.1  TLP 
 Xenopus laevis AAH90226.1  TLF 
 Danio rerio NP_991285.1  TLF 
 Caenorhabditis elegans CAB03082.2  TLF-1, isoform a 
     
 Homo sapiens NP_950248.1  TBP2 




 Arabidopsis thaliana P28148.1  TBP2 
     
 Homo sapiens NP_003185.1  TBP 
 Drosophila melanogaster NP_523805.1  TBP 
 Saccharomyces cerevisiae S288c NP_011075.3  TBP 
 Arabidopsis thaliana NP_187953.1  TBP 
 Plasmodium falciparum strain 
3D7 P32086.1 PF3D7_0506200 
TBP 
 Toxoplasma gondii ME49 XP_002368492.1  Putative TBP* 
 Xenopus laevis P27633.1  TBP 
 Danio rerio NP_956390.1  TBP 
 Caenorhabditis elegans P32085.1  TBP 
 









     
 Drosophila melanogaster AAF52600.1  TRF1 
*  - Conflicting descriptions for predicted TgTLP and TgTBP.  
 Plasmodium sequences used for alignment purposes 
PfTFIIB amino acid sequence: 







Sequence Length: 367 aa 
PfTLP amino acid sequence: 








Sequence Length: 368 aa 
Underlined regions are thought to be low-complexity. 




















   
N-terminus 20 - 22 S 
 23 - 27 H 
 36 - 43 H 
   
Ribbon; reader; linker 59 - 62 S 
 68 - 70 S 
 75 - 78 S 
 121 - 122 S 
 127 - 135 H 
   
(Core) BH1 140 - 159 H 
BH2 163 - 178 H 
BH3 187 - 201 H 
BH4 208 - 215 H 
BH5 220 - 233 H 
BH1’ 245 - 255 H 
BH2’ 260 - 275 H 
BH3’ 284 - 297 H 
BH4’ 310 - 316 H 
BH5’ 321 - 338 H 
   
C-terminus 341 - 343 H 
 351 - 365 H 
 
Table 7: Secondary Structure locations predicted for PfTFIIB 
by Phyre  







Table 8: Boundaries and calculated pIs of predicted secondary structures of 
PfTLP 
Region Residues Secondary 
Structure 
pI 
N-terminus 6 to 8 H 11.11 
 12 to 14 H 3.84 
 16 to 21 S 9.71 
 1 - 24  9.98 
    
Structured 1 25 to 37 S 7.56 
 43 - 49 H 6.32 
 57-59 H 6.41 
 62 - 64 S 8.55 
 25 - 66  8.05 
    
LCR 1 67 - 81 H 9.94 
 89 - 105 H 7.36 
 110 - 115 S 6.53 
 127 - 131 S 3.74 
 158 - 159 S 6.09 
 160 -165 H 4.10 
 176 -180 H 9.54 
 67 - 202  9.39 
    
Structured 2 203 - 209  S 6.1 
 212 - 217  S 8.55 
 222 - 238 H 10.51 
 247 -259  S 10.25 
 266 - 272  H 6.09 
 285 - 290 S 9.68 
 203 - 290  10.34 
    
LCR 2 291-327  4.46 
    
Structured 3 328 - 334 S 6.10 
 338 - 342 S 6.10 
 347 - 365 H 9.26 
 328 - 368  9.84 
    
 1 - 368  9.71 
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Vector information for this study 
Table 9: Vectors used for gene cloning and protein expression 
Vectors which were used for protein expression purposes are in bold. Vectors used for 
further vector construction are in italics. Pf stands for P. falciparum. Hs stands for H. 
sapiens.  
# Vector Purification Tag(s) Protease Site(s) Size (bp) 
1 pET11d-6His-HsTBP His Thrombin 7331 
2 pET11d-6His-PfTLP His Thrombin 6810 
3 pET11d-6His-PfTFIIB His Thrombin 6807 
4 pET11d-GST-6His GST; His Thrombin; TEV 6402 
5 pET11d-GST-6His-PfTBP’FL’ GST; His Thrombin; TEV 7362 
6 pET11d-GST-6His-PfTLP GST; His Thrombin; TEV 7485 
7 pET11d-GST-6His-PfTLPco* GST; His Thrombin; TEV 7485 
8 pET11d-GST-6His-
PfTLPco(aa)* 
GST; His Thrombin; TEV 7485 
* - vector 8 and 7 are similar, with an additional two amino acids (T and A) present in 8,
preceding the starting amino acid (M) of the protein sequence in 7, see Table 10 in the
Appendix.
The pET11d-6His-PfTFIIB and pET11d-6His-PfTLP vectors express the target genes fused 
to an N-terminal hexa-histidine (6His) epitope tag for metal-ion affinity purification. A 
thrombin cleavage site is located between the hexa-histidine tag and the target protein which 
allows for the removal of the purification tag through thrombin digestion (Figures 43-45). 
The pET11d-GST-6His-PfTLP and pET11d-GST-6His-PfTLPco vectors express the target 
gene fused to an N-terminal glutathione S-transferase (GST) tag followed by a hexa-histidine 
tag. A thrombin cleavage site is located between the GST and hexa-histidine tags. A tobacco 
etch virus (TEV) protease cleavage site is positioned between the hexa-histidine site and the 
target protein and allows for removal of the purification tag(s) by recombinant TEV protease 
digestion (Figure 47). 







Figure 44: Plasmid map of pET11d-6His-PfTFIIB. 
Figure 43: Plasmid maps of pET11d-6His. 
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Figure 46: Plasmid map of pET11d-GST-6His. 
Figure 45: pET11d-6His-PfTLP. 







  Nickel affinity purification of soluble proteins expressed in E.coli BL21-
codonPlus® (DE3)-RIL E. coli cells not carrying an expression vector 
 
Figure 48: Ni-affinity purification of E. coli 
BL21-codonPlus® (DE3)-RIL E. coli cells not 
carrying an expression vector. Cells were 
grown and induced for protein expression with 
1mM IPTG). Soluble protein was purified with 
nickel-affinity purification and analysed by 
SDS-PAGE. Lanes 1-3 represent the cleared 
lysate input (In, 25/1000 vol.), the protein 
fraction not bound to the Ni-beads (Ub, 
equivalent to In), and the protein fraction eluted 
from the Ni-beads with 2×SDS-loading buffer 
(E, ½ vol. loaded) respectively. A black arrow 
indicates 44kDa. 
Figure 47: pET11d-GST-6His-PfTLP[(co)]. 








Figure 49: Analysis of quantity and purity of 6His-PfTFIIB protein purified. 
BSA standards were loaded in lanes 1-4, 5µg, 2µg, 1µg and 0.5µg respectively. Lanes 5-
8, 10µl, 5µl, 2µl, and 1µl of pooled protein fractions respectively (1.4ml total). Expected 
size for 6His-PfTFIIB is 44kDa, indicated with a black arrow. Molecular weight (Mw) – 
5µl of Precision Plus Protein All Blue standard (Bio-Rad). 
 




 Rare codon analysis of PfTLP ORF 
atg tat CCC cct tgt aaa aag aaa aaa ctt aat aat aac gag gta aca 
aat att ttt tta aaa aat gaa aat aac atg agt gtt cat aat att tcc 
atg aat gct gtt tta tgt tcc tca tta aac CTA gat aat att tat aaa 
tat ttt tca aat tgt ATA tat aac cct aga gaa ttt aaa tgt 
atg aga att gat gtc CCC gtc act tta agt aca gta caa aaa tat ATA 
aaa tat ttg aat aat aaa aag gaa aaa caa aat gat gat ATA tgt aaa 
atg aaa aat gaa caa gtc aat caa aca aaa cat tct aat aat aat att 
aaa gaa gag att aaa acc aat gga agt aat aaa tta agt gat aat 
aaa CTA tta gat agt agt aac aat tca tcg agt aat aaa ATA tta aca 
aat aat aaa tca cat gaa aat CTA ATA aat ATA tct aaa aat aat tca 
tat tta gat gat aat gta aat aag aat aat ttt ttt ATA aat gat aat 
aat agt gat aat aaa aag ATA gat act tct gat att aaa aac atg gat 
cct ttt att gaa tct gaa cat ATA ATA aat aaa aaa tta att att aat 
gtt tcc att ttt tca aat gga aaa att ATA tgt aca ggt aat aac 
tca ATA gaa gct tgt aaa att gct atg aaa aaa att gaa aag aaa tta 
aaa caa tta aat ttt aaa aat att aaa tta aaa aaa ATA act att aca 
aat att ttg gct gta tat aat gtg gga ttt tct ATA gtc ttg 
ccg CTA ttt gct caa tat tat aaa agt gtg gat tat gat cca aat gta 
ttt cca gcg tgc aaa gta aaa att gct ctt atg aat gat gag aat aag 
tct aat gac aat aag gag cag aat gat aat aat ttt gct tgg tgt aat 
gct aaa aac aca ATA gac aag gat aaa agc aaa gtg gac att gtt tct 
gct agt att ttt tca aca ggt aat ATA aca tta act ggg ggg aaa agt 
tac gaa aac ctt caa aaa tgt ATA aat ATA tta tta cca tat tta att 
aaa agt aaa tcg caa cat taa tag   
Red = rare Arg codons AGG, AGA, CGA - 2 
Green = rare Leu codon CTA    - 4 
Blue = rare Ile codon ATA   - 18 
Orange = rare Pro codon CCC   - 2 
Total number of rare codons:   - 26 
Rare codons derived from (Zhang et al. 1991) 
 DNA alignment of the optimized regions (red) of the PfTLP gene  
Optimized 1    
ATGTATCCGCCGTGTAAAAAGAAGAAACTGAACAATAATGAAGTGACCAACATCTTCCTG 
Original  1     
ATGTATCCCCCTTGTAAAAAGAAAAAACTTAATAATAACGAGGTAACAAATATTTTTTTA 
Optimized 61   
AAAAATGAAAACAATATGAGCGTCCATAATATTTCAATGAACGCAGTTCTGTGCAGCTCT 
Original  61    
AAAAATGAAAATAACATGAGTGTTCATAATATTTCCATGAATGCTGTTTTATGTTCCTCA 
Optimized 121  
CTGAATCTGGATAACATCTACAAATACTTCTCGAACTGCATCTACAACCCGCGTGAATTC 
Original  121   
TTAAACCTAGATAATATTTATAAATATTTTTCAAATTGTATATATAACCCTAGAGAATTT 
Optimized 181  
AAATGTATGCGCATTGATGTGCCGGTTACCCTGAGTACGGTGCAGAAATACATCAAATAC 
Original  181   
AAATGTATGAGAATTGATGTCCCCGTCACTTTAAGTACAGTACAAAAATATATAAAATAT 
Optimized 241  
CTGAACAACAAAAAAGAAAAACAAAACGATGACATTTGTAAAATGAAAAATGAACAGGTT 
Original  241   
TTGAATAATAAAAAGGAAAAACAAAATGATGATATATGTAAAATGAAAAATGAACAAGTC 




Optimized 301  
AACCAAACCAAACATAGCAACAACAACATCAAAGAAGAAATCAAAACGAACGGCTCGAAC 
Original  301   
AATCAAACAAAACATTCTAATAATAATATTAAAGAAGAGATTAAAACCAATGGAAGTAAT 
Optimized 361  
AAACTGAGCGATAACAAACTGCTGGACAGTTCCAATAACTCATCGAGCAATAAAATTCTG 
Original  361   
AAATTAAGTGATAATAAACTATTAGATAGTAGTAACAATTCATCGAGTAATAAAATATTA  
Optimized 421  
ACCAATAACAAATCCCACGAAAACCTGATCAACATCTCTAAAAACAACAGTTACCTGGAT 
Original  421   
ACAAATAATAAATCACATGAAAATCTAATAAATATATCTAAAAATAATTCATATTTAGAT 
Optimized 481  
GACAATGTCAACAAAAACAACTTTTTCATCAACGATAACAACTCCGACAACAAGAAAATT 
Original  481   
GATAATGTAAATAAGAATAATTTTTTTATAAATGATAATAATAGTGATAATAAAAAGATA 
Optimized 541  
GATACCTCAGACATCAAAAACATGGACCCGTTTATTGAAAGCGAACATATCATCAACAAA 
Original  541   
GATACTTCTGATATTAAAAACATGGATCCTTTTATTGAATCTGAACATATAATAAATAAA 
Optimized 601  
AAACTGATCATCAACGTGTCCATCTTCTCAAATGGCAAAATTATCTGCACCGGTAATAAC 
Original  601   
AAATTAATTATTAATGTTTCCATTTTTTCAAATGGAAAAATTATATGTACAGGTAATAAC 
Optimized 661  
TCTATTGAAGCGTGTAAAATCGCCATGAAGAAAATTGAGAAAAAACTGAAACAGCTGAAC 
Original  661   
TCAATAGAAGCTTGTAAAATTGCTATGAAAAAAATTGAAAAGAAATTAAAACAATTAAAT 
Optimized 721  
TTCAAAAACATCAAACTGAAGAAAATTACCATCACGAACATTCTGGCAGTCTATAATGTG 
Original  721   
TTTAAAAATATTAAATTAAAAAAAATAACTATTACAAATATTTTGGCTGTATATAATGTG 
Optimized 781  
GGCTTTAGTATCGTGCTGCCGCTGTTCGCTCAATATTACAAATCCGTGGATTACGACCCG 
Original  781   
GGATTTTCTATAGTCTTGCCGCTATTTGCTCAATATTATAAAAGTGTGGATTATGATCCA 
 
Optimized 841  
AACGTTTTCCCGGCGTGCAAAGTCAAAATTGCCCTGATGAACGATGAAAACAAATCTAAC 
Original  841   
AATGTATTTCCAGCGTGCAAAGTAAAAATTGCTCTTATGAATGATGAGAATAAGTCTAAT 
Optimized 901  
GACAACAAAGAACAGAACGATAACAACTTCGCATGGTGTAACGCTAAAAACACCATCGAT 
Original  901   
GACAATAAGGAGCAGAATGATAATAATTTTGCTTGGTGTAATGCTAAAAACACAATAGAC 
Optimized 961  
AAAGACAAATCGAAAGTTGATATCGTCTCTGCCAGTATTTTCAGCACGGGTAACATCACC 
Original  961   
AAGGATAAAAGCAAAGTGGACATTGTTTCTGCTAGTATTTTTTCAACAGGTAATATAACA 
Optimized 1021  
CTGACGGGCGGTAAATCTTATGAAAATCTGCAAAAATGTATTAACATCCTGCTGCCGTAC 
Original  1021  
TTAACTGGGGGGAAAAGTTACGAAAACCTTCAAAAATGTATAAATATATTATTACCATAT 
Optimized 1081  CTGATTAAAAGTAAAAGCCAACACTGATAA 





Analysis of additional codons in pET11d-GST-6His-PfTLPco(aa) 
Molecule Sequence 
Wild type cDNA 5’-…cat atg tat ccg ccg…–3’ 
Mutated cDNA 5’-…cat aCA GCC Atg tat ccg ccg…-3’ 
Wild type AA N-… H M Y P P …-C 
Mutated AA N-… H T A M Y …-C 
Table 10: Mutated sequence in pET11d-GST-6His-PfTLPco(aa) 
Underlined – PfTLP ORF 
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